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ABSTRACT
Alexithymia has been defined as a personality construct that involves difficulties identifying
and describing feelings, as well as an externally oriented thinking style and impoverished
fantasy life, which places individuals at risk for various psychopathologies. For psychiatric
populations, it represents an obstacle to therapeutic success. Despite extensive research, there
is no consensus on the prevalence rate of alexithymia in the general psychiatric population
and no data on alexithymia prevalence in the Australian general psychiatric population. In
addition, there is inconsistency in the literature regarding the role of alexithymia in
therapeutic intervention and a lack of robust studies involving control or comparative
therapeutic conditions.

Two systematic literature reviews were conducted to evaluate the prevalence rate of
alexithymia in the psychiatric and community populations and the role of alexithymia in the
therapeutic process, respectively. The first review, comprising 124 studies, revealed that
prevalence rates of alexithymia, although extremely varied, were much higher in psychiatric
samples compared to community samples. While different psychiatric diagnoses were likely
to have contributed to the variation in rates of alexithymia across psychiatric samples, it was
unclear whether other sample characteristics may have contributed. The second review,
involving 31 studies, identified a balance between studies that found a negative influence of
alexithymia on some therapeutic outcomes and studies that found no influence of alexithymia
on therapeutic outcomes. In addition, numerous types of therapeutic intervention reduced
alexithymic features on average. All of the reviewed studies found a consistent degree of
change between individual’s alexithymia scores from before to after treatment (relative
stability).
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Study 1 examined differences in alexithymia between 166 general psychiatric outpatients and
216 community participants from Australia. Alexithymia was measured with the 20-item
Toronto Alexithymia Scale. Analysis of variance indicated that the psychiatric sample,
independent of demographic factors, had higher alexithymia scores than the community
sample. Chi-Square analysis showed a greater proportion of alexithymic participants in the
psychiatric sample compared to the community sample. The strength of the associations
between alexithymia and psychological distress (measured with the Depression Anxiety
Stress Scale) were found to be similar for both sample groups.

Study 2 examined the role of alexithymia in the therapeutic process in a subset (n = 61) of the
original psychiatric sample who were subject to one of two treatment conditions: emotion
focused group therapy or cognitive-behavioural focused group therapy. Higher alexithymia
scores before treatment were associated with less change in psychological distress severity
during treatment. This association was not significant in either treatment condition when
examined separately. Analysis of variance showed that mean-level change in alexithymia
from before to after treatment was not dependent on treatment condition. Correlation and
hierarchical regression analyses showed a high degree of relative stability in alexithymia
despite moderate change in psychological distress severity. Regression analysis showed that
change in alexithymia could not be directly accounted for by change in psychological
distress. Regression analysis also showed that less change in alexithymia severity during
treatment significantly predicted higher psychological distress scores after treatment, even
after controlling for group therapy type and psychological distress severity before treatment.

The theoretical, research, and clinical implications of these research findings are discussed.
The importance of identifying alexithymic patients prior to conducting therapeutic
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intervention was emphasised, as was the need to provide those patients, who were
alexithymic after treatment, with further psychiatric care.
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CHAPTER 1
INTRODUCTION
More than 25% of all people will develop a psychiatric disorder at some point in their
lives (World Health Organization, 2001). Individuals diagnosed with a psychiatric disorder
have high rates of socioeconomic disadvantage (e.g., unemployment, poor housing, less
social support, and less access to health services), morbidity (physical and mental disability
and non-fatal health outcomes) and premature mortality (AIHW et al., 2007). In fact, mental
illness was the third leading contributor to total burden of disease and the leading cause of the
disability burden in Australia in 2003 (AIHW et al.). The global burden of mental illness is
likely to increase rapidly in the future (Murray & Lopez, 1996). For these reasons, there is a
growing body of research investigating the prevention and treatment of psychopathology, as
well as potential risk factors for developing psychiatric disorders.
Alexithymia is considered an important risk factor in the development, maintenance,
and recovery from a broad range of psychiatric disorders, symptom presentations, and
maladaptive behaviours (Taylor, Bagby, & Parker, 1997). Alexithymia is a personality trait
that reflects a comprehensive deficit in the cognitive processing of emotions, that is the way
in which individuals experience and express emotion (Sifneos, 1994; Taylor et al., 1997).
Although alexithymia represents a trait that is normally distributed in the general population
(Mattila et al., 2010), rates of alexithymia are typically far greater in psychiatric populations
than in general populations. A number of studies have noted greater rates of alexithymia
amongst psychiatric patients, including those diagnosed with depression (Son et al., 2012),
anxiety and trauma related disorders (Frewen, Lanius, et al., 2008), somatoform disorders
(Müller & Bühner, 2006), eating disorders (Beales & Dolton, 2000), and substance misuse
(Evren, Cagil, et al., 2012).
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Alexithymia may pose a particular problem for psychiatric patients by contributing to
the chronicity of their disorder and interfering with their recovery. Alexithymia has been
associated with persistent high levels of psychological distress following treatment (Grabe et
al., 2008; Leweke, Bausch, Leichsenring, Walter, & Stingl, 2009; Ogrodniczuk, Piper, &
Joyce, 2004). Further, alexithymia has been associated with higher levels of psychiatric
symptomatology over extended periods of time (Bach & Bach, 1995; Speranza, Loas,
Wallier, & Corcos, 2007). Understandably, there is growing interest into the extent to which
alexithymia can be mitigated and the most effective treatments to achieve this.
Numerous studies have explored the extent to which alexithymia levels change over
time (alexithymia stability) as a result of therapeutic treatment for psychiatric disorders.
Conclusions from prospective studies as to whether alexithymia is stable or not largely
depend on the types of analyses conducted. The most common analyses conducted in
alexithymia studies assess mean-level stability (average alexithymia score in the overall
sample is consistent over time) and relative stability (differences between individual’s
alexithymia scores are consistent over time). Some studies have found mean-level stability in
alexithymia following treatment with multimodal cognitive-behavioural therapy (Rufer et al.,
2004) and pharmacotherapy (Schmidt, Jiwany, & Treasure, 1993; Todarello, Porcelli,
Grilletti, & Bellomo, 2005). However, many more studies have shown significant reductions
in alexithymia following multimodal psychotherapy (Honkalampi, Hintikka, Laukkanen,
Lehtonen, & Viinamäki, 2001), emotion regulation training (Clyne & Blampied, 2004), and
cognitive-behavioural therapy (Spek, Nyklίček, Cuijpers, & Pop, 2008).
The present thesis progressed in four stages: two systematic literature reviews and two
empirical studies. The first literature review is presented in Chapter 2. This literature review
evaluated the occurrence of alexithymia in psychiatric and community samples, prevalence
rates of alexithymia according to psychiatric diagnosis (e.g., mood disorders and somatoform
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disorders) and psychiatric setting (inpatient and outpatient settings), and the influence of
demographic factors of the study sample (e.g., gender) on alexithymia scores.
The second literature review is presented in Chapter 3. This literature review
evaluated the influence of alexithymia on therapeutic outcome in psychiatric samples. The
stability of alexithymia following different therapeutic interventions was also evaluated in
this review.
The two empirical studies conducted in the present research sought to address some of
the gaps and limitations that were highlighted in the literature reviews. Study 1 (Chapter 4)
established the prevalence of alexithymia in an Australian psychiatric outpatient sample and
then compared this rate to an Australian general community sample. To the researcher’s
knowledge, this is the first study to examine alexithymia rates in an Australian general
psychiatric sample. Given some conflicting findings reported on in the literature review
(Chapter 2) regarding the potential influence of demographic factors on alexithymia, Study 1
considered whether alexithymia poses a greater risk for particular groups of people by
examining the impact of participants’ gender, education level, and employment status on
alexithymia scores. The relationship between alexithymia and psychological distress for both
sample groups was also considered in this study in order to explore the role of alexithymia as
a predisposing factor to the development and/or maintenance of psychopathology.
Study 2 (Chapter 5) examined the role of alexithymia in the maintenance of
psychiatric symptomatology after group intervention. As very few studies in this area have
compared different therapeutic approaches, this study investigated the influence of
alexithymia on psychological distress levels in a sample of psychiatric outpatients after they
had completed one of two therapeutic groups. In addition, this study examined the
effectiveness of these therapy groups in reducing alexithymia over time.
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The final chapter (Chapter 6) of this thesis provided a general discussion of the
combined research findings from each chapter. This discussion included a general overview
of what has been covered in the present thesis and a synthesis of the main findings from each
chapter. This chapter also highlighted the strengths and limitations of the present research,
provided theoretical and practical implications of the findings, and offered recommendations
for future research.
The stress-diathesis model was applied as a theoretical framework to guide the design
and interpretation of the present research. The stress-diathesis model is a widely accepted
model of causation used to explain the interaction of multiple factors in the development and
maintenance of psychopathology (Zuckerman, 1999). In simple terms, this model suggests
that psychopathology is a result of environmental stressors (stress) in individuals who have a
vulnerability or predisposition (diathesis) to a given psychiatric disorder. Stress and a
combination of predisposing factors exceed a threshold through which the individual will
develop a psychiatric disorder. Factors that predispose an individual to develop a psychiatric
disorder may be inherited (genetic), biological stressors during the prenatal to postnatal
periods (e.g., damage to the neurological system), and/or psychological (e.g., early learning
experiences that influence cognitive and emotional aspects of personality). Psychological
predisposing factors are generally considered relatively stable but not necessarily permanent.
In the stress-diathesis model, alexithymia is considered a stable personality trait, or
psychological predisposing factor, that interacts with stressors to increase general
susceptibility to psychopathology.
The remainder of the present chapter has been written as an introduction to the
alexithymia construct. This section provides a brief history of alexithymia as well as how it
was conceptualised and is currently described, a discussion of various measures that have
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been designed to assess and validate alexithymia, and an outline of the prominent aetiological
theories that have been proposed to explain the origins of alexithymia.
History of Alexithymia
Freud was interested in the origin and treatment of patients with hysteria who
experienced a pattern of physical symptoms, such as blindness and paralysis, that had no
definable organic cause (also known as psychoneurotic disorders) (Breuer & Freud, 1895).
He theorised that many of the physical symptoms experienced by hysterical patients could be
connected to distressing childhood experiences that could not be recalled by the patient.
Freud attributed the manifestation of somatic symptoms to an attempt by the unconscious
mind to protect the patient from psychological distress. That is, whereby the somatic
symptoms function to relieve this distress directly (by redirecting attention toward the
presenting symptoms) or indirectly (e.g., avoiding work or responsibility).
Freud’s psychogenic explanation of somatic symptoms was central to the
development of psychoanalysis and the conceptualisation of psychosomatic disease (Taylor,
Bagby, & Parker, 1991). For instance, several psychoanalysts (e.g., Alexander, 1950)
advanced the idea that unconscious psychological conflicts and the distress associated with
them might play a role in the development, presentation, and maintenance of a definable
physical illness. However, psychoanalytic therapy as a treatment for psychosomatic disorders
(e.g., ulcerative colitis or essential hypertension) did not prove to be as effective as
anticipated (Eysenck, 1952; Lipowski, 1968). Many patients benefited more from supportive
psychotherapy and/or behavioural interventions (Kellner, 1975; Sifneos, 1983) than
psychoanalytic therapy, and other patients reported aggravated psychosomatic symptoms in
response to psychoanalysts’ attempts to identify and interpret unconscious psychological
conflicts (Sifneos, 1975). These limitations led several researchers to reject Freud’s
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conceptualisation and treatment of psychosomatic disorders (e.g., Macalpine, 1952;
MacLean, 1949; Ruesch, 1948).
Alternative hypotheses about somatic symptoms emerged after World War Two.
These approaches emphasised the role of affective disturbance rather than unconscious
psychological conflict in the development of psychosomatic disorders. For instance, Ruesch
(1948) and MacLean (1949) noticed that many patients with psychosomatic disorders showed
difficulties verbalising their emotions. Ruesch described these patients as having an infantile
personality, who lacked the symbolic and verbal skills necessary for the self-expression of
emotion. He also observed that these patients did not discharge tension by means of action or
through verbal, gestural or creative symbolism like mature adults. Moreover, psychoanalysts
Marty and de M'Uzan (1963) recognised a pattern of thinking in psychosomatic patients that
was devoid of fantasy, symbolism, imagination and personal elements. They referred to this
deficient form of thinking as pensee operatoire (operational thinking).
It was the investigations of Nemiah and Sifneos (1970) that resulted in the formal
classification of the alexithymia construct. These clinicians began systematic investigations
into the cognitive and affective characteristics of patients with psychosomatic disorders. The
results of their investigations indicated that, unlike psychoneurotic patients, many
psychosomatic patients had noticeable difficulty describing subjective feelings and
elaborating fantasies, and a style of thinking that was similar to operational thinking (Marty
& de M'Uzan, 1963). Sifneos (1973) proposed the term alexithymia (from the Greek: a =
lack, lexis = word, thymos = emotion) to categorise the set of characteristics he had observed
in patients with psychosomatic disorders.
The introduction of the alexithymia construct promoted great interest in the subject
and was chosen to be one of the main themes of the 11th European Conference on
Psychosomatic Research ( r utigam & Rad, 1977), alongside psychosomatic disease and
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operational thinking. Several key outcomes emerged from this conference, including a
distinction between psychoneurotic and psychosomatic disorders, further clarification of a
definition of alexithymia, a need to integrate different fields of research that would facilitate a
holistic approach to investigating alexithymia, and the need for more extensive and detailed
investigations into the treatment of alexithymia.
Describing Alexithymia
Before presenting a description of the alexithymia construct it is important to take into
consideration that alexithymia is not an independent psychiatric diagnosis that is included in
any diagnostic manual of mental disorders (Swiller, 1988). Rather, the term alexithymia
describes a number of related psychological disturbances. Taxometric analyses have
indicated that alexithymia is best conceptualised as a dimensional rather than a categorical
construct (Mattila et al., 2010; Parker, Keefer, Taylor, & Bagby, 2008). That is, alexithymia
is viewed as a characteristic that is normally distributed in the general population. While
alexithymia may be a dimensional construct, research often requires the identification of high
(alexithymic) or low (non-alexithymic) alexithymic participants. Throughout this thesis, and
the literature cited herein, the terms alexithymia and alexithymic are used to identify
individuals with more severe or problematic levels of alexithymia.
Alexithymia is currently defined by a set of four characteristics: 1) difficulties
identifying feelings and distinguishing feelings from bodily sensations of emotional arousal;
2) difficulties describing and communicating feelings to others; 3) constricted imaginal
processes, as indicated by a relative deficiency of affect-related fantasies; and 4) a style of
thinking characterised by a fixation on external stimuli. Although these characteristics are
conceptually different, it has been suggested that they are logically interrelated and
commonly manifest together (Taylor et al., 1997). For example, the ability to describe
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feelings to others is dependent on the ability to identify and distinguish feelings (Bagby,
Parker, & Taylor, 1994).
Alexithymic individuals have a greater tendency to experience negative emotions like
anger, anxiety, depression, and feelings of shame and embarrassment, as well as a reduced
capacity to experience positive emotions, such as happiness and affection (Bagby, Taylor, &
Parker, 1994; Krystal, 1988). However, while these individuals may report episodes of
emotional disturbance, they have difficulty identifying them as feelings and differentiating
them from physiological responses to emotional arousal (e.g., increased heart rate, sweating,
or dry mouth). For example, the experience of anxiety and hunger may be confused. The
limited capacity of alexithymic individuals to identify and differentiate negative emotion,
together with difficulties expressing these emotions in a sufficient or healthy way, leads them
to intensify and misinterpret ordinary bodily sensations associated with emotional arousal as
physical disease (Lane & Schwartz, 1987; Taylor et al., 1997). Consequently, individuals
who present to doctors with persistent complaints about bodily symptoms may be incorrectly
treated or diagnosed with a somatoform disorder (Taylor et al., 1997).
In addition to difficulties identifying and differentiating feelings, individuals with
alexithymia have difficulty describing and communicating their feelings to others, both
verbally and nonverbally. They often describe their feelings as vague tension states of which
they cannot interpret or elaborate any further (Taylor et al., 1997). Their communication style
is characterised as flat and monotone, with an absence of nuance, metaphor, or the use of
emotional language (Meganck, Vanheule, Inslegers, & Desmet, 2009; Taylor, 1984). These
features generate conversation that has been described by therapists as dull, lifeless, and
boring (Nemiah & Sifneos, 1970; Taylor, 1977). Furthermore, difficulties communicating
feelings nonverbally can produce a stiff wooden posture and limited facial expressions in the
individual (Taylor et al., 1997).
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Since emotions are not adequately communicated, it is difficult for individuals with
alexithymia to elicit support and comfort from others. Difficulty recognising emotions that
are being experienced by another person also limits their empathy and support for others
(Grynberg, Luminet, Corneille, Grèzes, & Berthoz, 2010; McNeill, 2014). Alexithymic
individuals may appear cold, detached, and socially avoidant (Vanheule, Desmet, Meganck,
& Bogaerts, 2007). This characteristic may limit their chances of developing a strong
working relationship with a therapist, forming intimate relationships (Humphreys, Wood, &
Parker, 2009), and from using social interactions in everyday life as a way of regulating and
coping with negative affect (C. Spitzer, Siebel-Jürges, Barnow, Grabe, & Freyberger, 2005).
Another feature of alexithymic individuals is a reduction or absence of fantasies,
imagination, or other phenomena related to their inner, private mental life of attitudes,
feelings, desires, and drives (Taylor et al., 1997). They lack the ability to self-reflect or
examine their conscious thoughts and feelings (introspection, Taylor et al., 1997) and to form
new images and sensations that are not perceived through their senses (imaginative ability,
Campos, Chiva, & Moreau, 2000), including daydreaming and dream recollection.
The externally-oriented cognitive style of alexithymic individuals is, to some extent,
reflected by their impoverished inner fantasy life (Bagby, Parker, et al., 1994; Marty & de
M'Uzan, 1963). The reduced fantasy and imaginal activity in alexithymic individuals are
replaced by a primary focus on external stimuli in their immediate environment, such as
physical sensations. Conversations often involve repetitive recitation of concrete facts in
excessive detail (Krystal, 1988). This monotonous style of communication in alexithymic
patients, as well as their inability to interact emotionally and to link physical symptoms to
feelings, may generate boredom and frustration in their therapist, which may ultimately affect
the outcome of psychotherapy (Ogrodniczuk, Piper, & Joyce, 2005).
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In addition to determining a definition of alexithymia, researchers have examined
various aspects of emotion processing in order to substantiate clinical observations of
individuals with alexithymia. Three interrelated sets of processes broadly define emotion:
physiological processes (e.g., activation of the autonomic nervous system), behavioural
processes (e.g., facial expression and tone of voice), and cognitive-experiential processes
(subjective awareness and verbal reporting of feelings) (Gross, 2013; Mauss, Levenson,
McCarter, Wilhelm, & Gross, 2005). The fundamental assumption underlying the
alexithymia construct is that features of alexithymia reflect a deficit in the cognitiveexperiential or cognitive processing of emotion (Taylor et al., 1997). Since these processes
are interrelated, a deficit in the cognitive processing of emotion disrupts emotional processing
on a physiological level as well as on a behavioural level.
Several studies have examined differences in autonomic activity between alexithymic
and non-alexithymic individuals, both at rest and in response to stressors or emotion-eliciting
slides. Findings across the literature are inconsistent. A number of studies have found that,
compared to non-alexithymics, individuals with alexithymia exhibit higher resting heart rate
(Fukunishi, Sei, Morita, & Rahe, 1999; Wehmer, Brejnak, Lumley, & Stettner, 1995) and
electrodermal activity (Friedlander, Lumley, Farchione, & Doyal, 1997; Stone & Nielson,
2001), as well as greater physiological reactivity during emotion provoking situations
(Waldstein, Kauhanen, Neumann, & Katzel, 2002). In contrast, some studies have found that
alexithymic individuals exhibit lower physiological reactivity when viewing emotioneliciting slides compared to non-alexithymic individuals, evidenced by fewer skin
conductance responses (Pollatos, Schubo, Herbert, Matthias, & Schandry, 2008) and heart
rate decelerations (Franz, Schaefer, & Schneider, 2003; Wehmer et al., 1995). Furthermore,
other studies have not found any differences at baseline between alexithymic and nonalexithymic individuals in heart rate or electrodermal activity (Franz et al., 2003; Neumann,

10

Sollers, Thayer, & Waldstein, 2004; Roedema & Simons, 1999) or in blood pressure during
stressful tasks (Fukunishi et al., 1999; Newton & Contrada, 1994). Inconsistent findings
across the literature regarding autonomic activity associated with alexithymia may reflect a
number of differences in methodologies and indicators of autonomic activity, measures used
to identify alexithymia, and tasks used to elicit emotion and induce stress (Freund, 2012).
Evidence that is more consistent has been found for differences in brain activity
between alexithymic and non-alexithymic individuals. Individuals with alexithymia display
lower brain activity in response to emotional stimuli compared to non-alexithymics when
studied using positron emission tomography (Kano et al., 2003; Karlsson, Näätänen, &
Stenman, 2008). In particular, individuals with alexithymia have been found to exhibit low
levels of brain activity in regions associated with empathic ability and perspective-taking
ability (Moriguchi et al., 2007; Moriguchi et al., 2006). Difficulties with empathy and
perspective-taking result in problems differentiating between emotional states of the self and
others and may lead to the contagion of others distress (Moriguchi et al., 2007; Moriguchi et
al., 2006). Moriguchi et al. (2006) have suggested that poor empathic ability and perspectivetaking partly explain the association between alexithymia and psychological distress, as well
as difficulties reading emotion from facial expressions. A literature review of 24 studies that
have investigated the association between alexithymia and the processing of emotional facial
expressions showed that alexithymia was associated with global impairments in perceiving
emotional facial expressions to such an extent that individuals with alexithymia had
difficulties detecting, matching, and labelling negative, positive, and neutral emotions
(Grynberg et al., 2012).
Studies that have examined brain activation, using functional magnetic resonance
imaging, have shown reduced blood flow and neural activity in the anterior cingulate cortex
(ACC) of alexithymic individuals (Frewen, Pain, Dozois, & Lanius, 2006; Heinzel et al.,
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2010). Abnormal activity in the ACC is viewed as a neurobiological correlate of alexithymia
since it has been linked to cognitive deficits in emotion awareness and appraisal of emotion
(Berthoz et al., 2002; Gündel et al., 2002). In addition to abnormal activity in the ACC,
individuals with alexithymia have shown greater activation in sensory and motor cortices of
their brains during emotion-provoking situations compared to non-alexithymic individuals
(Karlsson et al., 2008; Moriguchi et al., 2009). It has been suggested that the combination of
diminished emotion awareness and intensified bodily awareness may explain the external
focus or heightened awareness of physical sensations seen in those with alexithymia
(Karlsson et al., 2008).
Researchers that have examined the functioning of brain hemispheres have observed
lower activation of the right hemisphere in alexithymic individuals compared to nonalexithymic individuals (Hatin, 2011; Jessimer & Markham, 1997; Tabibnia & Zaidel, 2005).
The right hemisphere of the brain is thought to be primarily involved with emotion
processing; an idea known as the right hemisphere hypothesis (e.g., Smith & BulmanFleming, 2005). It has been suggested that right hemisphere dysfunction is responsible for
poor emotion recognition and relative dominance of the left hemisphere, which may lead to
the externally oriented style of thinking seen in individuals with alexithymia (Aftanas &
Varlamov, 2007). However, evidence for the right hemisphere hypothesis has been
conflicting. In particular, many studies have shown that individuals with alexithymia display
low activation of both the left and right hemispheres (Grabe et al., 2004; Parker, Keightley,
Smith, & Taylor, 1999; Richter et al., 2006; Romei et al., 2008; Tabibnia & Zaidel, 2005).
Some researchers have proposed that low activation of both brain hemispheres is linked to
deficits in the ability to verbally articulate (left hemispheric function) emotions (right
hemisphere function) in individuals with alexithymia (Berenbaum & Prince, 1994; Hariri,
Bookheimer, & Mazziotta, 2000).
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By examining different aspects of emotional processing in alexithymic individuals,
researchers have provided evidence to support the idea that features of alexithymia reflect a
deficit in the cognitive processing of emotion (Taylor & Bagby, 2004). While research into
autonomic activity associated with alexithymia remains contentious, previous studies have
found that alexithymic individuals show low brain activation in response to emotional stimuli
(Kano et al., 2003) as well as comprehensive difficulties in the processing of emotional facial
expressions (Lee et al., 2011). Studies finding reduced blood flow and neural activity of the
ACC in alexithymic individuals (Frewen et al., 2006; Heinzel et al., 2010) have provided
insight into the cognitive deficits in emotion awareness and appraisal of emotion present in
these individuals. Findings of greater activation of sensory and motor cortices of the brain in
response to emotional stimuli have helped to explain the externally-oriented focus or
heightened somatic awareness in individuals with alexithymia (Karlsson et al., 2008). In
addition, findings of low brain activation of the right (e.g., Aftanas & Varlamov, 2007) and
left and right hemispheres (e.g., Berenbaum & Prince, 1994) have substantiated clinical
observations of difficulties in emotion recognition and verbal expression of emotion in
alexithymic individuals, respectively.
The advancement of cognitive and physiological research on emotional processing in
individuals with alexithymia could not have been achieved if not for previous research efforts
to develop a uniform, valid, and reliable psychometric tool for measuring alexithymia. What
follows is an evaluation of some of the most common measures of alexithymia.
Measurement of Alexithymia
Following the 11th European Conference on Psychosomatic Research ( r utigam &
Rad, 1977) several measures for assessing alexithymia were developed. However, many of
these measures lacked empirical support. The Schalling-Sifneos Personality Scales (Apfel &
Sifneos, 1979) and the Minnesota Multiphasic Personality Inventory alexithymia Scale
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(Kleiger & Kinsman, 1980) for example, were found to show little evidence of scientific
rigour in their construction, lacked validity and reliability as a result, and were eventually
abandoned (Taylor, Bagby, & Luminet, 2000).
Two main approaches for assessing alexithymia have been proposed, which most
commonly include observer-rated measures and self-report measures. Observer-rated
measures, such as the Beth Israel Hospital Psychosomatic Questionnaire (BIQ; Sifneos,
1973), the Observer Alexithymia Scale (OAS; Haviland, Warren, & Riggs, 2000), and the
Toronto Structured Interview for Alexithymia (TSIA; Bagby, Taylor, Parker, & Dickens,
2006) are based on questionnaires that are completed by a clinician after interviewing the
participant or by someone (such as a family member) who is familiar with the participant.
Self-report measures, such as the Bermond-Vorst Alexithymia Questionnaire (BVAQ; Vorst
& Bermond, 2001) and the 20-item Toronto Alexithymia Scale (TAS-20; Bagby, Parker, et
al., 1994), are based on questionnaires that participants complete by themselves without
interference from others.
The following description of the psychometric properties and methodologies of a
range of common assessment measures of alexithymia was provided to inform the most
appropriate instrument to measure alexithymia in the present research samples. Only
measures that have been normalised on adult samples were considered as the present research
involved adult samples. This is not a major limitation, since few measures of alexithymia
have specifically targeted children or adolescents; the majority of measures have been
normalised using university student samples, which are comprised of adults.
Beth Israel Hospital Psychosomatic Questionnaire
The original BIQ (Sifneos, 1973) is a 17-item measure developed in the United States
of America (USA) in order to identify differences in alexithymia between patients with
psychosomatic disorders and patients with “neurotic complaints” (e.g., borderline personality,
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depression, hysterical personality, and alcoholism, Sifneos, 1973, p. 257). From the 17
questions, 8 key items were selected (Sifneos, 1973) that best assess alexithymia
characteristics. All items are scored by an interviewer or observer as either present (score 1)
or absent (score 0), whereby the more key items endorsed the higher the presence of
alexithymia. The questionnaire involves a combination of unstructured conversation with the
patient followed by semi-structured probing to determine the patient’s ability to verbalise
feelings and to report fantasies and dreams.
The use of dichotomous questioning has been criticised as being unstable in factor
analysis (Taylor & Bagby, 1988). In addition, although some research has supported the
validity of the BIQ (Gardos, Schniebolk, Mirin, Wolk, & Rosenthal, 1984) less support has
been found for the inter-rater reliability of this measure (e.g., r = .30, Taylor, Doody, &
Newman, 1981), which may be due to the fact that it does not include a set of standardised
interview questions (Lumley, Neely, & Burger, 2007). In addition, as an observer-rated
measure, the reliability of the BIQ may be affected by the observer’s previous experiences,
biases, and/or interviewing style (Taylor & Bagby, 1988). Furthermore, the BIQ has received
criticism for its lack of specificity in measuring the alexithymia construct, as only 8 items out
of the 17 are related and used to obtain an alexithymia score (Taylor et al., 2000).
Based on these criticisms, the BIQ was modified (Bagby, Taylor, et al., 1994) to
enhance reliability: four new items were included, nine items less relevant to alexithymia
were excluded, and the dichotomous questioning methodology was replaced with a 7-point
Likert-type design. The resulting 12-item modified BIQ comprises a two-factor structure: six
items relate to affect awareness (the ability to identify and communicate feelings) and six
items relate to operational thinking (imaginal activity and externally oriented thinking).
Therefore, the modified BIQ assesses both affective and cognitive traits of alexithymia.
Support for the two-factor structure of the BIQ has been shown in clinical samples in the
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USA (Haviland, Warren, Riggs, & Nitch, 2002) and university students and clinical samples
in Japan (Fukunishi, Nakagawa, Nakamura, Kikuchi, & Takubo, 1997).
The findings of several studies support the modified BIQ as a reliable and valid
measure of alexithymia (Bagby, Taylor, et al., 1994; Taylor et al., 2000), with good internal
consistency (α = .85, Haviland et al., 2002) and concurrent validity with the TAS-20
(Lumley, Gustavson, Partridge, & Labouvie-Vief, 2005). However, the modified BIQ is not
widely used amongst clinicians and researchers, possibly due to the demands of training, the
time required for interviewing, and the lack of standardised interview (Lumley et al., 2007).
Recommendations to obtain inter-rater reliability when using the modified BIQ (Taylor et al.,
2000) may have limited its use further.
Observer Alexithymia Scale
The OAS (Haviland et al., 2000) is another observer-rated measure of alexithymia. It
relies on collateral information obtained from a clinician, family member, or friend of the
patient being assessed and is therefore based on the idea that reliable observations of
alexithymia can be made by those close to the patient. The OAS consists of 33 items that
yield a total score of alexithymia as well as five factor scores that correspond to alexithymia
characteristics: Distant, Uninsightful, Somatizing, Humourless, and Rigid.
The psychometric properties of the OAS were originally assessed in university
student samples in the USA. The OAS was shown to demonstrate good internal reliability (α
= .90, Haviland, Warren, Riggs, & Gallacher, 2001) and two week test-retest reliability (r =
.87, Haviland et al., 2000). The five-factor structure of the OAS has been supported in
English and French-speaking university students (Berthoz, Haviland, Riggs, Perdereau, &
Bungener, 2005), Chinese-speaking university students (Yao, Yi, Zhu, & Haviland, 2005),
and a clinical sample (Haviland et al., 2001). However, concurrent validity of the OAS is not
strongly supported, with some studies showing small correlations with the TAS-20 (r ≤ .27,
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Lumley et al., 2005; Meganck, Vanheule, Desmet, & Inslegers, 2010). Furthermore, interrater reliability of four out of five OAS factors has been shown to be insufficient (α ≤ .62,
Meganck et al., 2010).
Toronto Structured Interview for Alexithymia
The TSIA (Bagby et al., 2006) is an interview-based observer-rated measure for
assessing alexithymia. It consists of 24 interview items that yield a total score of alexithymia
that ranges from 0 to 48, with higher scores indicating a greater degree of alexithymia. Each
item is scored along a 3-point Likert scale from zero to two. For some items, the scoring is
based on the frequency of the presence of a characteristic, and for other items, it is based on
the degree of the presence of a characteristic. For example, a score of zero is given if the
characteristic is never or rarely present, or is not a feature of the respondent; a score of one is
given if the characteristic is present some of the time or is a partial feature of the respondent;
and a score of two is given if the characteristic is present most of the time or is a strong
feature of the respondent. For each item, there are standardised prompts and probes designed
to elicit information to assist in the accurate scoring of the item. Administration of the TSIA
takes between 30 and 45 minutes.
The TSIA was developed and initially validated with Canadian psychiatric outpatients
and community participants where it demonstrated adequate item characteristics, acceptable
levels of inter-rater, internal, and test-retest reliability, as well as concurrent validity with the
TAS-20 (Bagby et al., 2006). Factor analysis identified a hierarchical four-factor model with
four lower-order factors nested within two higher-order factors consistent with the theoretical
underpinnings of the construct. This four-factor model consists of 24 items, 6 items for each
of the four lower-order facet scales: difficulty identifying feelings (DIF), difficulty describing
feelings (DDF), externally oriented thinking (EOT), and imaginal processes (IMP). The two
lower-order facet scales DIF and DDF formed a single higher-order domain scale labelled
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Affect Awareness (AA) and the other two lower-order facet scales EOT and IMP formed a
single higher-order domain scale labelled Operative Thinking (OT). Acceptable levels of
internal and inter-rater reliability have been obtained with German, Italian, and Dutch
language translations of the TSIA (Caretti et al., 2011; Grabe et al., 2009; Inslegers et al.,
2013). Confirmatory factor analyses with the German, Italian, and Dutch language versions
also supported the four-factor structure of the TSIA obtained with the original English
version.
Bermond-Vorst Alexithymia Questionnaire
The BVAQ (Vorst & Bermond, 2001) is a 40-item self-report scale designed to
measure alexithymia. Items are scored using 5-point Likert scales. The BVAQ is an extension
of the earlier 20-item Amsterdam Alexithymia Scale (AAS; Bermond, Vorst, Vingerhoets, &
Gerritsen, 1999), both of which have the same five-factor structure: Identifying, Verbalising,
Analysing, Fantasising, and Emotionalising. The goal of extending the AAS to the BVAQ
was to have two paralleled versions (A and B), each consisting of 20 items, and an extended
test (A+B) of 40 items (Vorst & Bermond, 2001). Each factor of the BVAQ comprises eight
balanced indicative and contra-indicative items.
The BVAQ has been translated into several languages. The BVAQ was shown to be a
valid and reliable measure of alexithymia in English, Dutch, and French (Belgian) speaking
university student samples, with good internal reliability between translations (α > .80) and
concurrent validity with the TAS-20 (Vorst & Bermond, 2001). However, confirmatory
factor analyses have provided contradictory findings, with some studies showing support for
the five-factor model of the BVAQ (Müller, Bühner, & Ellgring, 2004) and other studies
showing less support for the five-factor model (Zech, Luminet, Rimé, & Wagner, 1999).
Using data collected from a clinical sample, Müller et al. (2004) found that the five-factor
model of the BVAQ yielded a better global fit than the three-factor model of the TAS-20. On
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the other hand, they found that the smallest item loadings occurred in the factors Analysing
and Emotionalising, which yielded loadings below Chronbach’s alphas of .49. At a
conceptual level, Taylor et al. (2000) have argued that since the concept of Emotionalising
(the degree to which a person is emotionally aroused by emotion-inducing events, Vorst &
Bermond, 2001) was not part of the original definition of alexithymia, this factor should only
be considered a correlate of alexithymia.
Toronto Alexithymia Scale
Probably the most well-known and used self-report measure of alexithymia is the
Toronto Alexithymia Scale (TAS). There have been three revisions of the TAS: the original
TAS-26 scale (Taylor, Ryan, & Bagby, 1985), the revised TAS-R (Taylor, Bagby, & Parker,
1992), and the current TAS-20 (Bagby, Parker, et al., 1994). Factor analysis of the TAS-26,
conducted with Canadian university students, supported a four-factor structure that was
theoretically congruent with the alexithymia construct. The scale was shown to have good
internal reliability (α = .79) and test-retest reliability over five weeks (r = .75). However,
several shortcomings of the scale have been noted, including a high correlation between two
of the factors, low magnitude correlations between the items comprising the daydreaming
factor and the full-scale score, and a lack of congruence between the overall compositional
structure of the scale and features of alexithymia (Taylor et al., 1985).
Through a revision of TAS-26, three items relating to imaginal activity were removed,
which resulted in the 23-item TAS-R. Factor analysis of the TAS-R yielded a two-factor
model: the first factor comprised items assessing the ability to describe feelings to others and
the ability to distinguish between bodily sensations and feelings, and the second factor
comprised items assessing externally-oriented thinking. However, subsequent confirmatory
factor analyses found that the two-factor structure was not a good representation of the data
and so the scale was revised again (Bagby, Parker, et al., 1994).
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The TAS-20 is the most current revision of the scale. In constructing the TAS-20
Bagby, Parker, et al. (1994) extracted a new set of items from the item pool used in the
development of the TAS-R and included 17 newly written items relating to imaginal capacity
and daydreaming. The TAS-20 was cross-validated using a Canadian university student
sample and a psychiatric patient sample. Factor analysis supported a three-factor structure:
Difficulty Identifying Feelings (DIF; seven items); Difficulty Describing Feelings (DDF; five
items); and Externally-Oriented Thinking (EOT; eight items). Items relating to imaginal
capacity from the TAS-26 were removed from the TAS-20 due to high correlations with
measures of social desirability (Parker, Taylor, & Bagby, 2003). Some authors have criticised
the removal of items that reflect the reduced fantasy dimension of alexithymia and argue that
without this dimension, alexithymia is not being measured as was originally conceptualised
(see Sifneos, 1996; Vorst & Bermond, 2001). However, Bagby, Parker, et al. (1994) suggest
that reduced fantasy is measured indirectly because it correlates negatively with the EOT
factor.
Items of the TAS-20 are scored on a 5-point Likert type rating scale, from 1 (strongly
disagree) to 5 (strongly agree). The negatively keyed items are reversed prior to scoring (i.e.,
items 4, 5, 10, 18, and 19). Confirmatory factor analyses have found that the TAS-20’s threefactor structure is the best fitting model (Meganck, Vanheule, & Desmet, 2008; Parker,
Bagby, Taylor, Endler, & Schmitz, 1993; Parker et al., 2003).The TAS-20 has demonstrated
high internal reliability (α = .81), test-retest reliability over three weeks (r = .77, Bagby,
Parker, et al., 1994), construct validity, and concurrent validity with observer-rated measures,
such as the original BIQ (r = .53, Bagby, Parker, et al., 1994) and the Spanish version of the
BIQ (r > .47, Martínez-Sánchez, 1996). The TAS-20 has been shown to be a valid and
reliable measure of alexithymia for use in both psychiatric and community populations
(Meganck et al., 2008; Parker et al., 2003). In addition, the TAS-20 has been translated into
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several languages and has demonstrated cross-cultural validity in several countries (see
Taylor, Bagby, & Parker, 2003).
A total score measuring alexithymia as well as three factor scores can be calculated.
Preliminary cut-off scores for the total TAS-20 were developed. Individuals scoring below 52
are considered non-alexithymic and those scoring above 60 are considered alexithymic
(Taylor et al., 1997). While the applicability of these cut-off scores has not been investigated
in many countries they have been applied in numerous clinical and non-clinical samples
worldwide. The TAS-20 cut-off scores have enabled comparative studies on alexithymia
among diverse samples, including investigations into the prevalence of alexithymia across
various populations.
The main criticism of the TAS-20 has been that the EOT factor has shown low
internal reliability (α = .56, Meganck et al., 2008), far lower than the DIF and DDF factors
(Bressi et al., 1996; Kooiman, Spinhoven, & Trijsburg, 2002; Leising, Grande, & Faber,
2009; Loas et al., 2001; Loiselle & Cossette, 2001; Thorberg et al., 2010). Several studies
have also noted low factor loadings of some items on the EOT factor (Bressi et al., 1996;
Meganck et al., 2008; Müller, Bühner, & Ellgring, 2003; Pandey, Mandal, Taylor, & Parker,
1996). Gignac, Palmer, and Stough (2007) have interpreted the low internal reliability of the
EOT factor as indicating possible problems with the content of the items loading onto that
factor.
Researchers have also suggested that having an imbalance of positively and
negatively worded items between the three factors would result in response tendencies or bias
(Vorst & Bermond, 2001), and that this issue is especially exaggerated in the EOT factor
because four out of the five items are negatively phrased (Meganck et al., 2008). Revision of
the EOT factor and the use of negatively worded items has been suggested (Besharat, 2008;
Gignac et al., 2007; Meganck et al., 2008). Furthermore, Gignac et al. (2007) have
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recommended that future researchers who observe low internal reliability of the EOT factor
interpret the total TAS-20 score as a general measure of alexithymia rather than interpret the
separate TAS-20 factor scores as specific measures of alexithymia characteristics. While
limiting a more detailed assessment of alexithymia, interpreting the total TAS-20 score rather
than the factor scores of the TAS-20 may reduce concerns regarding the EOT factor when
comparing alexithymia results across studies.
The present review of observer-rated (BIQ, OAS, and TSIA) and self-report (BVAQ
and TAS-20) measures of alexithymia revealed methodological advantages and
disadvantages for use in clinical and research settings. A major problem with observer-rated
measures has been maintaining consistency between interviewers (Meganck et al., 2010) who
are subject to bias, differences in interviewing style, and differences in interpretation of the
construct being measured (McCrae, 1994). In addition, the increased time and complexity
involved in administering observer-rated measures makes them more appropriate to clinical
settings rather than research settings. In contrast, self-report measures are inexpensive,
simple, and fast to administer compared to observer-rated measures, which make them more
applicable to research settings. Self-report instruments have been used more frequently in
research and thus more information is available on the psychometric properties of these
measures. On the other hand, some authors have criticised the use of self-report measures to
assess alexithymia, questioning the extent that they can be used to accurately assess a
construct whose central characteristic involves inadequate self-awareness (Lundh, Johnsson,
Sundqvist, & Olsson, 2002; Mayer, Caruso, & Salovey, 2000; Suslow & Junghanns, 2002). It
has been recommended that in ideal situations, where time and resources allow, alexithymia
should be assessed using a multiple method approach (Caretti et al., 2011; Eid & Diener,
2006; Taylor & Bagby, 2004; Taylor et al., 2000), such as by using observer-rated and selfreport measures of alexithymia together.
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Despite criticisms of self-report measures, the TAS-20 has remained the most widely
used measure of alexithymia. The TAS-20 provides a sound assessment of alexithymia and
appears to meet the standards of validity and reliability necessary for research purposes.
Studies have found the TAS-20 to be suitable for use in both psychiatric and community
populations (Meganck et al., 2008; Parker et al., 2003), as well as in several cultures (see
Taylor et al., 2003). While some critics question the use of self-report scales to assess
alexithymia, studies have shown agreement between TAS-20 scores and observer ratings of
alexithymia (Bagby, Taylor, et al., 1994; Martínez-Sánchez, 1996). In addition, the TAS-20
cut-off scores used to identify alexithymic and non-alexithymic individuals offers a unique
advantage that is beneficial for research purposes by allowing for comparisons of rates of
alexithymia across studies (Taylor et al., 1997).
Aetiology of Alexithymia
The development of valid and reliable psychometric tools for measuring alexithymia
not only refined the definition and quantification of the construct, but also allowed for
extensive empirical research on alexithymia to accumulate. For instance, a considerable body
of empirical research has replaced much conjecture regarding the origin or aetiology of
alexithymia.
The aetiology of alexithymia has been considered and debated for over three decades
(see r utigam & Rad, 1977). Understanding the aetiology of alexithymia has theoretical and
practical implications, particularly for the way it is described, assessed, and approached in the
therapeutic setting. Early distinctions were made between primary alexithymia, which is
considered a life-long disposition, derived from genetic factors and/or factors that impact on
affect development during early childhood; and secondary alexithymia, which is considered
to arise not during development, but as a consequence of psychological and/or medicalsurgical events occurring later in life (Freyberger, 1977; Sifneos, 1988).
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Studies have found significant correlations between alexithymia scores obtained from
individuals and their first-degree relatives (Grabe et al., 2006; Lumley, Mader, Gramzow, &
Papineau, 1996). These findings of significant intrafamilial associations of alexithymia
indicate that underlying familial or genetic factors might contribute to the development of
alexithymia (Grabe et al., 2006). Heritability studies involving twin pairs have provided
stronger evidence to support views suggesting genetic and environmental factors underlying
alexithymia, yet only four investigations have been conducted concerning alexithymia.
In an early study, Heiberg and Heiberg (1977) examined genetic influences on
alexithymia in 33 twin pairs. The findings of their study showed less variation in alexithymic
characteristics between monozygotic twins (identical twins with an extremely high degree of
genetic similarity) than dizygotic twins (fraternal twins that are genetically like any other
sibling, just born at the same time).
Three studies have examined the influences of genetic factors as well as shared and
non-shared environmental factors on alexithymia in twin pairs. Shared environmental factors
include features that make siblings similar, such as the socioeconomic status of the family
and parental strategies on child rearing. On the other hand, non-shared environmental factors
include features that make siblings different, such as unpredictable events in the child’s life,
peer relationships, and differential parental treatment. Valera and Berenbaum (2001)
examined the influences of genetic, shared, and non-shared environmental factors on
alexithymia in 45 monozygotic and 32 same-sex dizygotic twin pairs. Results showed that
characteristics of alexithymia relating to an externally-oriented style of thinking were
influenced more by genetic factors than by aspects of the shared family environment.
However, characteristics relating to difficulties identifying and describing feelings were
influenced more by aspects of the shared family environment than by genetic factors. These

24

results indicate that inheritance may contribute more strongly to the development of certain
aspects of alexithymia.
Jørgensen, Zachariae, Skytthe, and Kyvik (2007) conducted the first large-scale
heritability study of alexithymia which involved 8,785 twin pairs (2,688 monozygotic, 3,248
same-sexed dizygotic, and 2,849 opposite-sexed dizygotic twins). The authors demonstrated
the heritability of alexithymia to range from 30 to 33%. The remaining similarities in
alexithymia scores between the twin pairs were accounted for by shared family
environmental factors (12–20%), whereas differences in alexithymia scores between the twin
pairs were accounted for by non-shared environmental factors (50–56%). The authors
concluded that the primary source of environmental influence on alexithymia scores was
related to factors that created differences in sibling’s alexithymia scores rather than
similarities in sibling’s alexithymia scores. This finding was in contrast to Valera and
Berenbaum (2001), who found that the primary source of environmental influence was
related to factors that created similarities in alexithymia scores (i.e., shared family
environmental factors).
Baughman et al. (2012) conducted a recent study to examine genetic and
environmental contributions to alexithymia in 216 monozygotic and 45 dizygotic same-sex
twin pairs. Consistent with the findings of Jørgensen et al. (2007), Baughman et al. (2012)
demonstrated the heritability of alexithymia to range from 33 to 50%. In addition, they found
that alexithymia was best accounted for by additive genetic and non-shared environmental
influences. Together, these studies provide evidence for both genetic and environmental
influences, particularly non-shared environmental influences, in the development of
alexithymia.
In addition to genetic factors and non-shared environmental influences, heritability
studies found evidence for the shared family environment as a contributing factor in the
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development of alexithymia (Jørgensen et al., 2007; Valera & Berenbaum, 2001). Some
researchers have proposed that, to some extent, the aetiology of alexithymia is related to
factors that impact on affect development during early childhood (McDougall, 1982; Taylor
et al., 1997), including parental emotion socialisation, infant attachment, and trauma.
Parental emotion socialisation refers to parental reactions to children’s emotions,
discussion of emotion, and expression of emotion (Eisenberg, Cumberland, & Spinrad, 1998).
There is strong empirical evidence to suggest that parental emotion socialisation has
longstanding influence on the emotional experience and expression in children as well as
social competence and emotion regulation strategies that will be employed in adulthood
(Eisenberg, Spinrad, & Eggum, 2010; Le, Berenbaum, & Raghavan, 2002). Berenbaum and
James (1994) have suggested that difficulties identifying and communicating emotion - an
essential characteristic of alexithymia - may be a consequence of a childhood environment
where parents fail to model nonthreatening expressions of emotion. Indeed, alexithymia has
been shown to occur more frequently in adults who recall childhood family environments that
did not encourage the expression of opinions and feelings within the family (Kench & Irwin,
2000), and especially the expression of positive feelings and physical affection (Le et al.).
Joukamaa et al. (2003) conducted a 31-year prospective study that examined the association
between alexithymia in adulthood and the social situation of the child’s family 31 years
earlier. They found that unwanted children or children born into families with many children
(≥ 5) reported elevated levels of alexithymia in adulthood. The authors concluded that factors
such as having unwanted or numerous children may limit the time and attention given to the
child and disturb the development of normal early mother-infant intimacy.
It has been suggested that the family environment influences a child’s affect
development at even earlier stages in life. owlby’s attachment theory (1969, 1973) provides
an explanation for the effects of early attachment relationships on affect development.
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According to this theory, emotional expression of the infant, particularly expression of
negative affect such as distress and discomfort, alerts caregivers to regulate the infant’s
biological and psychological needs. Insecurely attached infants have learned not to rely on
the caregivers’ responsiveness to regulate their emotional states, and these infants are thought
to have adapted their attachment strategies (i.e., insecure-avoidant and insecure-anxious)
based on these expectations in an attempt to regulate emotional states on their own (Cassidy,
1994; Mallinckrodt & Wei, 2005). Consequently, it has been suggested that insecure
attachment might prevent the infant from experiencing a variety of affective states and from
processing, communicating, and regulating these states effectively without resorting to a
defensive strategy (Fonagy, Gergely, Jurist, & Target, 2002; Harris, 1999).
Findings from a meta-analysis by Fraley (2002) have provided evidence that
attachment style remains relatively stable across the life span. It is possible that problems
with affect development arising from insecure attachment in childhood also remain stable
across the life span. For example, numerous studies have found associations between
alexithymia and insecure attachment style in adults (Mallinckrodt & Wei, 2005;
Montebarocci, Codispoti, Baldaro, & Rossi, 2004; Oskis et al., 2013; Picardi, Toni, &
Caroppo, 2005; Troisi, D'Argenio, Peracchio, & Petti, 2001; Wearden, Lamberton, Crook, &
Walsh, 2005).
Another framework for conceptualising affect development in childhood has been
proposed by Lane and Schwartz (1987). Lane and Schwartz proposed a model where
emotional awareness progresses along five developmental levels: 1) awareness of bodily
sensations or somatic responses to emotion arousal; 2) action tendencies associated with
emotions, whereby the individual is only aware of how he or she would like to act as a result
of an emotion; 3) awareness of unidimensional feelings, such as feeling good or bad but
nothing more differentiated; 4) awareness of combinations of discrete and differentiated
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feelings, such as joy, excitement, sadness, and fear; and 5) awareness of complex blends of
differentiated feelings in self and others, where multiple, often contradictive, feelings may be
present at one time. Taylor et al. (1997) claim that alexithymia and disorders of affect
regulation represent lower level functioning within this model that have occurred as a result
of developmental disturbances that prevent progress to higher levels or bring about regression
to lower levels.
One such disturbance that prevents affective development in early childhood is
trauma. Krystal (1988) theorised that infantile or childhood psychic trauma, resulting from a
lack of sufficient ego development (distinction between the inner self and the outer
environment) and defences to regulate the impact of the trauma, prevents the child from
progressing to more advanced affective developmental levels. This theory is supported by
studies finding that alexithymic individuals are more likely to have experienced sexual (Hund
& Espelage, 2005; McLean, Toner, Jackson, Desrocher, & Stuckless, 2006) and non-sexual
childhood abuse (Mazzeo & Espelage, 2002; McCaslin et al., 2006). Krystal also suggested
that trauma in adulthood would result in a regression in affective-cognitive function to an
infantile level of affect development. He proposed that the consequence of this regression
would result in an adult who lacks the ability to verbalise, tolerate, and modify their emotions
and whose affects remain undifferentiated and somatised.
Alexithymia that arises from traumatic events that occur in later life has been seen as
a defence mechanism in an attempt to cope with the stress of trauma (Freyberger, 1977),
whether it be psychic trauma or physical trauma (e.g., a life threatening illness or conditions
requiring intensive care). That is, alexithymia that develops secondary to a psychologically or
physiologically traumatic event has been considered a defence or protection against highly
emotional events. This view is supported by findings from a meta-analysis showing large
effect sizes associating Posttraumatic Stress Disorder with alexithymia (Frewen, Dozois,
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Neufeld, & Lanius, 2008) as well as studies finding higher levels of alexithymia in holocaust
survivors (Yehuda et al., 1997) and victims of sexual assault (Zeitlin, McNally, & Cassiday,
1993).
In summary, the present review of research into the aetiology of alexithymia has
revealed extensive research efforts incorporating biological theories and environmental
theories in particular. Heritability studies on twin pairs have found genetic factors to play a
role in the development of alexithymia, in addition to shared and non-shared environmental
factors. Environmental factors that influence affect development during early childhood, such
as negative childhood family environments and insecure attachment in childhood, are also
likely to play an important role in the development of alexithymia. Experiences of trauma at
any stage in life, including psychic and physical trauma, may also contribute to the
development of alexithymia. It has been suggested that the numerous yet interrelated
biological and environmental explanations for the origins of alexithymia indicates that the
aetiology of alexithymia is likely to involve multiple contributory factors (Taylor et al.,
1997).
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CHAPTER 2
ALEXITHYMIA AND PSYCHOPATHOLOGY
Alexithymia reflects a deficit in the cognitive processing of emotions that has been
shown to affect around 10% of the general population (Franz et al., 2008; Honkalampi,
Hintikka, Tanskanen, Lehtonen, & Viinamäki, 2000; Mattila, Salminen, Nummi, &
Joukamaa, 2006). Several researchers have argued that deficits in the cognitive processing
and regulation of emotions, such as those observed in alexithymia, lead to dysfunctional
emotional states, and it is dysfunctional emotional states that are a central feature to most
psychopathology (Krystal, 1988; Lane & Schwartz, 1987; Taylor, 1987). This idea is
consistent with several studies that have found greater rates of alexithymia in psychiatric
samples compared to community samples (Müller et al., 2003; Todarello, Taylor, Parker, &
Fanelli, 1995; Vanheule et al., 2007). In fact, studies have found rates of alexithymia at over
40% in patients diagnosed with depression (Saarijärvi, Salminen, & Toikka, 2001), anxiety
disorders (Fukunishi, Kikuchi, Wogan, & Takubo, 1997), somatoform disorders (Cox, Kuch,
Parker, Shulman, & Evans, 1994), addictive disorders (Evren, Evren, Dalbudak, Ozcelik, &
Oncu, 2009), schizophrenia (Todarello et al., 2005), and in general psychiatric samples with
varied diagnoses (Lecours & Bouchard, 2011).
However, the rates of alexithymia across studies of alexithymia in psychiatric samples
appear to be highly variable. For example, rates of alexithymia have ranged between 6%
(Karvonen et al., 2005) and 56.7% (Celikel & Saatcioglu, 2006) for patients diagnosed with
somatoform disorders and between 11% (Grabe et al., 2006) and 56% (Fukunishi, Kikuchi, et
al., 1997) for patients diagnosed with anxiety disorders. Several factors may affect the
proportion of patients who are identified as alexithymic in such studies, including the method
of assessing alexithymia as well as sample characteristics. Most studies that have reported
rates of alexithymia have utilised the TAS-20 as cut-off scores are provided to identify
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alexithymic and non-alexithymic individuals (Taylor et al., 1997). Therefore, variations in the
prevalence rate of alexithymia in psychiatric studies may be better accounted for by sample
characteristics, such as psychiatric diagnosis and illness severity.
The issue of whether psychiatric diagnosis may affect the proportion of patients
identified as alexithymic in psychiatric studies is unclear. Some researchers have questioned
whether alexithymia occurs more frequently in specific diagnostic groups or psychiatric
disorders, such as somatoform disorders or depression (Bankier, Aigner, & Bach, 2001;
Leweke, Leichsenring, Kruse, & Hermes, 2012). The conceptualisation of the alexithymia
construct originated from observations of patients with psychosomatic disorders (or
somatoform disorders) and thus some have considered alexithymia a pathological process
underpinning somatic distress (Sifneos, 1973; Taylor et al., 1997). It has been proposed
( r utigam & Rad, 1977; Taylor et al., 1991) that alexithymia is a useful conceptual
framework for explaining the interactions between emotions, personality, and bodily
functions that contribute to the aetiology of disease. Some studies support the theoretical and
clinical impression of a link between alexithymia and somatic symptoms (Burba et al., 2006;
Landa, 2009; Taylor, Parker, Bagby, & Acklin, 1992). However, some researchers have
questioned this association, finding that alexithymia scores were no higher for patients
diagnosed with somatoform disorders than for patients diagnosed with other disorders
(Bankier et al., 2001; Leweke et al., 2012).
Some researchers have suggested that there is a conceptual overlap between
alexithymia and depressive symptoms (e.g., Leising et al., 2009). Müller et al. (2004) has
proposed that depressive symptomatology, such as reduced cognitive processing speed,
distractibility, social withdrawal, and pessimistic views of one’s abilities, can lead to the over
reporting of symptoms like difficulties identifying and verbalising feelings that are also
common in alexithymia. Depressive symptoms may therefore increase the rate of alexithymia
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observed in patients diagnosed with depression. However, many studies have found no
differences in alexithymia scores between two (Duddu, Isaac, & Chaturvedi, 2003) and three
(Celikel & Saatcioglu, 2007; Onur, Alkin, Sheridan, & Wise, 2013) diagnostic groups, or in
mean alexithymia scores between six diagnostic groups (Subic-Wrana, Bruder, Thomas,
Lane, & Kohle, 2005).
Another sample characteristic that may affect prevalence rates of alexithymia in
psychiatric studies is the severity of psychopathology. Alexithymia has been shown to
correlate positively with psychopathology severity (Bach, Bach, Bohmer, & Nutzinger, 1994;
Leweke et al., 2009) and psychological distress (Liang & West, 2011; Mikolajczak &
Luminet, 2006). The treatment setting for psychiatric patients may be a general indicator of
psychopathology severity. Higher rates of alexithymia are likely to be identified in
psychiatric inpatient samples because patients admitted for inpatient hospitalisation are in
more acute phases of their illness and require more intensive intervention compared to
patients attending outpatient clinics for treatment. Therefore, the treatment setting of sample
populations needs to be taken into account when evaluating the prevalence of alexithymia in
psychiatric populations.
Further variation in the prevalence rate of alexithymia may arise from demographic
differences in the population surveyed. Some researchers have proposed that alexithymia is
likely to be more prevalent in certain demographic groups, such as males (Levant, 1992) and
those with less education or socioeconomic status (Borens, Grosse-Schulte, Jaensch, &
Kortemme, 1977). Few studies have explicitly reported differences in prevalence rates of
alexithymia between different demographic groups. Rather, a large number of studies have
examined differences in alexithymia scores between different demographic groups. While
these studies vary in the way alexithymia and demographic factors have been assessed (e.g.,
using continuous or categorical variables), a broad evaluation of these studies may offer
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insight into whether demographic differences in study samples are likely contributors to
variation in the prevalence rate of alexithymia.
It should be noted that Levant et al. (2006) included a narrative review of studies that
examined the link between alexithymia and gender that was part of the background to their
study. They found that the majority of studies in their review that involved clinical samples
(psychiatric and medical patients) reported no gender differences in alexithymia, whereas the
majority of studies that involved non-clinical samples reported significantly higher
alexithymia scores in males compared to females. Levant et al. (2006) concluded that this
finding provided support for Levant’s theory of a gender-linked, subclinical alexithymia
syndrome (see Levant, 1992). Unlike systematic reviews, narrative reviews are more likely to
involve bias as only research selected by the author is included. Hence, narrative reviews are
also more likely to provide a summary of evidence that is outdated and contradictory to
available evidence (Montori, Swiontkowski, & Cook, 2003). In contrast, systematic reviews
apply scientific strategies that limit bias, such as addressing a specific question, conducting a
comprehensive literature search, and providing explicit and objective criteria to identify
relevant studies (Montori et al., 2003). The narrative review that was conducted by Levant et
al. (2006) failed to include 10 studies that examined the link between alexithymia and gender
prior to and including 2006, which is equivalent to approximately 26% of the literature. The
present systematic review will extend the narrative review conducted by Levant et al. (2006)
by including the 10 studies that were missed and any additional studies post 2006, making it a
more comprehensive and current review of the literature in this area.
Furthermore, no study to date has systematically compiled and examined studies that
have reported rates of alexithymia in either the psychiatric or community populations. A
greater understanding of the prevalence rates of alexithymia in psychiatric and community
populations is desirable, particularly given the association between alexithymia and the
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development of psychiatric symptomatology in community samples (Heinrichs et al., 2005;
McCaslin et al., 2006; Tolmunen et al., 2011) and with the persistence of psychiatric
symptomatology in psychiatric samples over time (Bach & Bach, 1995; Loas, Fremaux,
Otmani, Lecercle, & Delahousse, 1997; Reese, 2008; Viinamäki et al., 2002). Confounding
factors, such as psychiatric diagnosis, severity of illness, and demographic differences make
it difficult to compare the prevalence data for alexithymia across the literature. It is therefore
necessary to take these factors into account when comparing data from different studies. This
improved theoretical understanding could, in turn, generate awareness of the alexithymia
construct amongst clinicians (mental health practitioners, including psychologists and
psychiatrists) and researchers who work with psychiatric populations, in an attempt to help
improve clinical outcomes and research practices.
The purpose of the present literature review was to compare rates of alexithymia in
studies involving psychiatric samples while taking psychiatric diagnosis and
psychopathology severity into consideration. In addition, a comparison of alexithymia rates
in studies involving community samples was conducted, and studies that have examined
alexithymia and demographic differences in psychiatric and/or community samples were
evaluated in order to obtain a clearer understanding of the factors that may influence
alexithymia rates.
It is important to note that the present review exclusively evaluated studies that have
utilised the TAS-20 as a measure of alexithymia. This decision was taken because the TAS20 provides cut-off scores, which have been applied to diverse samples. These cut-off scores
allow for the comparison of alexithymia rates across numerous international studies. The
TAS-20 is also been translated into more languages than any other measure, cross-culturally
validated in several countries (Taylor et al., 2003), and since it is the most widely used
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measure of alexithymia worldwide there is more information about alexithymia available
using the TAS-20 than any other measure.
Method
Search
A systematic search was conducted through Medline, ProQuest Psychology Journals,
and Web of Science databases to obtain potentially relevant articles. The database searches
were supplemented by searching Google Scholar for relevant articles and by crosschecking
the articles that were included in the subsequent systematic review (Chapter 3). All databases
were searched using combinations of the following keywords: alexithymia, prevalence,
demographics, gender, and TAS-20. The title and abstract of the identified articles were then
screened for relevance against the inclusion and exclusion criteria. If abstracts were not
available or unable to provide sufficient information, the full-text article was retrieved and
screened in the same manner.
Inclusion and Exclusion Criteria
For inclusion, studies were required to: (1) include adults (≥ 18 years old), (2)
measure alexithymia using the total TAS-20 score, (3) include psychiatric participants
(patients presenting for psychiatric treatment) and/or community participants, and (4) be
published in the English language. Studies involving psychiatric participants diagnosed with
organic mental disorders (e.g., dementia), mental retardation, developmental disorders, or
physiological conditions as the primary diagnosis were excluded. Also excluded were studies
involving community samples that had been screened for past or present psychiatric illness as
they are not representative of the general population. The census data for inclusion ranged
from 1994 to 2014.
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Data Extraction
Data from the included studies were independently extracted onto a standardised form
developed for this review. The following data were extracted: author(s) and date, country of
the study, characteristics of participants (sample size and psychiatric diagnosis for psychiatric
patients), prevalence rate of alexithymia (percentage), and study findings concerning the link
between alexithymia and demographic variables.
Results
The search effort resulted in 394 citations. Seventy-six duplicate citations were
removed and 107 citations were excluded as irrelevant after they were screened for potential
relevance. The remaining 211 full-text articles were assessed for eligibility. Eighty-six
studies were excluded for the following reasons: 43 studies did not report rates of alexithymia
(and rates could not be calculated from the data provided) or did not report demographic
variables (e.g., De Panfilis et al., 2008; Lumley & Sielky, 2000), 30 studies were follow-up
studies or studies that shared a participant sample with a larger study that was included in the
present review (e.g., Honkalampi, Hintikka, Laukkanen, et al., 2001; Mattila et al., 2010), 7
studies did not use the TAS-20 (e.g., Bermond et al., 1999; Sayar, Acar, & Ak, 2003), 2
studies provided sample descriptions that lacked sufficient in detail for rates of alexithymia to
be identified (Berthoz et al., 2002; Graugaard, Holgersen, & Finset, 2004), 1 study was a
literature review (Kooiman et al., 2002), 1 study did not use the total TAS-20 score (Kiyotaki
& Yokoyama, 2006), 1 study did not involve adults (Guttman & Laporte, 2002), and 1 study
involved a community sample that was screened for mental illness (de Vente, Kamphuis, &
Emmelkamp, 2006). As a result of the exclusion process, 125 studies were identified as being
eligible for the present review. Of the 125 studies, 72 studies involved psychiatric samples,
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62 studies involved community samples, and 9 studies involved both psychiatric and
community samples.
Table 1 presents the data from studies that reported prevalence rates of alexithymia in
psychiatric samples and Table 2 presents the data from studies that reported prevalence rates
of alexithymia in community samples. The studies that involved both psychiatric and
community samples appear in both Tables 1 and 2.
Characteristics of the Studies
Across the 125 studies in the present review, 76 studies reported rates of alexithymia,
84 studies examined demographic differences in alexithymia, and 35 studies reported both
rates of alexithymia and demographic differences in alexithymia.
Studies that reported prevalence rates of alexithymia.
Fifty-five studies that involved psychiatric samples reported rates of alexithymia. The
majority of these studies were undertaken in Europe (n = 40), followed by North America
(Canada and the USA, n = 10), Asia (n = 3), Australia (n = 1), and Britain (n = 1). Most of
the studies involved sample sizes greater than 100 (n = 26) that ranged from 20 to 1461
patients. Patients were most commonly recruited from outpatient (n = 23) and inpatient
settings (n = 14). The studies that involved inpatient settings generally involved larger sample
sizes (≥ 100) compared to the studies that involved outpatient settings. Two studies recruited
patients from both outpatient and inpatient settings, and the remaining studies recruited
patients from hospitals, mental health clinics and associations, community advertisement, a
social insurance office, or did not specify the setting. The studies involved patients diagnosed
with addictive disorders (e.g., eating disorders and substance misuse disorders, n = 21),
varied diagnoses (i.e., general psychiatric samples, n = 13), anxiety disorders (n = 10),
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somatoform disorders (n = 5), depressive disorders (n = 5), and one study involved patients
diagnosed with schizophrenia.
Twenty-six studies that involved community samples reported rates of alexithymia.
The majority of these studies were undertaken in Europe (n = 15), followed by North
America (n = 6), Australia (n = 3), Asia (n = 1), and Britain (n = 1). Most of the studies
involved sample sizes greater than 100 (n = 21). The size of the samples ranged from 67 to
5028 participants, with five studies involving samples sizes greater than 1000. A greater
proportion of the studies undertaken in Europe involved larger sample sizes (≥ 100)
compared to the studies undertaken outside of Europe, with most of these European studies
involving samples greater than or equal to 300. Participants were most commonly recruited
from university campuses (n = 13) and the general community (n = 8). Three studies
recruited employees from various places of employment (e.g., childcare centre) and two
studies recruited participants from both university campuses and the general community. The
studies that involved community and student participants often referred to these samples
interchangeably.
Studies that examined demographic differences in alexithymia.
The majority of the studies that examined demographic differences in alexithymia
were undertaken in Europe (n = 45), followed by North America (n = 27), Asia (n = 5),
Australia (n = 3), Britain (n = 1), and North Africa (n = 1). One study was undertaken in three
locations (Europe, Canada, and the USA) and another study was undertaken in two locations
(the USA and South America). The majority of the studies involved sample sizes greater than
100 (n = 65). The size of the samples ranged from 42 to 5028 participants, with 11 studies
involving samples sizes greater than 1000. Psychiatric samples were involved in 41 studies,
community participants were involved in 48 studies, and 5 studies involved both psychiatric
and community samples.
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Most of the studies examined multiple demographic factors, including gender (n =
70), age (n = 56), education (n = 37), economic status (including SES and income, n = 27),
marital status (n = 22), employment status (n = 8), and other factors (including ethnicity,
church membership, and rural or urban residency, n = 4). Age and education were examined
either as continuous variables (e.g., age and education in years) or as categorical variables
(e.g., age categories and levels of education). Gender, employment status, economic status,
SES, income, and marital status were only examined as categorical variables.
Prevalence of Alexithymia in Psychiatric and Community Samples
Overall, prevalence rates of alexithymia in the psychiatric samples ranged from
11.0% to 76.6% (median = 37.5%). Most of the studies that involved smaller sample sizes (<
100) reported rates of alexithymia that were greater than 37.5%, whereas most of the studies
that involved larger samples (≥ 100) reported rates of alexithymia that were less than 37.5%.
Approximately half of the studies undertaken in Europe reported rates of alexithymia
that were greater than 37.5% and the other half reported rates that were less than 37.5%. The
vast majority of the non-European studies (predominately studies in North America) reported
rates of alexithymia that were greater than 37.5%.
In regards to treatment setting, approximately half of the studies that recruited patients
from outpatient settings reported rates of alexithymia that were greater than 37.5% and the
other half reported rates that were less than 37.5%. The majority of the studies that recruited
patients from inpatient settings reported prevalence rates of alexithymia that were less than
37.5%.
Prevalence rates of alexithymia in community samples ranged from 0.0% to 22.9%
(median = 10.0%). Approximately half of the studies reported rates of alexithymia that were
greater than 10.0% and the other half reported rates that were less than or equal to 10.0%.
This distribution did not appear to change according to the sample size of the study (< 300 or
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≥ 300), the location of the study (European countries or non-European countries), or whether
the study recruited community or student participants.
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Table 1
Prevalence of Alexithymiaa in Psychiatric Samples, as well as Demographic Differences in Alexithymia
Study

Country

Sample

Prevalence (%)

Akkerman (1996)

USA

131 substance misuse inpatients

≠ gender

Bagby, Parker, et al. (1994)

Canada

218 general psychiatric outpatients

≠ gender; ≠ age

Bankier et al. (2001)

Austria

297 general psychiatric inpatients

≠ gender; ≠ age; lower education > higher
education (elementary school, junior high
school, and high school)

Beales and Dolton (2000)

Britain

79 members of an eating disorder association 74.0

Bonnaire, Bungener, and
Varescon (2009)

France

84 community sourced pathological
gamblers

Carano et al. (2006)

Italy

101 binge eating disorder patients

Celikel et al. (2010)

Turkey

81 depressed outpatients

53.6b, c

≠ gender
≠ gender; older patients > younger patients
(age in years; did not report correlation
coefficient); lower education > higher
education (< high school and ≥ high school);
≠ employment status; ≠ marital status

33.3

≠ gender; ≠ age; ≠ education; ≠ profession; ≠
marital status
≠ age; ≠ education; ≠ marital status

Celikel and Saatcioglu (2007) Turkey

124 depressive, anxiety, and somatoform
disorder outpatients

Celikel and Saatcioglu (2006) Turkey

30 somatoform disorder (chronic pain)
outpatients (female)

56.7

Coriale et al. (2012)

Italy

110 alcohol dependent inpatients

34.5

Cox et al. (1994)

Canada

55 somatoform disorder outpatients (chronic 53.0
pain)
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≠ gender; ≠ age

Table 1 (continued)
Study

Country

Sample

Prevalence (%)

Cox, Swinson, Shulman, and Canada
Bourdeau (1995)

146 anxiety disorder patients from a clinic

31.1

Cucchi et al. (2012)

Italy

139 panic disorder outpatients

25.9

De Berardis et al. (2005)

Italy

112 obsessive-compulsive disorder
outpatients

35.7

De Berardis et al. (2007)

Italy

84 panic disorder outpatients

38.1

Deborde et al. (2008)

France

45 eating disorder patients from unspecified 53.2b
setting

de Haan et al. (2013)

Netherlands

187 substance dependent inpatients

de Haan, Schellekens, et al.
(2012)

Netherlands

100 alcohol dependent inpatients (male)

de Haan, van der Palen,
Netherlands
Wijdeveld, Buitelaar, and De
Jong (2014)

130 substance dependent inpatients

De Panfilis, Rabbaglio, Rossi, Italy
Zita, and Maggini (2003)

64 eating disorder outpatients (female)
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≠ gender; ≠ age; lower education > higher
education (< high school and ≥ high school);
≠ employment status; ≠ marital status

≠ gender; ≠ age; fewer years of education >
greater years of education (r = -.19); ≠
employment status; ≠ marital status
45.0

≠ age; fewer years of education > greater
years of education (r = -.21); ≠ employment
status; ≠ marital status
≠ gender; ≠ age; ≠ education; ≠ employment
status; ≠ marital status

14.4

Table 1 (continued)
Study

Country

Sample

Prevalence (%)

Results

de Timary, Luts, Hers, and
Luminet (2008)

Belgium

70 alcohol dependent inpatients

32.4

≠ gender

Eizaguirre, de Cabezón, de
Alda, Olariaga, and Juaniz
(2004)

Spain

151 eating disorder patients (female)
referred from an eating disorder association

57.0

El Rasheed (2001)

Egypt

200 substance misuse inpatients

≠ gender; ≠ age; ≠ education; ≠ employment
status; ≠ marital status

Evren, Cagil, et al. (2012)

Turkey

118 alcohol dependent inpatients (males)

≠ age; fewer years of education > greater
years of education (r = -.28)

Evren, Cinar, and Evren
(2012ᵈ)

Turkey

200 substance dependent inpatients

34.0

Evren, Dalbudak, and
Çakmak (2008)

Turkey

176 alcohol dependent inpatients

30.1

Evren, Dalbudak, Cetin,
Durkaya, and Evren (2010)

Turkey

156 alcohol dependent inpatients

30.1

Evren et al. (2009)

Turkey

159 alcohol and other drug dependent
inpatients

45.3

Frewen, Lanius, et al. (2008)

Canada

105 post-traumatic stress disorder patients
from unspecified setting

47.0

Fukunishi, Kikuchi, et al.
(1997)

Japan

50 anxiety disorder patients from a hospital
and clinic

56.0c

Galderisi et al. (2008)

Italy

32 panic disorder outpatients

29.0

43

≠ age; ≠ education; ≠ employment; ≠ marital
status

≠ age; lower education > higher education
(elementary school, 6-8 years high school, 912 years high school, and university);
unemployed > employed; ≠ marital status

Table 1 (continued)
Study

Country

Sample

Prevalence (%)

Results

Grabe et al. (2008)

Germany

414 general psychiatric inpatients

27.0

Females > males; ≠ age; ≠ education; ≠
marital status

Grabe et al. (2006)

Germany

82 obsessive-compulsive disorder
outpatients

11.0

Güleç et al. (2013)

Turkey

100 depressive disorder patients

Haviland, Hendryx, Shaw,
and Henry (1994)

USA

204 substance dependent inpatients

41.7

Females > males

Honkalampi, Hintikka,
Saarinen, Lehtonen, and
Viinamäki (2000ᵈ)

Finland

169 depressive disorder outpatients

39.0

Males > females; ≠ age; lower education >
higher education (≤ high school and > high
school); ≠ economic status; ≠ marital status

Joukamaa et al. (2008)

Finland

161 general psychiatric outpatients

34.2c

≠ gender

Joyce, Fujiwara, Cristall,
Ruddy, and Ogrodniczuk
(2013)

Canada

51 general psychiatric outpatients

51.0

Kim et al. (2008)

Korea

104 depressive disorder patients from a
hospital

50.0

Kubota et al. (2012)

Japan

44 schizophrenia patients

Landa (2009)

USA

20 somatoform disorder patients from
several clinics

Lecours and Bouchard (2011) Canada

Males > females

≠ gender; ≠ age; ≠ education
≠ gender; ≠ age

64 general psychiatric outpatients

44

40.0
≠ gender; ≠ age; lower education > higher
education (elementary school, high school,
university preparation course, and university)

Table 1 (continued)
Study

Country

Sample

Prevalence (%)

Results

Leweke et al. (2012)

Germany

1461 general psychiatric outpatients

21.4

Males > females; ≠ age; lower education >
higher education (9 years, 10 years, and 13
years of school, still in school, and other
graduation)

Loas et al. (2001)

France

659 substance misuse and eating disorder
inpatients and outpatients

≠ gender

Luminet, Bagby, and Taylor
(2001)

Canada

46 depressive outpatients

≠ gender; ≠ age; ≠ education; ≠ SES; ≠
marital status

Lundh and Broman (2006)

Sweden

100 general psychiatric patients (with
insomnia) from a sleep disorders unit

20.4

Marchesi, Fonto, Balista,
Cimmino, and Maggini
(2005)

Italy

101 panic disorder patients from a clinic

44.2

Melin, Thulesius, and
Persson (2010)

Sweden

54 somatoform disorder outpatients (chronic 36.0
pain)

Müller and Bühner (2006)

Germany

300 general psychiatric inpatients

35.0

Müller et al. (2003)

Germany

204 general psychiatric patients from
inpatient and clinic settingse

17.6

Özsahin, Uzun, Cansever,
and Gulcat (2003)

Turkey

65 depressive disorder outpatients

49.2c

Pinaquy, Chabrol, Simon,
Louvet, and Barbe (2003)

France

40 binge eating disorder outpatients (female) 62.5

Pinard, Negrete, Annable,
and Audet (1996)

Canada

48 substance dependent patients
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≠ gender; ≠ age; ≠ education; ≠ SES; ≠
marital status

≠ gender; ≠ age

Table 1 (continued)
Study

Country

Sample

Prevalence (%)

Results

Porcelli et al. (2004)

Italy

52 general psychiatric outpatients

21.1

Reese (2008)

USA

84 somatoform disorder patients from clinics 23.8
and community

≠ gender; ≠ age; ≠ employment status; ≠
marital status; ≠ ethnicity

Rufer et al. (2010)

Germany

55 panic disorder outpatients

≠ gender; ≠ age

Rufer et al. (2004)

Germany

42 obsessive-compulsive disorder inpatients 14.0

≠ gender; ≠ age; ≠ employment status; ≠
marital status

Saladin et al. (2012)

USA

40 substance dependent patients from clinics 15.0
and community

Saarijärvi et al. (2001)

Finland

120 depressive disorder patients from social 46.0
insurance officesf

Son et al. (2012ᵈ)

Korea

388 general psychiatric inpatients and
outpatients

Speranza et al. (2004)

37.1c

Younger patients > higher patients (r = -.20);
fewer years of education > greater years of
education (r = -.12)

France,
564 addictive disorder inpatients and
Switzerland, outpatients (anorexia, bulimia, and alcohol
& Belgium dependence)

52.8b

≠ gender

C. Spitzer et al. (2005)

Germany

149 general psychiatric inpatients

35.5

≠ gender; ≠ age

Taylor, Parker, Bagby, and
Bourke (1996)

Canada

48 eating disorder patients from private
clinics

68.8

Thorberg et al. (2011)

Australia

254 alcohol dependent outpatients

32.4

Todarello et al. (2005)

Italy

29 schizophrenic outpatients

65.5
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Table 1 (continued)
Study

Country

Sample

Prevalence (%)

Results

Todarello et al. (1995)

Italy

113 general psychiatric outpatients

32.7

≠ gender; ≠ age; fewer years of education >
greater years of education (r = -.37)

Toneatto, Lecce, and Bagby
(2009)

Canada

143 pathological gamblers from community

76.6

Tutkun et al. (2004)

Turkey

154 general psychiatric outpatients

46.8

≠ age; fewer years of education > greater
years of education

Uzun (2003)

Turkey

56 alcohol dependent outpatients

48.2

≠ age; fewer years of education > greater
years of education; lower economic status >
higher economic status (good and poorg); ≠
marital status

Vanheule et al. (2007)

Belgium

404 general psychiatric outpatients

38.0

Verrocchio, Conti, and
Fulcheri (2010)

Italy

77 substance dependent inpatients

44.2

Zhu et al. (2007)

China

179 general psychiatric outpatients

≠ gender; ≠ age; ≠ education

Note. ≠ = no significant correlation between the demographic variable and alexithymia, or no significant differences between the categorical variables (e.g., male and female)
in alexithymia scores; > and < = respectively higher or lower levels of the demographic variable correlated with alexithymia (e.g., older age in years) or significantly greater
alexithymia scores in higher or lower levels of the categorical variable (e.g., older age group); SES = Socioeconomic status.
a
Percentage of patients with TAS-20 scores ≥ 61.
b
Alexithymia prevalence was determined using TAS-20 cut-off scores derived for French samples (see Loas et al., 1996).
c
Percentage of Alexithymia was calculated by the author.
d
The authors have published multiple articles using this participant sample. Therefore, either the original study was included or, if the sample was expanded in a subsequent
study, the study with the largest sample was included.
e
This sample was counted as a general psychiatric sample in present calculations as primary diagnoses were a mix of anxiety, somatoform, and alcohol dependence disorders.
f
Employees paid > 2 months sickness allowance due to major depression were included (excluded inpatients).
g
Author did not define economic status beyond categories ‘good’ and ‘poor’.

47

Table 2
Prevalence of Alexithymiaa in Community Samples, as well as Demographic Differences in Alexithymia
Study

Country

Sample

Prevalence (%)

Results

Bagby, Parker, et al. (1994) Canada

965 university students; 401 university
students

Males > females, younger participants > older
participants (965 sample; r = -.13); ≠ gender, ≠ age
(401 sample)

Balaban et al. (2012)

Turkey

246 university students

Berenbaum, Davis, and
McGrew (1998)

USA

62 university students

Males > females

Beyer (2008)

USA

190 community participants

≠ age

Bogutyn, Kokoszka,
Pałczyński, and Holas
(1999)

Poland

387 university students

Bonnaire et al. (2009)

France

100 community participants (gamblers)

≠ gender

Bonnet, Brejard, and
Pedinielli (2013)

France

256 university students

≠ gender

Bouchard (2009)

Canada

270 university students and community
professionals

≠ gender

Bressi et al. (1996)

Italy

206 community participants and
university students

≠ gender; ≠ age; fewer years of education > greater
years of education (r = -.33)

3.6

10.1
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Table 2 (continued)
Study

Country

Sample

Prevalence (%)

Results

Byrne and Ditto (2005)

Canada

610 community participants (blood
donors)

≠ age

Carpenter and Addis (2000) USA

172 university staff

Males > females; lower education > higher
education (some high school or graduate, some
college, 4-year college graduate, graduate degree)

Campos et al. (2000)

France

1171 university students

Chen, Xu, Jing, and Chan
(2011)

China

1788 university students

≠ gender; older participants > younger participants (r
= .05); ≠ education; ≠ income

De Berardis et al. (2009)

Italy

546 university students (female)

≠ age; ≠ employment status; ≠ marital status

Deborde et al. (2008)

France

253 university students and university
staff

Declercq, Vanheule, and
Deheegher (2010)

Belgium

136 nurses and ambulance staff

Males > females; ≠ age

Dion (1996)

Canada

950 university students

≠ gender

Franz et al. (2008)

Germany

1859 community participants

10.7

13.8b

10.0
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Males > females; ≠ age; lower education > higher
education (school degree and university degree);
lower income > higher income (3 categories of
income); unemployed > employed; divorced >
married; church membership > no church
membership

Table 2 (continued)
Study

Country

Sample

Prevalence (%)

Results

Honkalampi, Hintikka,
Tanskanen, et al. (2000)

Finland

2018 community participants

10.3

Males > females; older participants > younger
participants (age in years); fewer years of education
> greater years of education; lower economic status
> higher economic status (subjective rating of good
and poor), ≠ marital status

Jørgensen et al. (2007)

Denmark

8785 community participants (twins)

Joukamaa et al. (2003ᶜ)

Finland

5028 community participants

7.1

Katz, Martin, Page, and
Calleri (2009)

Canada

67 university students

10.0

Kench and Irwin (2000)

Australia

92 university students

10.9

Kojima, Senda, Nagaya,
Tokudome, and Furukawa
(2003)

Japan

120 employees of a gas utility company

19.2

Lane, Sechrest, and Riedel
(1998)

USA

380 community participants

Males > females; older participants > younger
participants (five age categories); fewer years of
education > greater years of education (r = -.30);
lower SES > higher SES (working, middle, and
upper classes)

Levant et al. (2006)

USA

407 university students

Males > females

Levant et al. (2003)

USA

1151 university students and community
participants

≠ age; ≠ SES; ≠ marital status; lower income >
higher income (six categories)
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Males > females; significant difference in age (did
not report correlation coefficient or direction)
Males > females; lower social class > higher social
class (high, low, and farmer); rural location > urban
location

≠ gender; older participants > younger participants (r
= .07)

Table 2 (continued)
Study

Country

Sample

Prevalence (%)

Results

Loas et al. (2001)

France

769 community participants

Loiselle and Cossette
(2001)

USA; Peru 561 university students (USA and
Peruvian campuses)

Males > females; ethnicity (Peruvian sample > USA
sample)

Lundh et al. (2002)

Sweden

88 community participants and university
students

Males > females; lower education > higher
education (university students vs. community
participants)

Lundh and SimonssonSarnecki (2001)

Sweden

137 community participants

≠ gender

2.2

Males > females; ≠ age; ≠ education; ≠ SES

Lyvers, Onuoha, Thorberg, Australia
and Samios (2012)

314 community participants (drinkers)

Younger participants > older participants (r = -.14)

Mason, Tyson, Jones, and
Potts (2005)

Britain

371 university students

Mattila et al. (2006)

Finland

5418 community participants

Males > females; Older participants > younger
participants (6 age categories); lower education >
higher education (basic, secondary, and higher
schooling); lower income > higher income (3
categories); unmarried > married

McCaslin et al. (2006)

USA

166 urban police officers

Males > females

McNeill (2014)

Australia

171 community participants (couples)

Messina, Fogliani, and
Paradiso (2010)

Italy

111 university students

Montebarocci et al. (2004)

Italy

301 university students

17.9

8.2d

Females > males

Males > females
≠ gender

8.3
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≠ gender

Table 2 (continued)
Study

Country

Sample

Prevalence (%)

Results

Müller et al. (2003)

Germany

224 office workers and skilled workers

6.3

Pandey et al. (1996)

India

285 teachers, office workers, and
university students

≠ gender; ≠ age; fewer years of education > greater
years of education (r = -.23)

Paradiso, Vaidya,
McCormick, Jones, and
Robinson (2008)

USA

24 volunteers from unspecified setting

Older participants > younger participants (r = .48)

Parker, Bagby, et al. (1993) Canada;
Germany;
USA

1003 university students (Canadian,
German, and USA campuses)

Males > females in all samples; location (USA and
Canadian sample > German sample)

Parker, Shaughnessy,
Wood, Majeski, and
Eastabrook (2005)

Canada

123 aboriginal community participants

≠ gender; ≠ age

Parker, Taylor, and Bagby
(1993)

Canada

70 university students

Parker, Taylor, and Bagby
(2001)

Canada

734 community participants

Males > females

Parker et al. (2003)

Canada

1933 community participants

Males > females; fewer years of education > greater
years of education (r = -.23)

Parker, Wood, Bond, and
Shaughnessy (2005)

Canada

562 university students

12.0

Parry (2012)

Australia

323 university students and general
community

9.0

Peters (2006)

USA

162 community participants (African
American)

8.0

22.9

52

≠ gender

Table 2 (continued)
Study

Country

Sample

Picardi et al. (2005)

Italy

221 university students

Prevalence (%)

Results
≠ gender; younger participants > older participants (r
= -.17)

Posse, Hallstrom, and
Finland
Backenroth-Ohsako (2002)

864 childcare employees (female)

7.9

≠ age; lower education > higher education (< high
school and ≥ high school)

Salminen, Saarijärvi,
Äärelä, Toikka, and
Kauhanen (1999)

Finland

1285 community participants

12.8

Males > females; older participants > younger
participants (r = .15 in men and r = -.10 in women);
lower education > higher education (secondary
school graduate and non-graduate); lower SES >
higher SES (private entrepreneur, white-collar
workers, blue-collar workers, and others)

Samson, Huber, and Gross
(2012)

USA

27 community participants

0.0

Scimeca et al. (2013)

Italy

300 university students

10.0

Scott (2009)

USA

150 university students

Taylor et al. (1996)

Canada

234 university students

Tsaousis et al. (2010)

Greece

340 university students

Vanheule et al. (2007)

Belgium

157 university students

2.0

Verrocchio et al. (2010)

Italy

77 university students and community
participants

20.8

Viinikangas et al. (2009)

Finland

669 community participants

Males > females; ≠ age

Yelsma, Hovestadt,
Anderson, and Nilsson
(2000)

USA

295 university students

≠ gender

≠ gender
13.7

Males > females
Males > females; ≠ age
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Table 2 (continued)
Study

Country

Sample

Zhu et al. (2007)

China

870 university students

Prevalence (%)

Results
≠ gender

Note. ≠ = no significant correlation between the variable and alexithymia or no significant differences between the categorical variables (e.g., male and female) in alexithymia
scores; > and < = respectively higher or lower levels of the variable correlated with alexithymia (e.g., older age in years) or significantly greater alexithymia scores in higher
or lower levels of the categorical variable (e.g., older age group); SES = Socioeconomic status.
a
Percentage of patients with TAS-20 scores ≥ 61.
b
Alexithymia prevalence was determined using TAS-20 cut-off scores derived for French samples (see Loas et al., 1996)
c
The authors have published multiple articles using this participant sample. Therefore, either the original study was included or, if the sample was expanded in a subsequent
study, the study with the largest sample was included.
d
Percentage of Alexithymia was calculated by the author.
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Prevalence of alexithymia according to psychiatric diagnosis.
In order to evaluate whether psychiatric diagnosis impacted on the proportion of
patients identified as alexithymic, each of the studies were categorised according to one of
five broad diagnostic groups as follows: depressive disorders (n = 5), anxiety and stress
related disorders (various anxiety disorders, panic disorder, obsessive-compulsive disorder,
and post-traumatic stress disorder, n = 10), somatoform disorders (somatoform disorders,
chronic pain disorder, somatoform disorder with chronic pain, and functional dyspepsia, n =
5), addictive disorders (eating disorders, alcohol and/or substance-dependence, and
pathological gambling, n = 21), or general psychiatric (various diagnoses, n = 13). The study
that involved patients diagnosed with schizophrenia was not included because rates of
alexithymia within this group could not be compared.
The majority of the studies in the addictive, depressive, and somatoform disorders
groups reported rates of alexithymia that were greater than 37.5%, whereas the majority of
the studies in the anxiety and stress-related disorders, and the general psychiatric disorders
groups reported rates of alexithymia that were less than 37.5%. Across all of the diagnostic
groups, two studies in the anxiety and stress-related disorders group reported the lowest rates
of alexithymia at 11.0% (Grabe et al., 2006) and 14% (Rufer et al., 2004) in patients
diagnosed with obsessive-compulsive disorder. Five studies in the addictive disorders group
reported the highest rates of alexithymia at 57% (Eizaguirre et al., 2004), 62.5% (Pinaquy et
al., 2003), 68.8% (Taylor et al., 1996), and 74% (Beales & Dolton, 2000) in patients
diagnosed with eating disorders, and 76.6% in community participants diagnosed as
pathological gamblers (Toneatto et al., 2009).
Two studies in the present review directly compared prevalence rates of alexithymia
and alexithymia scores (as a continuous variable) between different diagnostic groups
(Leweke et al., 2012; Son et al., 2012). Leweke et al. (2012) conducted a study with 1,461
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German psychiatric outpatients and found that the proportion of alexithymic patients was
significantly greater in the group of patients diagnosed with depressive disorders compared to
four other diagnostic groups (adjustment disorders, psychological and behavioural factors
associated with disorders or diseases, somatoform disorders, and eating disorders). In
addition, after controlling for depression symptoms in the anxiety disorders group,
alexithymia scores were only found to correlate significantly with depressive disorders
compared to the other diagnostic groups. In contrast, Son et al. (2012) conducted a study with
388 Korean psychiatric inpatients and outpatients and found no differences in alexithymia
scores or in the proportion of alexithymic patients between four diagnostic groups (depressive
disorders, somatoform disorders, anxiety disorders, and psychotic disorders).
Alexithymia and demographic factors.
Some studies recruited and examined demographic factors in multiple samples.
Therefore, the following results refer to the number of samples rather than the number of
studies. In addition, age and education were the only demographic variables to be examined
as either continuous variables (e.g., age and education in years) or as categorical variables
(e.g., age categories and levels of education). Results of correlational analyses will be
reported on first, for each of these variables. All other demographic variables (e.g., gender
and employment status) were examined as categorical variables only.
In 70.3% of the samples where age was examined as a continuous variable (n = 38),
age was not found to be associated with alexithymia. Small correlations were found between
younger age and higher alexithymia score in four samples (r ranged between -.13 and -.20)
and small to moderate correlations were found between older age and higher alexithymia
score in seven samples (r ranged between .05 and .48). One study reported a significant
correlation between age and alexithymia in their sample but did not report the correlation
coefficient or specify the direction of the association (Jørgensen et al., 2007) and another
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study reported a significant correlation in their sample between older age and higher
alexithymia score but did not report the correlation coefficient (Carano et al., 2006).
In 90% of the samples that examined categorical differences between age and
alexithymia (n = 18), no significant differences were found. In two samples, groups of older
participants reported higher alexithymia scores compared to groups of younger participants.
In 20% of the samples that examined education as a continuous variable (n = 3), no
association was found between years of education and alexithymia score. Small to moderate
correlations were found between fewer years of education and higher alexithymia score (r
ranged between -.12 and -.37) in the remaining 12 samples.
In 41% of the samples that examined categorical differences between education and
alexithymia (n = 9), no significant differences were found. In 13 samples, participants with
lower education levels reported higher alexithymia scores compared to participants with
higher education levels.
In 59.2% of the samples (n = 45), no differences in alexithymia scores were found
between genders. Males reported higher alexithymia scores than females in 28 samples,
whereas females reported higher alexithymia scores in three samples.
In 66.7% of the samples (n = 18), there were no differences in alexithymia scores
between various economic factors (including SES, employment status, and income). In nine
samples, participants who identified as having a lower economic status or income rate
reported higher alexithymia scores. There were no differences in alexithymia scores between
married and unmarried participants in 91% of the samples (n = 20), whereas higher
alexithymia scores were found in unmarried participants in 9% of the samples (n = 2).The
studies that examined other demographic factors generally found significant differences in
alexithymia scores between the factors under examination. One study found higher
alexithymia scores in participants from Peru compared to participants from the USA (Loiselle
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& Cossette, 2001). Another study found no differences in alexithymia scores between
participants from the USA who were identified as Caucasian, African-American, and
Hispanic (Reese, 2008). One study reported higher alexithymia scores in participants who
were members of a church compared to non-members of a church (Franz et al., 2008), and
another study reported higher alexithymia scores in participants residing in a rural location
compared to an urban location (Joukamaa et al., 2003).
Finally, differences were observed in the findings of the present studies based on
whether the study involved a psychiatric sample or a community sample. In 70.5% of the
psychiatric samples, alexithymia scores were not found to be related to demographic
variables, such as gender, age, education, economic status, marital status, employment status,
and other factors included in the present findings (demographic variables were measured as
categorical or continuous variables). In contrast, alexithymia scores were related to
demographic variables in 71.2% of the community samples. In addition, the studies
conducted in psychiatric and community settings where greater prevalence rates of
alexithymia were reported (above the median rate of alexithymia for each group of studies,
respectively) generally found significant differences in alexithymia scores between
demographic variables compared to the psychiatric and community studies that reported
lower prevalence rates of alexithymia. Essentially, the effect of demographic variables on
alexithymia was more salient in studies that involved community participants and in studies
that identified high prevalence rates of alexithymia.
Discussion
A systematic literature review was carried out to obtain a clearer understanding of the
factors that may influence alexithymia rates in order to generate awareness of the alexithymia
construct amongst clinicians and researchers who work with psychiatric populations. This
review examined rates of alexithymia in studies involving psychiatric samples while taking
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psychiatric diagnosis and psychopathology severity into consideration. Rates of alexithymia
in the psychiatric samples were compared to rates of alexithymia reported in studies
involving community samples. This review also evaluated studies that have examined
alexithymia and demographic differences in psychiatric and/or community samples to obtain
a clearer understanding of the factors that may influence alexithymia rates.
Findings from the studies that involved psychiatric samples indicated a high degree of
variability in prevalence rates of alexithymia independent of the study location (Europe or
elsewhere) or sample size (< 100 or ≥ 100 patients). In addition, greater rates of alexithymia
were more frequently reported in psychiatric studies that were undertaken outside of Europe
(predominately North America). The prevalence range of alexithymia in the community
samples were similar across studies involving European samples, which tended to be larger,
and studies involving non-European samples, which tended to be smaller. The similarity in
prevalence range of alexithymia in the community samples, despite sample size or location,
indicates that the differences in prevalence rates in the psychiatric samples for different
countries is unlikely to be a result of sample size or cultural influences on alexithymia scores,
but rather something to do with psychopathology in the different cultures. More specifically,
the variety of psychiatric diagnoses did not differ according to the location that the studies
were undertaken. Therefore, the differences in prevalence rates in the psychiatric samples for
different countries are likely to be a result of diagnostic severity or other unknown factors
that influence psychopathology in different cultures.
It was expected that a greater proportion of studies involving patients with severe
psychiatric illness that are commonly observed in inpatient settings would report higher rates
of alexithymia compared to studies involving patients in outpatient settings. However, most
of the studies that involved inpatient samples reported lower rates of alexithymia compared to
the studies that involved outpatient samples. One explanation for this finding is that treatment
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setting of a patient sample in the studies reviewed did not offer an ideal indication of
psychopathology severity. For example, many studies that involved patients diagnosed with
chronic and acute psychiatric disorders, such as somatoform disorder with chronic pain
(Celikel & Saatcioglu, 2006; Cox et al., 1994) and schizophrenia (Todarello et al., 2005),
recruited patients from outpatient settings. These studies in particular reported some of the
highest rates of alexithymia across studies that involved outpatient samples. Therefore,
speculation about whether psychopathology severity is a likely contributor to greater rates of
alexithymia requires further examination.
Type of psychiatric diagnosis was another sample characteristic considered to
influence the prevalence rate of alexithymia. Most of the studies reviewed where patients
were diagnosed with addictive disorders, depressive disorders, and somatoform disorders
reported higher rates of alexithymia (that is, rates of alexithymia > 37.5%), whereas most of
the studies reviewed where patients were diagnosed with anxiety and stress-related disorders
and general psychiatric samples reported lower rates of alexithymia. These general trends in
the literature were not consistent with a study in the present review (Son et al., 2012) that
directly compared prevalence rates of alexithymia between various psychiatric diagnoses and
found no significant differences. However, the present findings are partially consistent with
the findings of Leweke et al. (2012) who found a significantly greater prevalence rate of
alexithymia amongst patients diagnosed with a depressive disorder compared to other
psychiatric diagnoses. The present findings are also partially consistent with early
alexithymia researchers who considered alexithymia a pathological process underpinning
somatic distress (Sifneos, 1973; Taylor et al., 1997). Moreover, and based on the present
findings, a greater proportion of patients with addictive disorders, particularly eating
disorders, may be identified as alexithymic given that some of the highest rates of
alexithymia were reported in studies involving patients diagnosed with eating disorders.
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The prevalence rates of alexithymia reported in studies that involved psychiatric
patients were generally much higher than the rates reported in studies that involved
community participants, with median rates of alexithymia at 37.5% and 10%, respectively.
Comparing psychiatric and community samples has emphasised the link between alexithymia
and psychopathology. In addition, the common practice across the alexithymia literature of
employing and referring to community and student samples interchangeably was supported
by the present finding that the distribution of alexithymia rates was similar in studies
involving community and student samples.
The relative number of studies that found no differences in alexithymia between
various demographic groups, such as gender, age, employment status, SES, income, and
marital status, indicate that prevalence rates of alexithymia are unlikely to be influence by
demographic factors. In addition, there were a number of contradictory findings in the
literature regarding age and gender. While most studies found non-significant correlations
between age and alexithymia score, some studies found small to moderate negative or
positive correlations between age and alexithymia, indicating that alexithymia was related to
younger participants in some samples and older participants in other samples. Similarly, most
studies reported no differences in alexithymia between genders, yet some studies reported
higher alexithymia scores in males and other studies reported higher alexithymia scores in
females. It may be premature to conclude that these demographic factors do not influence or
relate to the alexithymia construct in some way. However, inconsistencies in the literature,
particularly concerning differences in alexithymia by age and gender, further complicate the
relationship between alexithymia and demographic factors.
In contrast, there is more evidence to suggest that education level may influence
alexithymia rates in psychiatric and/or community populations, as most studies found that
higher alexithymia scores were related to fewer years or a lower level of education. The small
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to moderate correlations that were found between fewer years of education and higher
alexithymia scores across the literature indicate that difficulties identifying, communicating,
and examining ones feelings may have a small to moderate negative impact on the amount of
time an individual spends at school. Perhaps alexithymia prevents individuals from
continuing with higher education, or removes their desire to do so, due to the difficulties they
experience in processing and regulating emotions. Alternatively, additional years of
schooling, particularly at a tertiary level, may have enhanced individuals’ ability to
communicate and verbally articulate their feelings. It would be interesting to assess whether
additional years of schooling was linked to the Difficulty Describing Feelings subscale
specifically, and whether this subscale was responsible for higher total TAS-20 scores in
these studies.
Over two thirds of the studies that found significant differences in alexithymia scores
between demographic factors involved community samples. The exact opposite was true of
the psychiatric studies, with over two thirds of these studies finding non-significant
differences in alexithymia scores between demographic factors. This finding supports a
previous observation by Levant et al. (2006), where significant differences in alexithymia
scores between males and females were more frequently found in non-clinical studies
compared to clinical studies that involved psychiatric and medical patients. Levant suggested
that this observation provided support for his theory of a gender-linked subclinical
alexithymia syndrome (Levant, 1992). However, the present findings dispute the specificity
of a gender-linked subclinical alexithymia syndrome and rather indicate that this syndrome
would be linked to numerous demographic variables and not just to gender. A more probable
explanation for the finding that the effect of demographic factors on alexithymia was more
salient in studies that involved community samples compared to psychiatric samples, is that
the larger sample sizes employed in the community studies provided greater statistical power
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to detect small effects between alexithymia and demographic factors. In addition, the
relationships between alexithymia and different demographic factors may have been detected
more easily in the community samples because variables related to psychopathology were not
present to confound or dilute analyses. The finding that significant differences in alexithymia
scores between demographic factors were more often reported in studies that reported higher
rates of alexithymia could be explained in a similar way: a greater proportion of alexithymic
participants may provide greater statistical power to detect relationships between alexithymia
and different demographic factors. Overall, the findings from the present review indicate that
the possible effect of demographic factors such as gender, age, employment status, SES,
income, and marital status on prevalence rates of alexithymia is likely to be small.
Limitations and Recommendations
There are several limitations to the findings of the present review. The review focused
on studies where the TAS-20 was used as the measure of alexithymia. Although a number of
studies were not included in this review because they employed other measures of
alexithymia, such as the TAS-26 or BVAQ, the populations they studied were represented in
the selection of studies included in this review. Therefore, the decision to include only the
studies employing the TAS-20 was unlikely to make the selected studies unrepresentative of
the populations studied to date. In addition, while systematic reviews do have a number of
advantages, findings from studies that vary in sample size are treated equally when evaluating
the impact of the findings on the conclusions made. The samples sizes of individual studies
identified for this review varied from 20 to 8785. Further empirical examination of these data
is required to draw findings that are more conclusive (i.e., by conducting a meta-analysis)
where issues such as sample size are accounted for in determining the size of effects.
The main limitation observed across the literature was the underrepresentation of
studies undertaken in countries outside of Europe and North America. This lack of
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representation may affect the international applicability of the present findings to psychiatric
and community populations. Previous researchers who have examined the international
prevalence rates of attention-deficit/hyperactivity disorder (see Faraone, Sergeant, Gillberg,
& Biederman, 2003; Polanczyk, de Lima, Horta, Biederman, & Rohde, 2007) have also
raised this issue. The examination of alexithymia rates in Australian psychiatric and
community samples that is conducted in Chapter 4 of the present thesis will contribute to this
gap in the alexithymia literature. There is also a need for more research to directly compare
prevalence rates of alexithymia by psychiatric diagnosis in order to examine the role that
psychiatric diagnosis has on the prevalence rate of alexithymia in the psychiatric population.
The findings of this research need to be extended into clinical practice, with a better
awareness of alexithymia and effective means of alleviating alexithymic features on the
individual. The influence of alexithymia on therapeutic outcome and the impact of different
treatment approaches will be the focus of Chapters 3 and 5 in the present thesis, whereby
more detailed recommendations on these topics are provided.
Conclusion
The purpose of the present literature review was to evaluate prevalence rates of
alexithymia in psychiatric and community samples. The data from studies using the TAS-20
to assess the prevalence of alexithymia indicates that, despite some variability, alexithymia
reflects a pervasive problem affecting a large proportion of psychiatric patients because the
prevalence rates of alexithymia were far greater in the psychiatric population than in the
community population. Trends across the literature indicate that variation in the prevalence
rate of alexithymia in the psychiatric population might have been influenced by psychiatric
diagnosis, with higher rates being reported more frequently in studies involving patients
diagnosed with depressive and somatoform disorders, and especially in studies involving
patients diagnosed with addictive (eating) disorders. This finding is consistent with some
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previous research, yet more studies are needed to directly examine prevalence rates of
alexithymia between different diagnostic groups. In addition, there are other unknown factors
that may influence differences in psychopathology between European and non-European
samples, which might have contributed to the variation in the prevalence rate of alexithymia
in the psychiatric population.
Findings in the literature revealed numerous inconsistencies regarding the influence of
demographic factors on prevalence rates of alexithymia in psychiatric and community
populations, and thus speculation about the impact of demographic differences in study
samples on alexithymia rates remains valid. Future researchers should continue to account for
the potential confounding influence of demographic factors on alexithymia, particularly the
influence of gender, education level, and economic status. Further studies are needed to
report prevalence rates of alexithymia, particularly studies involving large samples and
samples recruited from populations outside of Europe and North America. Studies assessing
the prevalence of alexithymia and directly comparing the prevalence of alexithymia in
different countries are also required to provide a clearer picture of the affliction of
alexithymia worldwide.
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CHAPTER 3
ALEXITHYMIA AND THERAPEUTIC INTERVENTION
Since the early conception of alexithymia, it has been widely assumed that
alexithymia would have an adverse role in the therapeutic process. In particular, alexithymic
individuals were thought to produce poorer therapeutic outcomes compared to nonalexithymic individuals and it has been suggested that alexithymic features are difficult to
improve during therapy (Sifneos, 1972/1973, 1975; Taylor et al., 1997).
There are several reasons for why alexithymia has been considered an obstacle for
therapeutic success. The original clinical observations of patients with alexithymic features
described them as having responded poorly to psychodynamic psychotherapy (Sifneos,
1975). Many forms of psychotherapy regard a certain level of introspection or awareness of
emotion as fundamental to achieving positive outcomes. It has been suggested that an
externally-oriented thinking style predisposes patients to experience difficulties with insightoriented therapies, and a reduced capacity to examine ones thoughts and feelings and to think
symbolically or imaginatively about inner experiences impedes client engagement (Taylor et
al., 1997). Difficulties communicating feelings to others, particularly to healthcare providers,
may hinder the detection and diagnosis of psychiatric disorders as well as the development of
appropriate treatment approaches for individuals with alexithymia (Bamonti et al., 2010).
Alexithymia may also interfere with the utilisation of emotion regulation skills such as
modification and acceptance of emotions, which have been shown to significantly contribute
to the prediction of mental health and treatment gains (Berking et al., 2008). In particular, an
awareness and understanding of emotions are considered basic skills that are needed to
facilitate the application of the emotion regulation skills of modification and/or acceptance
(Berking et al., 2008; Lumley et al., 2005). Therefore, core characteristics of alexithymia,
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namely difficulties identifying and differentiating emotions, may be counter to effective
emotion regulation, thereby obstructing therapeutic success.
Although alexithymia has been defined by deficits that are thought to interfere with
therapeutic outcome, the empirical evidence to support this reasoning has not been consistent.
Some studies have found higher baseline levels of alexithymia to be a predictor of poor
therapeutic outcome (Bach & Bach, 1995; Leweke et al., 2009; Özsahin et al., 2003) while
others have found no link between alexithymia and therapeutic outcome (de Haan,
Schellekens, et al., 2012; Rufer et al., 2010; Rufer et al., 2004; C. Spitzer et al., 2005).
Moreover, some authors have proposed that alexithymia may interfere less with behaviouralbased treatments, such as cognitive behavioural therapy (CBT, Rufer et al., 2010), because an
external focus of alexithymic patients may enhance their adherence to structured exercises
and behavioural recommendations (Lumley et al., 2007). In contrast, it has been proposed
that alexithymic patients may respond unfavourably to treatments that focus on insight or
emotional awareness because they have difficulties examining their problems from a
psychological perspective (Lumley et al., 2007; Sifneos, 1973).
In addition to the assumption that alexithymic individuals produce poor therapeutic
outcomes, it has also been suggested that alexithymic features are difficult to improve during
therapy (e.g., Sifneos, 1972/1973). One reason why alexithymia has been considered difficult
to treat involves the view that alexithymia is a personality trait. The perception of alexithymia
as a personality trait implicates the construct as a vulnerability factor for psychological
distress and persistent psychopathology (Taylor & Bagby, 2004). Personality traits are
defined in such a way as to be pervasive and entrenched aspects of a person’s behaviour,
affect, and cognition (Allemand, Steiger, & Hill, 2013). In this context, alexithymia may
create a persistent problem for patients receiving psychiatric treatment. Moreover, the stable
nature of personality traits mean that they are more resistant to change or change at a slower
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rate over time compared to clinical states, such as negative affect (Allemand et al., 2013).
Nevertheless, stability does not imply that meaningful changes to personality do not occur
(Widiger, 2003). Thus, what is of interest to clinicians is whether alexithymia is a stable
personality trait and the therapeutic approaches most effective at reducing alexithymia.
Researchers have argued that assessment of change in personality is best done by
assessing multiple forms of stability because assessing mean-level stability alone for
example, cannot account for individual differences in personality in response to treatment
effects nor can it provide strong support for the stable nature of personality traits (Allemand
et al., 2013; Santor, Bagby, & Joffe, 1997). Change in personality, and alexithymia, has
typically been approached by assessing mean-level stability and relative stability.
Mean-level stability refers to the extent to which the average alexithymia score for a
group of patients remains consistent over time (Allemand et al., 2013). It is typically
measured using t-tests or analysis of variance, where a significant difference in the average
scores measured across time equates to mean-level change. Mean-level stability provides a
general indication of change in alexithymia scores on average: at a group level. However,
while this form of assessment can produce a constant standard deviation with a varying mean,
there is no guarantee that patients’ scores are not changing by roughly the same amount for
each patient in the group. That is, alexithymia scores in a group can maintain the same
distribution from the mean even though some patients’ scores may increase and other
patients’ scores may decrease over time. Relative stability, on the other hand, is a stronger
indicator that patients’ scores are roughly changing by the same amount.
Relative stability is implied by a high test-retest correlation, where a perfect positive
correlation indicates that patients’ alexithymia scores have changed by exactly the same
amount over time (Allemand et al., 2013). Furthermore, high test-retest correlations can be
interpreted as, for an arbitrary score the distances to nearby scores before treatment are
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roughly maintained after treatment. This would amount to an approximation of a movement
or translation of scores.
It is noteworthy that relative stability and mean-level stability are conceptually and
statistically distinct as they provide different interpretations of change in a set of scores over
time (Allemand et al., 2013). Therefore, observing average change in scores at a group level
does not rule out the possibility of observing relative stability among scores at an individual
level (Santor et al., 1997). For example, high degrees of relative stability have been observed
in the personality traits neuroticism and extraversion over a five-week treatment period in
addition to significant mean-level declines in these traits and in depression severity (Santor et
al., 1997). Similarly, relative stability and mean-level change in alexithymia has been
observed in previous studies (e.g., Luminet et al., 2001).
Some have argued that, in addition to examining numerous forms of stability, change
in alexithymia must be examined in the context of acute change in clinical symptoms before
judgments are made concerning the degree to which alexithymia can change following
treatment (Luminet et al., 2001). Significant reductions in alexithymia scores alongside
reductions in clinical symptoms is one of the primary observations that led critics to conclude
that alexithymia is not a stable trait construct, and rather that alexithymia is dependent on
change in clinical symptoms and thus does not constitute a personality vulnerability to
psychopathology (Honkalampi, Hintikka, Saarinen, et al., 2000). Few studies have examined
different forms of stability in the context of change in clinical symptoms. Therefore,
premature conclusions are likely to have been reached regarding the stability of alexithymia,
whether it is dependent on clinical symptoms, and whether it influences the onset and course
of psychopathology (Luminet et al., 2001; Santor et al., 1997).
Many studies examining change in alexithymia have found significant mean-level
reductions in alexithymia over time in response to various therapeutic interventions,
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including pharmacotherapy (Luminet et al., 2001), CBT (Rufer et al., 2010), and
psychotherapy (Ogrodniczuk, Sochting, Piper, & Joyce, 2012). Given the responsivity of
alexithymia to various interventions, many researchers have speculated about the most
effective interventions to treat alexithymia. Taylor (1992) and Lumley et al. (2007) have
suggested the potential value of autogenic training and biofeedback for the treatment of
alexithymia, yet no empirical studies have examined these approaches. In addition, some
authors have also described targeted treatments for alexithymia including: a three-step
integrative therapy that helps patients to develop accounts of their own affective experiences
and make use of communication with others in order to manage stress (Vanheule, Verhaeghe,
& Desmet, 2011), a skills-based training intervention that helps patients to attend to and
express their feelings more effectively (Kennedy & Franklin, 2002), and a hypnotic imagery
intervention that helps patients process emotions and activate mental images (Gay, Hanin, &
Luminet, 2008). However, the majority of studies that have investigated change in
alexithymia have done so incidentally to investigating change in clinical symptoms following
treatment for a psychiatric disorder of interest. Therefore, researchers have speculated about
which prevailing approaches to treatment would be the most effective in reducing levels of
alexithymia. Treatments conducted in a group format have been considered beneficial for
alexithymic patients as groups provide a safe and supportive environment for patients to
experience and learn about emotions through a wide range of interpersonal situations (ApfelSavitz, Silverman, & Bennett, 1977; Swiller, 1988). Supportive therapy, which has a more
directive and external focus, has been considered more effective at reducing alexithymia in
patients compared to traditional interpretive or analytic psychotherapies (Ogrodniczuk, Joyce,
& Piper, 2013; Sifneos, 1975), which demand a level of introspection that may be
challenging for these patients (Ogrodniczuk et al., 2013). Behavioural interventions like CBT
also provide a directive and external focus and have been suggested to be less anxiety
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provoking for alexithymic patients as they focus on coping with unpleasant emotions and
bodily sensations due to physiological reactivity (Rufer et al., 2010) rather than an inward
examination of the self. Lastly, some have proposed that emotion-focused interventions that
target the identification and expression of emotion are the most effective type of treatment to
mitigate alexithymia features (Becker-Stoll & Gerlinghoff, 2004; Hyer, Woods, &
Boudewyns, 1991; Vanheule et al., 2011), since these interventions aim to enhance the way
patients process and experience emotions.
Overall, questions remain in the literature regarding the impact of alexithymia on
therapeutic outcome, the stability of alexithymia following therapeutic intervention, and the
most effective treatment approaches for reducing alexithymia levels. Vast differences
between studies, including psychiatric diagnosis, treatment approaches, and outcome
measures, have made it difficult to discern a clear picture of alexithymia’s role in the
therapeutic process. Understanding this role is essential if therapeutic interventions designed
to treat psychiatric disorders are to be improved, particularly since alexithymia is considered
to be a predisposing factor for psychological distress and persistent psychopathology (Taylor
et al., 1997).
The purpose of the present literature review was to evaluate the role of alexithymia in
the therapeutic process, while taking factors such as therapeutic approach and outcome
measure into consideration. This review also evaluated the stability of alexithymia following
therapeutic intervention and the effectiveness of several therapeutic interventions in reducing
alexithymia levels. A comprehensive and systematic review of the literature will help to
clarify the most effective therapeutic interventions that are currently available as well as
provide more compelling recommendations for clinicians and future researchers working in
psychiatric settings about how to improve alexithymic features in psychiatric patients.
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It should be noted that Kojima (2012) conducted a recent review of the prognostic
value of alexithymia among clinical populations. However, it was judged that the focus and
inclusion criteria of the present review differed significantly enough to be carried out. For
example, the present review focused on the role of alexithymia in therapeutic intervention
rather than the influence of alexithymia on prognosis of psychopathology. In addition, the
present search criteria included psychiatric samples exclusively rather than clinical samples
in general (i.e., medical and psychiatric). Therefore, the present review offers a broader
insight into the role of alexithymia in the therapeutic process and is more specific to the
psychiatric population.
Method
Search
A systematic search was conducted through Medline, ProQuest Psychology Journals,
and Web of Science databases to obtain potentially relevant articles. The database searches
were supplemented by searching Google Scholar for relevant articles and by crosschecking
the articles that were included in the previous systematic review (Chapter 2). All databases
were searched using combinations of the following keywords: alexithymia, treatment
outcome, stability, and TAS-20. The title and abstract of the identified articles were then
screened for relevance against the inclusion and exclusion criteria. If abstracts were not
available or unable to provide sufficient information, the full-text article was retrieved and
screened in the same manner.
Inclusion and Exclusion Criteria
For inclusion, studies were required to: (1) include adults (≥ 18 years old), (2)
measure alexithymia using the total TAS-20 score, (3) include psychiatric participants, and
(4) be published in the English language. Studies involving participants diagnosed with
72

organic mental disorders (e.g., dementia), mental retardation, developmental disorders, or
physiological conditions as the primary diagnosis were excluded. Also excluded, were studies
examining change in categories of alexithymia exclusively without examining change in
alexithymia scores because categorical changes in alexithymia can give a misleading
impression of instability since alexithymia scores bordering a category would only need to
change slightly to move into another category (Luminet et al., 2001). The census data for
inclusion ranged from 1994 to 2014.
Data Extraction
Data from the selected studies were independently extracted onto a standardised form
developed for this review. The following data were extracted: author(s) and date, country of
the study, characteristics of participants (sample size and psychiatric diagnosis), treatment
approach, format (individual or group), method (whether the study used comparative or
control groups), outcome measure(s), and study findings (which included information about
the form of stability examined and whether the study accounted for change in clinical
symptoms). This information is summarised in two tables: Table 3 presents the data from
studies that examined the impact of alexithymia on therapeutic outcome and Table 4 presents
the data from studies that examined the stability or change in alexithymia following
treatment. In addition, the recruitment setting and treatment specifications (duration of
treatment and individual sessions) for each study were extracted (recruitment setting data not
shown in tables).
Results
The search effort resulted in 177 citations. Twelve duplicate citations were removed
and 118 citations were excluded as irrelevant after they were screened for potential relevance
as based on the inclusion and exclusion criteria. The remaining 47 full-text articles were
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assessed for eligibility. Sixteen studies were excluded for the following reasons: five studies
were follow-up studies that shared a participant sample with a study that was already
included in the present review (Honkalampi, Hintikka, Antikainen, Lehtonen, & Viinamäki,
2001; Honkalampi et al., 2007; Honkalampi, Hintikka, Laukkanen, et al., 2001; Rufer et al.,
2006; Saarijärvi, Salminen, & Toikka, 2006), four studies examined TAS-20 factors only
rather than total TAS-20 score (De Gucht, Fischler, & Heiser, 2004; McCallum, Piper,
Ogrodniczuk, & Joyce, 2003; Ogrodniczuk et al., 2004, 2005), three studies were not
prospective (Carton et al., 2010; Chen et al., 2011; Coriale et al., 2012), two studies examined
alexithymia at baseline only (Joyce, O'Kelly, Ogrodniczuk, Piper, & Rosie, 2012; Viinamäki
et al., 2003), one study examined change in TAS-20 categories exclusively (Honkalampi,
Hintikka, Saarinen, et al., 2000), and one study examined change in TAS-20 scores in
remitted patients only rather than the whole patient sample (Marchesi et al., 2005). Cleland,
Magura, Foote, Rosenblum, and Kosanke (2005) published a second study (Rosenblum et al.,
2005) that involved the same sample but they examined and reported on different aspects of
alexithymia and therapeutic outcome, and thus these studies were counted as two separate
studies in the present review. In addition, Speranza, Loas, Guilbaud, and Corcos (2011)
extended their earlier study (Speranza et al., 2007) by examining whether treatment approach
influenced alexithymia stability. Their latter study was not counted as a separate study in the
present review, but the findings were noted in the results column of the 2007 study. After this
process of eligibility, 31 relevant studies were retained for review. Of these 31 studies, 16
studies examined the role of alexithymia in therapeutic outcome (the impact of alexithymia
on treatment outcome), 24 studies examined the stability or change in alexithymia following
therapeutic intervention (the impact of treatment on change in alexithymia), and 9 studies
examined both the role of alexithymia in therapeutic outcome and change in alexithymia
following therapeutic intervention.
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Characteristics of the Studies Examining Alexithymia and Therapeutic Outcome
Most of the 16 studies that examined the influence of alexithymia on therapeutic
outcome were undertaken in Europe (n = 9) and involved sample sizes smaller than 100
participants (n = 10). The size of the samples ranged from 32 to 297 (median = 77.5). The
studies involved psychiatric samples with the following diagnoses: addictive disorders (n =
6), anxiety disorders (n = 3), varied diagnoses (i.e., general psychiatric samples, n = 4),
depressive disorders (n = 2), and somatoform disorders (n = 1). The study samples were
recruited from outpatient settings (n = 9), inpatient settings (n = 4), and hospitals and/or
clinics (n = 2). One study did not specify a recruitment setting. All of the studies reported that
the therapeutic interventions employed were effective at reducing clinical symptomatology in
patient samples.
The formats of treatment employed in the present studies were group therapy (n = 8),
individual therapy (n = 2), and a combination of group and individual therapy (n = 3). Three
studies did not specify a treatment format. Approaches to treatment included CBT (n = 6),
psychodynamic psychotherapy (n = 3), CBT or a motivational intervention (n = 2),
unspecified psychotherapy (n = 2), pharmacotherapy (n = 1), pharmacotherapy with exposure
techniques (n = 1), and psychoeducation with assertiveness training (n = 1). Half of the
studies conducted treatments that ran for less than 12 weeks, ranging between 5 to 10 weeks
and half of the studies conducted treatments that ran for 12 weeks or more, ranging between
12 to 18 weeks. Two studies did not specify the duration of treatment. Ten studies specified
the number of days per week sessions were conducted (ranging between 1 to 7 days per
week) and seven studies specified session duration (ranging between 1 to 9 hours per
session). Eight studies used specific measures of therapeutic outcome relevant to psychiatric
diagnosis (e.g., Beck Depression Inventory, Beck, Steer, & Brown, 1996), four studies used
general outcome measures such as those assessing psychological distress (e.g., Global
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Severity Index, Derogatis, 1983), and four studies used a combination of specific and general
measures of therapeutic outcome.
All of the studies that examined the influence of alexithymia on therapeutic outcome
employed a prospective research design. Four studies involved longitudinal follow-up periods
of 3 months (Ogrodniczuk et al., 2012), 6 months (Rufer et al., 2010), and 12 months (de
Haan, Schellekens, et al., 2012; Spek et al., 2008). One study employed an experimental
research design with a control group (Reese, 2008). Two studies employed a comparative
research design, yet only one of these studies examined the influence of alexithymia on
therapeutic outcome between the treatment conditions (Rosenblum et al., 2005).
The Influence of Alexithymia on Therapeutic Outcome
It is important to note that the studies that found alexithymia to have a negative
influence on therapeutic outcome(s) refer to findings that higher alexithymia scores
correlated with lower outcome scores or that alexithymic patients produced less improvement
in outcomes compared to non-alexithymic patients. This is different to finding that
alexithymic patients, or patients with higher alexithymia scores, made no therapeutic gains or
that they reported greater clinical symptomatology after treatment than at the beginning of
treatment. Moreover, no study in the present review found that higher alexithymia scores
were associated with better therapeutic outcome.
Of the 16 studies that examined the influence of alexithymia on therapeutic outcome,
2 studies found that higher levels of alexithymia before treatment had a negative influence on
therapeutic outcome. Six of the remaining studies that were reviewed found that higher levels
of alexithymia had a negative influence on some therapeutic outcomes (i.e., these studies
reported mixed findings) and eight studies found that alexithymia had no influence on
therapeutic outcome.
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The two studies that found higher alexithymia levels before treatment to have a
negative influence on therapeutic outcome examined categorical levels of alexithymia (TAS20 scores ≥ 61) on therapeutic outcome. Grabe et al. (2008) conducted a study on 297 general
psychiatric inpatients who were treated with 8 to 12 weeks of psychodynamic group
psychotherapy. In this study, patients identified as alexithymic had significantly higher
psychological distress scores before, during, and after treatment compared to the nonalexithymic patients. Özsahin et al. (2003) conducted a study on 65 patients diagnosed with
depression who were treated with 10 weeks of pharmacotherapy and found that although
alexithymic patients and non-alexithymic patients had similar levels of depression before
treatment, the alexithymic patients reported significantly smaller reductions in depression
severity after treatment compared to the non-alexithymic patients. In addition, higher
alexithymia scores before treatment were found to significantly predict higher depression
scores after treatment.
The six studies that reported mixed findings regarding the influence of alexithymia on
therapeutic outcome employed a variety of therapeutic approaches that most commonly
involved CBT (n = 3). The average duration of treatment across the studies that reported
mixed findings was 10 weeks (ranging between 10 and 12 weeks). In addition, all of these
studies were primarily conducted in North America and involved patients diagnosed with
addictive disorders. One of these studies conducted a 3 month follow-up assessment of 68
general psychiatric patients treated with intensive integrated therapy (Ogrodniczuk et al.,
2012). Ogrodniczuk et al. (2012) found that, after controlling for change in depression
severity, less improvement in alexithymia over the course of treatment was associated with
less improvement in interpersonal problems after treatment and with higher levels of
aggression at the 3 month follow-up. However, alexithymia during the treatment period
(measured at pre, post, and change score from pre to post treatment) was not associated with
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interpersonal problems at the 3 month follow-up. One study in the present review examined
the impact of alexithymia after treatment on therapeutic outcome (Fukunishi, Kikuchi, et al.,
1997). In this study, patients who were identified as alexithymia after treatment reported
significantly greater anxiety severity compared to patients who were non-alexithymic after
treatment.
The eight studies that found alexithymia to have no influence on therapeutic outcome
involved CBT (n = 5), psychodynamic psychotherapy (n = 2), and intensive psychotherapy (n
= 1). The average duration of treatment in these studies was 10 weeks (ranging between 5 and
18 weeks). These studies were conducted primarily in Europe and involved various
diagnostic samples. Four of the five studies that employed CBT conducted follow-up
assessments. These studies found alexithymia to have no impact on therapeutic outcome at 6
month (Rufer et al., 2010) and 12 month follow ups (de Haan, Schellekens, et al., 2012;
Reese, 2008; Spek et al., 2008).
There were two studies in the present review that examined the influence of
alexithymia on therapeutic outcome using a control or comparative condition (Reese, 2008;
Rosenblum et al., 2005). Reese (2008) conducted a study involving 84 patients diagnosed
with somatoform disorders who were treated with either 10 weeks of CBT or a control
condition that involved regular visits to their primary care physician. Alexithymia was not
found to be a mediator in the association between treatment type and therapeutic outcome
(somatisation symptoms, physical functioning, and mental health). Reese concluded that
alexithymia could not account for the difference in effectiveness of CBT, compared to the
control condition, in modifying therapeutic outcomes. Rosenblum et al. (2005) conducted a
study involving 186 patients diagnosed with substance misuse disorders who were treated
with either 10 weeks of CBT or motivational intervention. Alexithymia was not shown to
moderate the differences in addiction severity after treatment between the treatment
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conditions. However, patients with higher levels of alexithymia before treatment abstained
from alcohol for shorter periods following motivational intervention compared to CBT.
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Table 3
Influence of Alexithymia on Therapeutic Outcome
Reference

Country

Sample

Treatment

Outcome measure

Results

Balestrieri, Isola,
Baiano, and Ciano
(2013)

Italy

98 binge eating
disorder and eating
disorders not
otherwise specified
outpatients

Psychoeducation and
assertiveness training (10
weeks, 1x p/week for 1.5
hours)

Eating disorder symptoms subscales body
dissatisfaction and bulimia
(EDI-BD and EDI-BU);
mean body mass index
(BMI); median weekly
frequency of binges;
recovery (proportion of
patients without diagnosis)

Pre TAS-20 ≠ Δ MI, ΔEDI-BD,
ΔEDI-BU, frequency of binges;
lower pre TAS-20 scores ~
recovery

Becker-Stoll and
Gerlinghoff (2004)

Germany

47 eating disorder
outpatients (female)

Intensive group
psychotherapy (16 weeks, 7x
p/week, from 08:00 to 17:00
hours)

Eating disorder symptoms
(EDI); recovery scorea
(higher = better recovery);
prognosis scorea (higher =
better prognosis)

Pre TAS-20 ≠ any outcome
variable

Cleland et al. (2005ᵇ) USA

186 substance misuse (1) group CBT or (2) group Addiction Severity Index for
outpatients
motivational intervention
alcohol and drug use (ASI);
(10 weeks, 2x p/week); data therapeutic alliance (HAQ)
collected at pre and post
treatment 9-21 weeks
(average 15 weeks)
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Higher pre TAS-20 predicted
higher ASI alcohol, ≠ ASI drugs;
higher pre TAS-20 ~ lower HAQ
scores

Table 3 (continued)
Reference

Country

Sample

Treatment

Outcome measure

de Haan,
Schellekens, et al.
(2012)

Netherlands

100 alcohol
dependent
inpatients (male)

One month detox before
inpatient group therapy:
cognitive behavioural
approach; data collected at
12 month follow up

Abstinence one month
Pre TAS-20 ≠ any outcome measures at 12
before follow up; ≤ 5 units month follow up
of alcohol use p/day over
12 months before follow
up; time in treatment;
improvement on
EuropASI domains
Alcohol, Psychiatry, and
Drugs

Fukunishi, Kikuchi, Japan
et al. (1997)

50 anxiety disorder Pharmacotherapy and
patients
repeated hyperventilation
provocations and
respiratory training
combined with exposure
in vivo (12 weeks, 1x
p/week)

Grabe et al. (2008)

297 general
psychiatric
inpatients

Germany

Severity of anxiety
(HAM-A); severity of
depression (HAM-D)

Psychodynamic group
General psychological
therapy (8-12 weeks, 3x
distress (GSI)
p/week for 1.5hrs); data
collected at pre, during (4
weeks), and post
treatment; individual
therapy (1hr p/week)
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Results

Higher pre TAS-20 ~ higher post HAM-A,
≠ HAM-D; alexithymic patients post
treatment ~ higher post HAM-A

Alexithymics (TAS-20 ≥ 61) had higher
GSI pre, during, and post treatment

Table 3 (continued)
Reference

Country

Sample

Treatment

Outcome measure

Results

Joyce et al. (2013)

Canada

32 general
psychiatric
outpatients

(1) psychodynamic group
psychotherapy (18 weeks);
(2) 73% patients had
concomitant
pharmacotherapy

Symptom distress,
interpersonal
relationships, social role
performance and global
functioning (OQ-45);
interpersonal distress
(IIP); quality of life
(QOLI)

Controlling for trait anxiety, pre TAS-20 ≠
any outcome measures

Ogrodniczuk et al.
(2012)

Canada

68 general
psychiatric
outpatients

Intensive integrated group
therapy (12 weeks, 5x
p/week, for 3hrs); data
collected at pre and post
treatment, and 3 month
follow up

Interpersonal problems
(IIP-28) total score and
subscales: Interpersonal
Sensitivity, Interpersonal
Ambivalence, and
Aggression

Controlling for Δ depression, pre to post
ΔTAS-20 ~ pre to post ΔIIP-28 scores and
lower Aggression (IIP-28 subscale) at
follow up; post to follow-up ΔTAS-20 ~
post to follow-up ΔIIP-28 scores; pre, post,
or ΔTAS-20 ≠ IIP-28 scores at follow-up

Özsahin et al.
(2003)

Turkey

65 depressive
outpatients

Pharmacotherapy (SSRI
20mg/day for 10 weeks)

Severity of depression
(HAM-D)

Higher pre TAS-20 ~ higher post HAM-D

Reese (2008)

USA

84 somatoform
disorder patients

(1) individual CBT or (2)
control: primary care
physician medical
treatment as usual (10
weeks, 1x p/week, for1hr);
data collected at pre and
post treatment, and 6 and
12 month follow up

Somatisation symptoms
(CGI); physical
functioning & mental
health (SF-36)

Pre TAS-20 not mediator of ~ between
treatment and outcomes
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Table 3 (continued)
Reference

Country

Sample

Treatment

Outcome measure

Results

Rosenblum et al.
(2005ᵇ)

USA

186 substance
misuse outpatients

(1) group CBT or (2)
group motivational
intervention (10 weeks, 2x
p/week); data collected at
pre and post treatment 921 weeks (average 15
weeks)

Addiction Severity Index
for alcohol and drug use
(ASI); days abstinent
(TLFB method)

Pre TAS-20 moderated abstinence but not
ASI in type of therapy: higher pre TAS-20
~ higher abstinence after group CBT vs.
group motivational intervention

Rufer et al. (2004)

Germany

42 obsessivecompulsive
disorder inpatients

(1) individual and group
CBT (mean 10 weeks,
individual 3-4x p/week +
group unspecified; (2)
60% patients had
concomitant
pharmacotherapy (SSRI)

OCD symptoms (Y-BOCS Pre TAS-20 ≠ ΔY-BOCS
change scores)

Rufer et al. (2010)

Germany

55 panic disorder
outpatients

(1) short-term group CBT Panic and agoraphobia
(5 weeks, 1x p/week, for symptoms (PAS); global
2.5 hrs); (2) 35% patients improvement (CGI)
had concomitant
pharmacotherapy; data
collected at pre and post
treatment, and 6 month
follow up

Spek et al. (2008)

Netherlands

119 sub-threshold CBT; data collected at pre Depression severity (BDI) Pre TAS-20 ≠ DI post or follow up
depressive patients and post treatment, and 1
year follow up

C. Spitzer et al.
(2005)

Germany

100 general
psychiatric
inpatients

Psychodynamic group
Interpersonal functioning
therapy (mean 6 weeks, 3x (IIP-C); post scores and
p/week, for 1hr)
change scores
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Pre TAS-20 ≠ post or follow up PAS or
CGI

Pre TAS-20 category ≠ post IIP-C or ΔIIPC

Table 3 (continued)
Reference

Country

Sample

Treatment

Outcome measure

Results

Stasiewicz et al.
(2012)

USA

71 alcohol
dependent
outpatients

(1) group CBT plus one of
two treatment enhancers:
(a) affect regulation
training, or (b) health and
lifestyle (12 weeks, 1x
p/week)

Alcohol dependence
severity (SADD);
drinking-related negative
consequences (DrInC);
drinks per drinking day;
percent days heavy
drinking

Controlling for anxiety, depression, pretreatment scores, and number of sessions
attended, higher pre TAS-20 ~ higher post
SADD, but no other outcome measure

Note. ≠ = no association; ~ = association; Δ = change score from pre to post treatment; ASI = Addiction Severity Index (McLellan et al., 1992); BDI = Beck Depression
Inventory (Beck et al., 1996); CGI = Clinical Global Impression Scale (Guy, 1976); DrInC = The Drinker Inventory of Consequences (W. R. Miller, Tonigan, &
Longabaugh, 1995); EDI = Eating Disorder Inventory (Garner, Olmstead, & Polivy, 1983); EuropASI = European Addiction Severity Index (Hendriks, Kaplan, van Limbeek,
& Geerlings, 1989); GSI = Global Severity Scale (Derogatis, 1983); HAM-A = Hamilton Anxiety Rating Scale (Hamilton, 1959); HAM-D = Hamilton Depression Rating
Scale (Hamilton, 1960); HAQ = Helping Alliance Questionnaire (Luborsky et al., 1996); IIP = The Inventory of Interpersonal Problems (L. M. Horowitz, Rosenberg, Baer,
Ureño, & Villaseñor, 1988); IIP-C = The Inventory of Interpersonal Problems-Circumplex Scales (L.M. Horowitz, Alden, Wiggins, & Pincus, 2000); IIP-28 = Inventory of
Interpersonal Problems-28 (Stern, Kim, Trull, Scarpa, & Pilkonis, 2000); OQ-45 = The Outcome Questionnaire-45 (Asay, Lambert, Gregersen, & Goates, 2002); PAS = The
Panic and Agoraphobia Scale (Bandelow, 1995); QOLI = The Quality of Life Inventory (Lehman, 1996); SADD = The Short Alcohol Dependence Data Questionnaire
(Davidson & Raistrick, 1986); SF-36 = Short-Form Health Survey (Ware & Sherbourne, 1992); TLFB = Time-Line Follow-Back (Sobell & Sobell, 1992); Y-BOCS = YaleBrown Obsessive Compulsive Scale (Goodman et al., 1989).
a
Recovery scores based on improvement in body mass index and/or frequency of bingeing and/or vomiting p/week; prognosis scores based on danger of relapse.
b
These studies shared data, but were counted as two separate studies as they assessed different therapeutic outcomes.
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Characteristics of the Studies Examining Change in Alexithymia
The majority of the 24 studies that examined change in alexithymia following
therapeutic intervention were undertaken in Europe (n = 13) and involved sample sizes
smaller than 100 patients. The sample sizes ranged from 3 to 297 (median = 61.5). The
studies involved psychiatric samples with the following primary diagnoses: addictive
disorders (n = 10), varied diagnoses (i.e., general psychiatric samples, n = 5), anxiety
disorders (n = 4), depressive disorders (n = 2), somatoform disorders (n = 2), and
schizophrenia (n = 1). The study samples were recruited from outpatient settings (n = 10),
inpatient settings (n = 7), hospitals and/or clinics (n =6), and community advertisement (n =
1).
Most studies did not specify a treatment format. However, the studies that did specify
a treatment format employed group therapy (n = 5), individual therapy (n = 3), and a
combination of group and individual therapy (n = 3). Approaches to treatment included CBT
(n = 6), naturalistic and non-active approaches (e.g., detoxification, n = 4), psychoeducation
with assertiveness training or behavioural management skills (n = 2), pharmacotherapy (n =
2), and eight studies used a variety of other therapeutic approaches (including a 12-step
program, psychodynamic psychotherapy, unspecified psychotherapy, pharmacotherapy with
exposure techniques, a targeted treatment for alexithymia, affect school therapy, and an
interpretive or supportive psychotherapy condition). Two of the studies reviewed did not
specify a treatment approach. Most of the studies conducted treatments that ran for less than
12 weeks (n = 11), ranging from 2 to 12 weeks. Five studies did not specify the duration of
treatment. Eleven studies specified the number of days per week that sessions were conducted
(ranging between 1 to 7 days per week) and seven studies specified session duration (ranging
between 50 minutes to 9 hours per session).
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All of the studies that examined change in alexithymia employed a prospective
research design. Eight studies were longitudinal and involved follow-up periods of 2 to 3
months (Clyne & Blampied, 2004), 3 months (Ogrodniczuk et al., 2012), 6 months
(Ogrodniczuk et al., 2013; Rufer et al., 2010), 12 months (Kennedy & Franklin, 2002; Reese,
2008), or numerous follow up periods of 3 to 12 months (Todarello et al., 2005) and 6 to 24
months (Honkalampi et al., 2004). One study employed an experimental research design with
a control group (Reese, 2008) and one study employed a comparative research design
(Ogrodniczuk et al., 2013). One study employed a case-series design that involved three
patients (Kennedy & Franklin, 2002).
Stability and Treatment of Alexithymia
All of the 24 studies that examined change in alexithymia following therapeutic
intervention assessed mean-level stability. Relative stability was assessed in 12 of these
studies in addition to mean-level stability. In addition, 14 of the studies that examined change
in alexithymia following therapeutic intervention took into account change in clinical
symptoms. All together, 20 studies found mean-level instability or change in alexithymia
scores following treatment. The remaining four studies found mean-level stability, or no
change, in alexithymia scores following treatment.
Of the 20 studies that reported mean-level change in alexithymia over time, 9 studies
examined whether this change was dependent of the severity of clinical symptoms. Two
studies found significant moderate to large positive correlations (according to Cohen, 1988)
between alexithymia change scores and clinical severity change scores (Baker et al., 2012;
Fukunishi, Kikuchi, et al., 1997). However, the other seven studies found that mean-level
change in alexithymia was independent of baseline clinical severity (Rufer et al., 2010) or
change in clinical severity (Ogrodniczuk et al., 2013), and that change in clinical severity
accounted for a non-significant amount of variance in alexithymia change (de Timary et al.,
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2008; Luminet et al., 2001; Melin et al., 2010; Ogrodniczuk et al., 2012) or a small amount of
variance in alexithymia change (16%, Grabe et al., 2008).
Three of the four studies that found mean-level stability in alexithymia showed that
alexithymia scores remained stable despite significant decreases in clinical symptomatology
during the same period (Picardi et al., 2012; Rufer et al., 2004; Todarello et al., 2005). The
other study that found mean-level stability in alexithymia showed that, while depression
severity decreased over time, alexithymia and general psychopathology severity remained
stable (Pinard et al., 1996). These studies involved small sample sizes (≤ 42), which were
below the median sample size of the studies in the present review. Sample size was the only
factor to differentiate the studies that found change in alexithymia scores across time from
those that did not; factors such as the country of the study, sample diagnosis, recruitment
setting, or duration of treatment were similarly varied across all of the studies that examined
change in alexithymia.
Relative stability in alexithymia was reported by 100% of the 12 studies that assessed
it. Three studies confirmed the relative stability of alexithymia during follow up periods of 6
months (Rufer et al., 2010), 12 months (Todarello et al., 2005), and 3 years (Speranza et al.,
2007).
Seven of the 12 studies also examined factors that could impact on the relative
stability of alexithymia. Using regression analyses, all of these studies showed that
alexithymia before treatment was the best predictor of alexithymia after treatment compared
to various measures of clinical severity assessed before and after treatment, such as
depression severity (de Haan, Joosten, et al., 2012; de Haan et al., 2014; de Timary et al.,
2008; Grabe et al., 2008; Luminet et al., 2001; Picardi et al., 2012; Todarello et al., 2005).
There were two studies in the present review that examined change in alexithymia
using a control or comparative condition (Ogrodniczuk et al., 2013; Reese, 2008). These
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studies showed significant declines in alexithymia scores across all treatment conditions.
However, even greater declines in alexithymia scores were observed following particular
treatment conditions. Reese (2008) found a significant decline in alexithymia scores in both a
CBT and control condition during treatment and at 12 month follow up. While significantly
greater declines in alexithymia scores were found in the CBT condition during treatment
compared to the control condition, from post treatment to 12 month follow up there was no
difference in the amount of change in alexithymia between the treatment conditions.
Ogrodniczuk et al. (2013) obtained similar findings in 112 general psychiatric patients when
comparing supportive and interpretive psychotherapy conditions. While alexithymia scores
declined significantly from before to after 20 weeks of treatment in both conditions, there
was a significantly greater decline in alexithymia scores from before to after treatment in the
supportive psychotherapy condition. However, despite further decreases in alexithymia
scores at 6 month follow up, there was no difference between the treatment conditions in the
amount of change in alexithymia scores during this time.
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Table 4
Change in Alexithymia Following Treatment
Reference

Country

Akkerman (1996) USA

Sample

Treatment

Results

139 substance
misuse inpatientsa

12-step program with AA components (7- Mean instability
10 days of detox then 26-30 day treatment)

Baker et al.
(2012)

United Kingdom 55 general
psychiatric patients

Individual CBT; unspecified duration

Mean instability; ΔTAS-20 ~ Δ SI

Balestrieri et al.
(2013)

Italy

98 binge eating
disorder and eating
disorders not
otherwise specified
outpatients

Psychoeducation and assertiveness
training (10 weeks, 1x p/week for 1.5
hours)

Mean instability

Becker-Stoll and Germany
Gerlinghoff
(2004)

47 eating disorder
outpatients (female)

Intensive group psychotherapy (16 weeks, Mean instability; relative stability
7x p/week from 08:00 to 17:00 hours)

Clyne and
New Zealand
Blampied (2004)

11 binge eating
Group psychoeducation and behavioural
Mean instability at each study phase
b
disorder participants management (11 weeks, 1x p/week for
(female)
2hrs); data collected at pre and post, and 23 month follow up

de Haan, Joosten, Netherlands
et al. (2012)

140 substance use
disorder inpatients

Individual and group CBT for 3 months;
some patients received additional 5
sessions of CBT with motivational
interviewing, relapse prevention, and
social skills training
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Mean instability and relative stability; pre TAS-20
score predicted post TAS-20 score over and above
clinical symptoms of anxiety and depression;
intervention type did not account for change in
TAS-20

Table 4 (continued)
Reference

Country

Sample

Treatment

Results

de Haan et al.
(2014)

Netherlands

101 substance use
disorder inpatients

Detoxification (2-3 weeks, average 14
days); pharmacotherapy in first few
days (benzodiazepines and/or
methadone)

Mean instability and relative stability; pre TAS-20 score
predicted post TAS-20 score over and above post
depression severity

Fukunishi,
Kikuchi, et al.
(1997)

Japan

50 anxiety disorder Pharmacotherapy, repeated
patients
hyperventilation provocations,
respiratory training and exposure in
vivo (12 weeks, 1x p/week)

Mean instability; ΔTAS-20 ~ ΔHAM-A; ΔTAS-20 ≠
ΔHAM-D

Grabe et al.
(2008)

Germany

297 general
psychiatric
inpatients

Psychodynamic group therapy (8-12
weeks, 3x p/week for 1.5hrs); data
collected at pre, during (4 weeks), and
post treatment; individual therapy (1hr
p/week)

Mean instability from pre to post, and pre to discharge;
ΔTAS-20 ~ ΔGSI; relative stability from pre to discharge;
pre TAS-20 best predictor of post TAS-20

Honkalampi et
al. (2004)

Finland

106 depressive
outpatients

≥ 50% of time patients received
pharmacotherapy, psychotherapy, and
inpatient care; data collected at pre
treatment and 6 month, 12 month, and
24 month follow ups

Mean instability at each study phase

Kennedy and
Australia
Franklin (2002)

Case series: 3
anxiety disorder
patients

Skills-based intervention for
Mean instability from pre to post; 2/3 cases mean
alexithymia specifically (16-24 weeks, instability at 4 week post and 12 month follow up
1x p/week); data collected at pre
(average of 4 weeks prior to treatment
and pre treatment), post, and 4 weeks
post treatment, and 12 month follow up

Luminet et al.
(2001)

46 depressive
outpatients

Pharmacotherapy (antidepressants);
data collected at pre treatment and 14
week follow up

Canada
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Mean instability; ΔTAS-20 ≠ ΔHAM-D; relative stability;
pre TAS-20 best predictor of post TAS-20

Table 4 (continued)
Reference

Country

Sample

Treatment

Results

Melin et al.
(2010)

Sweden

46 somatoform
disorder outpatients
(chronic benign
pain)

(1) Affect School group therapy (8
weeks, 1x p/week); (2) 22% had
concomitant pharmacotherapy
(antidepressants)

Mean instability; ΔTAS-20 ≠ ΔHAD-D

Ogrodniczuk et
al. (2013)

Canada

112 general
psychiatric
outpatients

(1) interpretive individual
psychotherapy or (2) supportive
individual psychotherapy (20 weeks, 1x
p/week, for 50mins); data collected at
pre and post treatment, and 6 month
follow up

Mean instability during each study phase and therapy type,
after controlling for pre to 6 month follow up Δ DI; pre to
post TAS-20 > decline in supportive vs. interpretive
therapy; post to follow up TAS-20 ≠ between therapy
types

Ogrodniczuk et
al. (2012)

Canada

68 general
psychiatric
outpatients

Intensive integrated group therapy (12 Mean instability from pre to post; pre to post ΔTAS-20 ≠
weeks, 5x p/week for 3hrs); data
pre to post Δ DI; stability from post to 3 month follow up
collected at pre and post treatment, and
3 month follow up

Picardi et al.
(2012)

Italy

41 general
psychiatric
inpatients

Unspecified treatment (average 8
weeks, ± 32.6 days)

Pinard et al.
(1996)

Canada

21 substance
dependent patients

Detoxification (4-6 weeks, average 36.6 Mean stability; ΔTAS-20 ~ Δ DI and ΔGSI
days)

Reese (2008)

USA

84 somatoform
disorder patients

(1) individual CBT or (2) control:
primary care physician medical
treatment as usual (10 weeks, 1x
p/week, for1hr); data collected at pre
and post treatment, and 6 and 12 month
follow up
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Mean and relative stability for both groups; pre TAS-20
best predictor of post TAS-20

Mean instability from pre to post: pre to post TAS-20 >
decline in treatment vs control; relative stability from pre
to post in both groups; post to follow up TAS-20 ≠
between groups

Table 4 (continued)
Reference

Country

Sample

Treatment

Rufer et al.
(2010)

Germany

55 panic disorder
outpatients

(1) short-term group CBT (5 weeks, 1x Mean instability from pre to post and pre to follow up,
p/week, for 2.5 hrs); (2) 35% patients
after controlling for BDI; relative stability from pre to post
had concomitant pharmacotherapy; data and post to follow up
collected at pre and post treatment, and
6 month follow up

Rufer et al.
(2004)

Germany

42 obsessivecompulsive
disorder inpatients

(1) individual and group CBT (mean 10 Mean stability and relative stability
weeks, individual 3-4x p/week + group
unspecified; (2) 60% patients had
concomitant pharmacotherapy (SSRI)

Speranza et al.
(2007ᶜ)

France

102 eating
disorders patients
(female)

Unspecified treatment: 57%
psychotherapy, 40% pharmacotherapy,
and/or combination of these; data
collected at pre treatment and 3 year
follow-up

Mean instability and relative stability; independent of
treatment type (Speranza et al., 2011)

Stasiewicz et al. USA
(2012)

71 alcohol
dependent
outpatients

(1) group CBT plus one of two
treatment enhancers: (a) affect
regulation training, or (b) health and
lifestyle (12 weeks, 1x p/week)

Mean instability in both samples

de Timary et al. Belgium
(2008)

70 alcohol
dependent
inpatients

Detoxification (14-18 days);
pharmacotherapy in first 48hrs
(benzodiazepines)

Mean instability; ΔTAS-20 ≠ Δ DI or ΔSTAI-S; relative
stability; pre TAS-20 best predictor of post TAS-20

Todarello et al.
(2005)

29 schizophrenic
outpatients

Pharmacotherapy (antipsychotics,
Mean stability at 3, 6, and 12 month follow ups; relative
antidepressants, and/or mood
stability from pre to 12 month follow up; pre TAS-20 best
stabilisers); data collected at pre
predictor of post TAS-20
treatment and 3, 6, and 12 month follow
ups

Italy

Results
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Table 4 (continued)
Reference

Country

Sample

Treatment

Results

Note. AA = alcoholics anonymous; ≠ = no association; ~ = association; Δ = change score from pre to post treatment; BDI = Beck Depression Inventory (Beck et al., 1996);
HAD-D = Hospital Anxiety and Depression Scale – depression subscale (Zigmond & Snaith, 1983); HAM-A = Hamilton Anxiety Rating Scale (Hamilton, 1959); HAM-D =
Hamilton Depression Rating Scale (Hamilton, 1960); GSI = Global Severity Index (Derogatis, 1983); STAI-S = State-Trait Anxiety Inventory – state portion (Spielberger,
1983).
a
68 patients completed post-tests.
b
Participants were recruited via community advertisement and then diagnosed using The Binge Eating Scale (Gormally, Black, Daston, & Rardin, 1982) and The
Questionnaire on Eating and Weight Patterns (R. L. Spitzer et al., 1993).
c
This study published follow up data, which is presented in the corresponding results column.
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Discussion
Assumptions about the role of alexithymia in the therapeutic process have been
widely debated in the literature and infrequently investigated. A systematic literature review
was carried out to evaluate the influence of alexithymia on therapeutic outcome, to
investigate the stability of alexithymia during therapeutic intervention, to evaluate the
efficacy of different therapeutic approaches that are currently available to improve
alexithymic features in psychiatric patients, and to provide more compelling
recommendations for clinicians and future researchers working with alexithymic patients.
The studies in the present review were evenly divided between those that found
higher levels of alexithymia to have a negative influence on all or some therapeutic outcomes
and those that found alexithymia to have no influence on therapeutic outcomes. The studies
that conducted follow-up assessments also presented conflicting findings, with one study
finding that change in alexithymia scores during treatment had a negative influence on
patients’ aggression levels 3 months after treatment (Ogrodniczuk et al., 2012) and other
studies finding that alexithymia scores before treatment had no influence on therapeutic
outcome 6 to 12 months after treatment (e.g., de Haan, Schellekens, et al., 2012; Rufer et al.,
2010). No major differences were found between these groups of studies concerning the
therapeutic approach or outcome measures that were employed.
However, the studies that found alexithymia to have a negative influence on all or
some therapeutic outcomes differed to the studies that found alexithymia to have no impact
on therapeutic outcomes in terms of the psychiatric diagnosis of the study samples and the
location where the studies were undertaken. The studies that reported alexithymia to have a
negative influence on all or some therapeutic outcomes involved samples that were mainly
diagnosed with addictive disorders and that were predominately undertaken in North America
whereas the studies that found alexithymia to have no influence on therapeutic outcomes
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involved various diagnostic samples and were predominately undertaken in European
countries. This finding indicates that alexithymia is more problematic for patients with
addictive disorders and for patients residing in North America in terms of the benefit they
may receive from treatment. A probable explanation for this finding is that the greater
proportions of alexithymic patients reported in the studies that involved patients diagnosed
with addictive disorders and the studies that were undertaken in North America (see Chapter
2) provided more statistical power to detect a relationship between alexithymia and
therapeutic outcome.
One study in the present review provided a stronger level of evidence than the other
studies on this issue by employing a control group. Reese (2008) found that the effectiveness
of CBT compared to a control condition in modifying therapeutic outcome was independent
of alexithymia score. However, as the study sample was small and involved patients
diagnosed with somatoform disorders, the generalisablity of the finding to other psychiatric
populations may be limited.
It was difficult to observe trends regarding whether alexithymia has more or less
influence on therapeutic outcome following certain interventions because there was a scarcity
of studies employing comparative conditions. The overrepresentation of CBT compared to
other therapeutic interventions across the studies in the present review added to the
ambiguity. Given that most of the present studies employed CBT and reported that
alexithymia had no impact on therapeutic outcome, it is reasonable to suggest that
alexithymia interferes less with CBT compared to other interventions. One study in the
present review provided some evidence to support the idea that alexithymia may interfere less
with behavioural-based treatments, such as CBT (Rufer et al., 2010). Rosenblum et al. (2005)
found that patients with higher alexithymia scores before treatment achieved better a
therapeutic outcome (abstaining from alcohol) following CBT compared to motivational
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intervention. However, the lack of influence of alexithymia on therapeutic outcome does not
appear to be specific to CBT as studies that employed numerous other interventions also
found alexithymia to have no influence on therapeutic outcomes. Moreover, alexithymia was
shown to have no influence on outcomes following treatments that demanded insight and
emotional awareness from patients (psychodynamic psychotherapy, Joyce et al., 2013; C.
Spitzer et al., 2005), and which are considered more problematic for alexithymic patients
compare to CBT (Lumley et al., 2007; Sifneos, 1973).
The vast majority of studies that examined change in alexithymia following
therapeutic intervention observed mean-level change in alexithymia scores. Numerous
treatment approaches were shown to be effective at reducing alexithymia scores, including
CBT (e.g., Reese, 2008; Stasiewicz et al., 2012), pharmacotherapy (Luminet et al., 2001), and
more traditional psychodynamic psychotherapies (Grabe et al., 2008). Therefore, in general,
alexithymic patients appear to be able to improve their abilities to recognise, communicate,
and examine their feelings following most therapeutic interventions. However, given that the
majority of these studies involved quasi-experimental designs that did not involve control
groups, it is not clear whether reductions in alexithymia were a result of treatment effects or
other factors. The only study in the present review that did employ a control condition found
that alexithymia scores declined during both CBT and the control condition (Reese, 2008).
This finding raises the question about whether alexithymia levels are likely to decline over
time regardless of therapeutic intervention, perhaps as a response to declines in clinical
symptomatology. Moreover, studies that found declines in alexithymia following non-active
therapeutic interventions, such as detoxification (de Haan et al., 2014; de Timary et al.,
2008), support the idea that change in alexithymia may be dependent on change in clinical
symptoms.
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Many of the studies that did investigate whether mean-level change in alexithymia
was dependent on change in clinical symptoms showed that change in alexithymia after
treatment was largely independent of baseline clinical severity or change in clinical
symptoms from before to after treatment (de Timary et al., 2008; Grabe et al., 2008; Luminet
et al., 2001; Melin et al., 2010; Ogrodniczuk et al., 2013; Ogrodniczuk et al., 2012; Rufer et
al., 2010). The findings from these studies do not support the idea that alexithymia is merely
a state-dependent construct (see Honkalampi, Hintikka, Saarinen, et al., 2000) that fluctuates
alongside fluctuations in clinical states. Rather these findings indicate that reductions in
alexithymia are more likely to result from other influences, such as treatment effects.
The present review of the literature found that there is not enough evidence to clarify
speculation about which treatment approaches may be more effective at reducing alexithymia
because only one study compared the influence of different therapeutic interventions.
Ogrodniczuk et al. (2013) found a greater decline in alexithymia following supportive
psychotherapy compared to interpretive psychotherapy. This finding strengthens the
proposition that supportive psychotherapy is more suited to alexithymic patients compared to
traditional interpretive or analytic psychotherapies because supportive approaches provide
more reassurance and less anxiety provocation, which alexithymic patients require (Sifneos,
1975). On the other hand, in the same study Ogrodniczuk et al. (2013) also found no
differences in the amount of change in alexithymia between supportive psychotherapy and
interpretive psychotherapy at 6 month follow-up despite further decreases in alexithymia
scores. Reese (2008) observed a similar finding where alexithymia scores declined more
during CBT compared to a control condition. However, there was no difference in the amount
of change in alexithymia between the treatment conditions from post treatment to 12 month
follow up. The findings from these studies indicate that although alexithymia scores may be
reduced to a greater extent during certain interventions and compared to no treatment at all,
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once an intervention has finished so does the added benefit of that intervention for
alexithymic patients and that the superiority of one treatment over another does not appear to
be long lasting.
All of the studies in the present review that examined relative stability in alexithymia
confirmed that alexithymia was relatively stable. Several studies in the present review also
observed relative stability in alexithymia during follow-up periods of 6 months (Rufer et al.,
2010), 12 months (Todarello et al., 2005), and 3 years (Speranza et al., 2007). In addition, all
of the studies that went on to examine the relative stability of alexithymia in the context of
change in clinical symptoms provided stronger evidence to support alexithymia as a stable
personality trait by showing that the relative stability of alexithymia was independent of
individual differences in clinical severity (de Haan, Joosten, et al., 2012; de Haan et al., 2014;
de Timary et al., 2008; Grabe et al., 2008; Luminet et al., 2001; Picardi et al., 2012; Todarello
et al., 2005).
Some studies in the present review indicated that while alexithymia scores may
decline on average for a group of patients following treatment, moderate to high levels of
alexithymia can persist for some patients (Grabe et al., 2008) and may increase their risk of
experiencing ongoing psychiatric symptomatology (Fukunishi, Kikuchi, et al., 1997).
Fukunishi, Kikuchi, et al. (1997) found that although alexithymia scores declined during
treatment, patients that remained alexithymic after treatment reported significantly greater
anxiety severity compared to patients that were non-alexithymic after treatment. In addition,
Ogrodniczuk et al. (2012) found that less change in alexithymia during treatment (i.e., more
stable alexithymia) was associated with poorer therapeutic outcomes after treatment. Patients
with persistent levels of alexithymia that remain after treatment are more likely to experience
residual symptoms (symptoms that persist despite evident response to treatment or remission
of mental illness) that may prolong their recovery from a psychiatric illness.
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Limitations and Recommendations
A delimitation of the present systematic review was a focus on the consistency of
reported associations rather than an assessment of the strength of these associations. Thus, the
results of studies that found large effect sizes could be masked by the results of many studies
that found small effect sizes. In addition, the samples sizes of individual studies identified for
this review varied from 3 to 297 and the findings from these studies were treated equally with
this method. Further empirical examination of these data will help to substantiate the present
findings (i.e., by conducting a meta-analysis) where issues such as sample size are accounted
for in determining the size of effects.
A number of limitations were observed across the majority of studies in the present
review. In general, small sample sizes were included, which reduced the statistical power and
generalisability of findings. The studies were predominately conducted in Europe and North
America, and most studies involved patients diagnosed with addictive disorders. Thus,
conclusions from the present review would be most applicable to psychiatric populations
similar in nature to those with eating and substance use disorders and those receiving
psychiatric treatment in Europe and North America.
Little was known about the degree of treatment integrity involved in the present
studies that were reviewed, as few studies assessed the extent to which interventions were
delivered as intended, or provided detailed information about the interventions that were
employed, including how they differed from other interventions. A lack of treatment integrity
poses a threat to inferences drawn about the relationship between treatment and outcome as
well as the comparative efficacy of different treatments (Bhar & Beck, 2009). The mixed
findings in literature regarding the relationship between alexithymia and therapeutic
intervention raise questions about treatment integrity. For example, it is not known whether
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the present studies that employed CBT adhered to a similar CBT protocol or how many of the
interventions delivered were unique to CBT.
An important factor that has received little attention in the reviewed literature is the
influence of persistent or stable levels of alexithymia after treatment on therapeutic outcome.
Preliminary evidence suggests that patients are at greater risk of experiencing residual
symptoms when their level of alexithymia is high after treatment (Fukunishi, Kikuchi, et al.,
1997) or changes little during treatment (Ogrodniczuk et al., 2012). Replication of these
studies is needed to confirm whether stable levels of alexithymia influence therapeutic
outcome. From a practical perspective, acknowledgement that alexithymic patients may be
vulnerable to residual symptomatology following treatment may encourage clinicians to
closely monitor their patient’s progress and help alexithymic patients to prepare and
accommodate for such difficulties.
Only one study in the present review employed a control condition when examining
the influence of therapeutic intervention on change in alexithymia (Reese, 2008).
Unfortunately, this study did not report whether there were significant reductions in clinical
symptoms for the control group nor was there an investigation into whether the change in
alexithymia scores was dependent on change in clinical symptoms. Therefore, there is a lack
of experimental research to examine whether alexithymia levels are likely to decline
regardless of therapeutic intervention or in response to a decline in clinical symptomatology.
In addition, only three studies (Cleland et al., 2005; Ogrodniczuk et al., 2013; Rosenblum et
al., 2005) employed different therapeutic interventions for comparison and consequently a
detailed understanding of alexithymia’s role across different therapeutic interventions could
not be acquired. It will be necessary for future researchers to compare different therapeutic
approaches in order to understand whether alexithymia interferes more with particular
approaches or whether particular approaches are more effective at reducing alexithymia.

100

Study 2 (Chapter 5) in the present thesis will contribute to this body of research by examining
the relationship between alexithymia and two types of group therapy.
Conclusion
The purpose of the present literature review was to evaluate the role of alexithymia in
the therapeutic process. It can be confidently stated that the role of alexithymia in the
therapeutic process remains contentious. Findings from the studies that examined the
influence of alexithymia on therapeutic outcome were divided, including findings from
studies that employed control or comparative conditions. Half of the literature in the present
review indicated that higher levels of alexithymia before treatment may lead to poorer
therapeutic outcomes, particularly in patients diagnosed with addictive disorders and in
patients receiving treatment in North America. However, robust studies with experimental
designs are needed to corroborate these findings. In addition, speculation about whether
alexithymia may interfere more with certain interventions remains unresolved as very few
studies in the present review compared different therapeutic interventions.
The literature also indicates that numerous therapeutic approaches are likely to be
effective at improving alexithymia at a group level. However, questions remain regarding the
most effective therapeutic approach to improve alexithymia as very few studies in the present
review employed comparative treatment conditions. There was strong evidence in the
literature to support the idea that alexithymia is a relative stable personality trait. Therefore,
although alexithymia can be reduced following therapeutic intervention, some degree of
alexithymia is likely to remain as a stable aspect of a patient’s psychology. Future studies will
need to examine the extent of change in alexithymia compared to clinical states (e.g., effect
sizes) in order to substantiate that alexithymia is more resistant to change following
intervention compared to clinical states.
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CHAPTER 4
STUDY 1
Alexithymia is typically more prevalent in the psychiatric population compared to the
general community population (see Chapter 2). It has been proposed that individuals who
experience greater difficulties identifying, communicating, and examining their inner
thoughts and feelings are at greater risk of developing psychiatric illness (Taylor et al., 1997).
However, even simple estimates of an alexithymic individual’s risk of developing psychiatric
illness are problematic because rates of alexithymia in the psychiatric literature have been
shown to vary substantially (see Chapter 2). For instance, rates of alexithymia have ranged
from 17.6% (Müller et al., 2003) to 51.0% (Joyce et al., 2013) in studies that have involved
general psychiatric samples.
The majority of studies reporting on prevalence rates of alexithymia have been
undertaken in Europe and North America. The literature review conducted in Chapter 2 noted
that psychiatric rates of alexithymia reported in studies undertaken outside of Europe (mainly
in North America) tended to be greater than the psychiatric rates of alexithymia reported in
studies undertaken in Europe. There are few studies on alexithymia in the Australian
population, and no information about the prevalence rate of alexithymia in the Australian
general psychiatric population. Australian research evaluating the occurrence of alexithymia
in psychiatric samples would contribute to the literature by examining where these rates fall
in comparison to the range of alexithymia rates that have been reported globally. Research in
this area would also provide normative information for clinicians working with psychiatric
populations in Australia (as compared to norms derived from the original Canadian outpatient
sample, Bagby, Parker, et al., 1994).
Comparisons of prevalence rates of alexithymia in psychiatric and community
populations have generally been made across international studies that have examined these
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populations separately. Studies that compare prevalence rates of alexithymia between
psychiatric and community samples from a common population are ideal as they reduce the
amount of variation that is incurred between international samples, whereby the main
difference between the samples is the presence of a psychiatric diagnosis and not numerous
cultural differences, including social, political, historical, and economic circumstances.
However, few researchers have compared prevalence rates of alexithymia between general
psychiatric and community samples from one common population.
Another way to obtain accurate estimates of prevalence rates of alexithymia is to
consider the influence of potential confounding factors on alexithymia, such as demographic
differences in study samples. Previous researchers have suggested that higher rates of
alexithymia are found in certain demographic groups, such as males (e.g., Levant, 1992).
However, the literature review reported on in Chapter 2 revealed many inconsistencies in the
literature regarding the relation between alexithymia and demographic factors, particularly
gender, education level, and economic status. In addition, this review found that alexithymia
was related to demographic factors more often in studies that involved community samples
and less often in studies that involved psychiatric samples. Examining the extent to which
these demographic factors may impact on high levels of alexithymia in general psychiatric
and community samples from one common population may lead to a more accurate
understanding of this issue. Moreover, research in this area could help to identify
demographic groups of people who experience higher levels of alexithymia as well as
encourage researchers to control for the potential confounding influence of these factors in
future alexithymia research.
Differences in psychological distress severity may also help to explain variability in
the prevalence rates of alexithymia in general psychiatric and community populations. There
is growing evidence of a link between alexithymia and psychological distress, with the
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outcomes of several studies showing that alexithymic individuals report significantly greater
levels of psychological distress than non-alexithymic individuals in psychiatric (Evren et al.,
2008; Leweke et al., 2009; C. Spitzer et al., 2005) and community samples (Bouchard, 2009;
Liang & West, 2011). While the direction of causality is unclear, a prominent theory
proposes that alexithymia poses a vulnerability to the development and maintenance of
psychiatric illness because it reflects a broad deficit in the cognitive processing of emotion
that leads to elevated psychological distress (Taylor et al., 1997).
Some evidence for the theory that alexithymia is a risk factor for psychiatric illness
has been provided by studies that have found high alexithymia scores to be associated with
the new incidence of psychiatric symptomatology in non-clinical samples (Heinrichs et al.,
2005; McCaslin et al., 2006; Tolmunen et al., 2011) and with the persistence of psychiatric
symptomatology in psychiatric samples over time (Bach & Bach, 1995; Loas et al., 1997;
Reese, 2008; Viinamäki et al., 2002). Another way to examine the link between alexithymia
and psychological distress is to compare the strength of this association in different
populations, such as in general psychiatric and community samples. If the strengths of the
relationship between alexithymia and psychological distress were similar in a psychiatric and
community sample, it would indicate that sample group is not a contributing factor to the
relationship and that psychological distress is a probable consequence for most individuals
with alexithymia. Findings about the relationship between alexithymia and psychological
distress may reinforce our understanding of alexithymia as a risk factor in the development of
psychopathology.
The overall aim of Study 1 was to examine differences in alexithymia between a
sample of Australian psychiatric patients and a sample of Australian community participants.
There were three specific aims: 1) to compare differences in alexithymia between the sample
groups; 2) to examine the potential influence of gender, education level, and employment
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status on alexithymia scores in the sample groups; and 3) to compare the association between
alexithymia and psychological distress in the sample groups. Alexithymia was expected to be
more prevalent in the psychiatric sample compared to the community sample, in line with
overall findings in the literature. Differences in alexithymia scores were expected to be
dependent on demographic variables of gender, education level, and employment status in the
community sample but not in the psychiatric sample, in line with the general trend in the
literature. Also, given the theory that alexithymia is a risk factor for psychiatric illness
(Taylor et al., 1997), the relationship between alexithymia and psychological distress was
expected to be a similar strength in both sample groups.
Method
Participants
The present study drew data from an outpatient mental health facility, which was
linked with a tertiary hospital in the southern suburbs of Perth Western Australia. The
psychiatric sample comprised 151 patients1 who attended the outpatient facility at some time
in 2008 to 2011, inclusive. The overall sample ranged in age from 18 to 66 years (M = 41.89
years, SD = 12.23 years) and comprised 109 (72.2%) females patients. Hospital psychiatrists
had diagnosed patients based on the International Classification of Mental and Behavioural
Disorders (ICD-10, World Health Organization, 2010). When a patient had been diagnosed
with more than one psychiatric condition, only the primary diagnosis was noted in the present
research. Patients had been diagnosed with a variety of psychiatric conditions (see Table 6)
1

Note: Data was initially collected from 284 psychiatric patients. Since many of the patients attended more than

one therapy group and completed additional tests data were retained from patients’ earliest therapy group to try
to control for possible cumulative treatment effects. In addition, some patients were removed from the dataset if
they had not completed corresponding sets of pre and post alexithymia and psychological distress tests. These
conditions resulted in the final sample size of 151.
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and many had been prescribed psychotropic medication as part of their ongoing treatment.
They had also experienced a diverse treatment history, ranging from one inpatient
hospitalisation to numerous hospitalisations and/or ongoing private treatment. All patients
required a written referral from their case-manager to attend the facility, who was either a
general practitioner or an allied health professional from an external agency. Only patients
who did not require inpatient care or major adjustments to their medication and who were
free of alcohol or substance misuse were eligible for the outpatient program.
The community sample consisted of 216 participants living in Perth, Western
Australia. This sample ranged in age from 18 to 75 years (M = 33.48 years, SD = 14.37 years)
and comprised 157 (72.7%) females participants.
Measures
Psychiatric patients completed the 20-item Toronto Alexithymia Scale (TAS-20), the
42-item Depression Anxiety Stress Scale (DASS, Lovibond & Lovibond, 1995), and a
demographic questionnaire and consent form for the data to be used in research (see
Appendices A and B for a copy of these documents; the TAS-20 is not provided for copyright
reasons). Community participants completed the TAS-20, 21-item DASS, a demographic
questionnaire, and a consent form for the data to be used in research (see Appendices C, D,
and E for a copy of these documents).
Alexithymia.
The TAS-20 (Bagby, Parker, et al., 1994) is a self-report questionnaire designed to
measure alexithymia as a personality trait. Participants respond on a 5-point Likert type rating
scale for each of the 20 items, from 1 (strongly disagree) to 5 (strongly agree). Each item
corresponds to one of three factors associated with the TAS-20: difficulties identifying
feelings and distinguishing feelings from bodily sensations of emotional arousal (DIF, factor
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one), difficulties describing feelings to others (DDF, factor two), and externally oriented
thinking (EOT, factor three). Three factor scores and a total score can be calculated. Cut-off
scores for the TAS-20 have been recommended: individuals scoring below 51 are considered
non-alexithymic and those scoring above 61 are considered alexithymic (Taylor et al., 1997).
A recent study by Parry (2012) determined that the cut-off scores developed by Taylor et al.
(1997) were appropriate for use in Western Australian samples. The TAS-20 is the most wellestablished and widely used instrument to measure alexithymia, with evidence of high
internal consistency in community and psychiatric samples (α > .79, agby, Parker, et al.,
1994; α > .77, Meganck et al., 2008), as well as adequate test-retest reliability, construct
validity, and criterion validity in community and psychiatric samples (Bagby, Parker, et al.,
1994).
Psychological distress.
The DASS is a self-report questionnaire designed to measure symptoms of
depression, anxiety and stress. There are two versions of the DASS: the short 21-item version
and the original 42-item version. It has been suggested that the DASS-21 is preferable for
research purposes because it reduces administration time (The University of New South
Wales, 2013). Participants respond on a 4-point Likert type rating scale, where response
options range from 0 (did not apply to me at all) to 3 (applied to me very much, or most of the
time). The DASS-21 and DASS-42 yield three scale scores for depression, anxiety, and
stress, as well as a total composite score (ranging from 0 to 63 and 0 to 126, respectively).
The total score measures negative emotional symptoms (Sinclair et al., 2012; The University
of New South Wales, 2013) and can be interpreted as reflecting negative affectivity or
psychological distress (Gregorio, 2010; Page, Hooke, & Morrison, 2007; Willemsen, Markey,
Declercq, & Vanheule, 2011). The DASS-21 is found to have good reliability for the separate
scales of depression (α = .91), anxiety (α = .84), and stress (α = .90) (Lovibond & Lovibond,
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1995). Similarly the DASS-42 is found to have good reliability for depression (α = .94),
anxiety (α = .88), and stress (α = .93) (Nieuwenhuijsen, de Boer, Verbeek, Blonk, & van
Dijk, 2003). Both versions of the DASS have been found to be valid and reliable measures
for psychiatric populations (Ng et al., 2007; Page et al., 2007) and community populations
(Crawford & Henry, 2003; Gregorio, 2010). The total score of the DASS-21 for the
community sample was doubled so that it could be compared to the norms of the original
DASS-42 (The University of New South Wales, 2013).
Procedure
Both the Faculty of Computing Health and Science Ethics Committee at Edith Cowan
University and the ethics committee of the tertiary hospital granted approval for the present
research. The psychiatric patients completed the TAS-20 and DASS-42 assessments at the
beginning and at the completion of group therapy. These assessments were then filed at the
outpatient mental health facility, collected by the researcher, and organised into an electronic
database.
The participants from the community sample were recruited using snowball sampling.
A study flyer was placed at various community-oriented locations around Perth (Appendix
F). Participants were offered a chance to win one of two $100 department store gift vouchers
for participating in the present research. Participants who responded to the study flyer
accessed the package of assessments via a web link (URL) to Qualtrics (a password protected
survey software program). The package included an information sheet for potential
participants (Appendix G), a consent form, the TAS-20, DASS-21, a demographic
questionnaire, and a list of counselling and support organisations (Appendix H).
Participant anonymity was maintained as names and contact details were not
necessary in completing the package of assessments. However, participants were given the
choice to enter a draw to win one of two $100 Department store gift vouchers by emailing an
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address created specifically for this purpose. This email address was provided following
completion of the assessments and the personal details were not linked to any assessment
information. Participants were informed that winners would be required to nominate a postal
address in order to obtain their prize. Data were obtained from the Qualtrics database
approximately six months after collection began. This data were then organised and exported
into Statistical Package for the Social Sciences version 19.0 (SPSS, IBM Corp., 2010) for
analysis.
Statistical Analysis
While a large body of research has supported the TAS-20 as a good measure of
alexithymia, several studies have challenged this view, arguing that there is unacceptably low
internal reliability in the externally oriented thinking factor in particular (Besharat, 2008;
Gignac et al., 2007; Meganck et al., 2008; Vorst & Bermond, 2001). In addition, while
previous studies have evaluated the reliability of the TAS-20 for use in Australian community
populations (see Gignac et al., 2007; Parry, 2012), no study could be located that has
evaluated the reliability of the TAS-20 for use in Australian psychiatric populations.
Therefore, the present study examined the internal reliability of the overall TAS-20 scale and
three factors for use with the psychiatric and community samples before further analyses
were conducted. Bivariate correlations between the separate TAS-20 factors were also
examined. Internal reliabilities of the overall TAS-20 and three factors were estimated using
Chronbach’s alpha (α), where coefficient values of .50, .60, and .70 correspond to
unacceptable, acceptable, and good levels of internal reliability, respectively (see George &
Mallery, 2003).
Chi-Square analysis was used to examine differences in demographic factors between
the psychiatric and community samples. Three, two-way analysis of variance (ANOVA) tests
were conducted to examine whether differences in alexithymia scores (dependent variable)
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between the psychiatric and community samples (independent variable) were dependent on
the gender of the participants, their educational background, or current employment status
(independent variables). Chi-Square analysis was used to examine differences in categorical
levels of alexithymia between the psychiatric and community samples. An ANOVA was
conducted to examine differences in psychological distress scores between the psychiatric
and community samples. Pearson’s correlations and Fisher’s Z transformation were used to
examine correlations between alexithymia and psychological distress and to standardise these
distributions, respectively. Pearson’s correlation coefficient (r) values of .10, .30, .50, and
.70, correspond to small, medium, large, and very large effect sizes, respectively (see Cohen,
1988). Effect sizes for ANOVA’s were estimated using partial eta-squared (partial η2), where
values of .01, .09, and .25, correspond to small, medium, and large effect sizes, respectively
(see Cohen, 1988). All data were analysed using SPSS version 19.0 (IBM Corp., 2010).
Results
Data Preparation
No data was missing from the community sample. There were a small number of
missing items remaining in the psychiatric dataset (0.23%). These missing items were
assumed to be missing at random (see Fichman & Cummings, 2003). The expectation
maximisation (EM, IBM Corp., 2010) method was chosen over listwise deletion in order to
maximise the size of the dataset. The EM method involved replacing missing test items with
imputed values (by estimating the means, correlations, and covariances). No univariate
outliers were detected as each test variable was equivalent to standardised test scores, or zscores, below 3.29 (as recommended by Field, 2005), with 95% of the data having standard
scores below 1.96 (p < .05, two-tailed test). The assumption of normality was assessed by
way of the Shapiro-Wilks statistics. Normality was found to be violated for the DASS in the
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community sample only. However, this sample was sufficiently large and the DASS data was
used in a one-way ANOVA, which is robust against deviations from normality (Keppel &
Wickens, 2004; Tabachnick & Fidell, 2007).
Internal reliability of the TAS-20.
Cronbach alpha (α) coefficients for the overall TAS-20 scale in the psychiatric sample
was .80 and .76 in the community sample. Alpha coefficients for the three TAS-20 factors
differed greatly. In the psychiatric sample, the DIF, DDF, and EOT factors obtained α
coefficients of .86, .51, and .29, respectively. The α coefficient of the DDF factor would have
increased to .76 if item 4 (“I am able to describe my feelings easily”) was deleted. The α
coefficient of the EOT factor could not be improved by deleting any item. In the community
sample, the DIF, DDF, and EOT factors obtained α coefficients of .89, .36, and .20,
respectively. The α coefficients of the DDF or EOT factors could not be improved by
deleting any item. Due to the unacceptable internal reliability of the EOT factor in the
psychiatric and community samples for the present study, it was unlikely that any meaningful
interpretation of the separate factor scores could be possible, except taken together in total
TAS-20 score as a general indication of alexithymia (Gignac et al., 2007; Vorst & Bermond,
2001). Consequently, all further analyses of alexithymia in the present psychiatric and
community samples used the total TAS-20 score only.
Bivariate correlations between the separate TAS-20 factors for the psychiatric and
community samples are displayed in Table 5. All Pearson’s correlations between the separate
TAS-20 factors were positive and significant in both group samples, p < .01. There was a
moderate (r = .30 to .69) and strong (r >.70) association between the DIF and DDF factors
for the psychiatric and community samples, respectively (based on criteria established by
Cohen, 1988). In both group samples, the DDF and EOT factors were moderately associated
whereas the DIF and EOT factors were weakly associated (r < .30).
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Table 5
Bivariate Correlations Between TAS-20 Factors for the Psychiatric and Community Samples
Factors

DIF

DDF

EOT

Psychiatric
DIF

1.0

DDF

.66**

1.0

EOT

.27**

.45**

1.0

Community
DIF

1.0

DDF

.71**

1.0

EOT

.29**

.41**

1.0

** p < .01.

Demographic Characteristics
Demographic details of the psychiatric and community samples are presented in Table
6. This table includes frequency counts and percentages for gender, education level,
employment status, and ICD-10 diagnosis (diagnosis for the psychiatric sample only).
Females were overrepresented in the psychiatric sample, with a similar high
proportion of females observed in the community sample, χ2 (1) = 0.01, p = .916. The
proportion of psychiatric patients who had completed primary/secondary education and who
had completed some form of post-secondary education (including technical college and
university) was relatively balanced. The community sample, on the other hand, included a
higher percentage of post-secondary educated participants compared to the psychiatric
sample, χ2 (1) = 58.21, p < .001. There were also a higher percentage of employed
participants in the community sample compared to the psychiatric sample, χ2 (1) = 147.79, p
< .001.
Over half of the psychiatric patients had been diagnosed with a mood (affective)
disorder that included bipolar affective disorder, depressive episodes, recurrent depressive
disorders, and persistent mood disorders such as cyclothymia and dysthymia. Approximately
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one quarter of the patients had been diagnosed with a neurotic, stress-related, and
somatoform disorder; including social phobia, panic disorder, generalized anxiety disorder,
obsessive-compulsive disorder, and adjustment disorders (i.e., post-traumatic stress disorder).
The remaining patients had been diagnosed with schizophrenia, schizotypal, and delusional
disorders (i.e., paranoid and simple schizophrenia, delusional disorder, schizoaffective
disorder, and unspecified non-organic psychosis); behavioural syndromes associated with
physiological disturbances and physiological factors (i.e., anorexia nervosa); and disorders of
adult personality and behaviour (i.e., borderline personality disorder, avoidant personality
disorder, and mixed personality disorder.
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Table 6
Demographic Characteristics of the Psychiatric and Community Samples

Characteristic

Psychiatric
(N = 151)

Community
(N = 216)

Frequency (%)

Frequency (%)

Gender
Female
Male
Total

109
42
151

72.2
27.8
100

157
59
216

72.7
27.3
100

80
62
142
9
151

53
41
94
6
100

38
178
216

17.6
82.4
100

33
118
151

21.9
78.1
100

184
32
216

85.2
14.8
100

13
79
38
1
20
151

8.6
52.3
25.2
0.7
13.2
100

Education
Primary/Secondary
Post-Secondary a
Total
Missing
Total
Employment
Paid
Unpaid/Unemployed
Total
Diagnosis b
F20-F29
F30-F39
F40-F48
F50-F59
F60-F69
Total
a

Post-Secondary includes technical and university education.
Diagnosis by ICD-10 Category: F20-F29 schizophrenia, schizotypal, and delusional disorders; F30-F39
mood (affective) disorders; F40-F48 neurotic, stress-related, and somatoform disorders; F50-F59 behavioural
syndromes associated with physiological disturbances and physiological factors; and F60-F69 disorders of
adult personality and behaviour.
b

Alexithymia in the Psychiatric and Community Samples
Means and standard deviations of alexithymia scores by gender, education level, and
employment status as well as overall scores for the psychiatric and community samples are
presented in Table 7. Overall, the psychiatric patients reported significantly greater
alexithymia scores compared to the community participants, F(1, 365) = 103.38, p < .001.
Even when accounting for demographic variables the size of the group differences in
alexithymia was still significant, partial η2 = .22 (medium to large effect).
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Table 7
Descriptive Statistics of Alexithymia Scores by Gender, Education, and Employment
Psychiatric
Demographic Variable

Community

M

SD

M

SD

59.74
59.89

12.09
12.30

48.52
45.55

13.01
12.54

60.92
57.93

12.03
12.52

46.42
46.35

12.87
12.71

58.97
60.09

13.29
11.93

46.10
47.84

12.87
11.82

59.85

12.20

46.36

12.71

Gender
Male
Female
Education
Secondary/ High school
Tertiary/ TAFE
Employment
Employed
Unemployed
Overall

Results of the two-way ANOVA tests examining the influence of gender, education
level, and employment status on differences in alexithymia scores between the psychiatric
and community samples are presented in Table 8. The difference in alexithymia scores
between the samples did not depend on the gender, education level, or employment status of
the participants as the interactions between sample group and demographic variables were not
significant.
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Table 8
Results of Two-Way ANOVAs by Sample Group and Demographic Variables
Variables

F

p

Gender x Samplea

1.11

.292

Gendera

0.91

.341

Samplea

74.27

< .001

Education x Sampleb

0.89

.345

Educationb

0.98

.322

Sampleb

71.40

< .001

Employment x Samplea

0.03

.858

Employmenta

0.69

.406

Samplea

53.27

< .001

Partial η2

.17

.17

.13

Note. Sample = psychiatric and community; gender = male and female; education = secondary/ high school; and
employment = employed and unemployed.
a
df = 1(363). bdf = 1(354).

According to TAS-20 cut-off scores, 87 patients (57.6%) in the psychiatric sample
were identified as alexithymic (TAS-20 scores of ≥ 61) and 35 patients (23.2%) were
identified as non-alexithymic (TAS-20 scores ≤ 51). In the community sample, 33
participants (15.3%) were identified as alexithymic and 148 participants (68.5%) were
identified as non-alexithymic. Pearson’s Chi-Square indicated that there was a significant
difference between the psychiatric and community samples in the proportion of participants
that were identified as alexithymic and non-alexithymic, χ2 (1) = 85.84, p < .001. Cramer’s V
indicated a large and significant association (.53, p < .001) between categorical level of
alexithymia and group sample (see Cohen, 1988). Alexithymia was 3.8 times more prevalent
in the psychiatric sample than in the community sample.
Alexithymia and Psychological Distress in the Psychiatric and Community Samples
Results of the ANOVA showed that the psychiatric patients reported significantly
greater psychological distress scores (M = 58.22, SD = 29.94) compared to the community
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participants (M = 26.03, SD = 21.78), F(1, 365) = 142.16, p < .001, partial η2 = .28 (large
effect). Results from Pearson’s correlations showed a medium positive and significant
association (see Cohen, 1988) between DASS and TAS-20 scores for both the psychiatric,
r(166) = .46, p < .001, and community, r(216) = .46, p < .001, samples. A Fisher’s Z
transformation showed that the difference in the correlation sizes between DASS and TAS-20
scores for the two sample groups was not significant, z-obs = .06, p = .951.
Discussion
The purpose of Study 1 was to examine differences in alexithymia between a sample
of Australian psychiatric patients and a sample of Australian community participants. This
study also examined the influence of the gender, education level, and/or employment status
of the participants on differences in alexithymia between the sample groups. Lastly, the
present study examined the relation between alexithymia and psychological distress in the
psychiatric and community samples.
Prior to the analyses, the internal reliability of the TAS-20 and the three separate
factors were evaluated for use in the present research. The overall TAS-20 scale
demonstrated good internal reliability (α ≥ .70, George & Mallery, 2003) in both the
psychiatric and community samples. This finding was consistent with previous studies where
good internal reliability for the overall scale has been found for both psychiatric samples
(Loas et al., 2001; Müller et al., 2004; Stasiewicz et al., 2012) and community samples
(Martίnez-Sanchez, Ato-Gárcίa, & Ortiz-Soria, 2003; Scott, 2009; Tsaousis et al., 2010),
including Australian community samples (Gignac et al., 2007; Parry, 2012). In addition,
correlations between the TAS-20 factors for the psychiatric and community samples
indicated the existence of discriminant validity as the correlation coefficients were all less
than .80 (see Anderson & Gerbing, 1988). Correlation coefficients less than .80 between the
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TAS-20 factors indicate that each factor is likely to be measuring a theoretically unique facet
of alexithymia (see Groth-Marnat, 2009).
Although the overall TAS-20 scale has been found to have good internal reliability,
there were inconsistencies in the internal reliability of the separate TAS-20 factors in the
present study. The DIF factor demonstrated good internal reliability in the psychiatric and
community samples, yet the DDF and EOT factors demonstrated poor to unacceptable
internal reliability, respectively. Alpha coefficients for the EOT factor in the present samples
were much lower than α coefficients for the DIF and DDF factors, which has also been found
in many previous studies (Kooiman et al., 2002; Leising et al., 2009; Loas et al., 2001;
Loiselle & Cossette, 2001; Meganck et al., 2008; Thorberg et al., 2010). It has been
suggested that the low internal reliability of the EOT factor may result from a response bias
to the large number of reverse-scored items that load onto the EOT factor (Meganck et al.,
2008; Vorst & Bermond, 2001). Revision of the EOT factor and the use of reverse-scored
items has been suggested (Besharat, 2008; Gignac et al., 2007; Meganck et al., 2008). The
unacceptable internal reliability of the EOT factor in the present study indicates that revision
of this factor is needed before meaningful interpretation of the separate factor scores can be
made in Australian samples.
The mean TAS-20 score for the psychiatric sample was consistent with previous
research (Clyne & Blampied, 2004; de Haan, Schellekens, et al., 2012; Frewen, Lanius, et al.,
2008; Meganck et al., 2009) and was similar to findings reported from a study of 404 general
psychiatric outpatients in Belgium (Vanheule et al., 2007). The mean TAS-20 score for the
community sample was also consistent with previous research (Bouchard, 2009; Kreitler,
2002; Lundh & Simonsson-Sarnecki, 2001; Parker et al., 2001; Scott, 2009) and was similar
to the mean TAS-20 scores reported by Gignac et al. (2007) and Parry (2012) in their
Australian community studies.
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There was a medium to large difference in alexithymia scores between the psychiatric
and community sample. As expected, the psychiatric patients reported significantly greater
alexithymia scores than the community participants. These findings were consistent with
previous international studies that have demonstrated greater alexithymia scores in
psychiatric samples compared to community or student samples (Müller et al., 2003;
Vanheule et al., 2007). Comparing differences in categories of alexithymia (alexithymic and
non-alexithymic) between the sample groups also produced expected results, as the
proportion of participants identified as alexithymic was significantly greater in the psychiatric
sample than in the community sample. The prevalence rate of alexithymia was almost four
times higher in the psychiatric sample compared to the community sample. This finding
highlights the pervasiveness of alexithymia amongst general psychiatric patients and supports
the idea that dysfunctional emotional states, characterised by alexithymia, are a central
feature to most psychopathology (Krystal, 1988; Lane & Schwartz, 1987; Taylor, 1987).
The prevalence rates of alexithymia in the present psychiatric and community samples
fell within the range of alexithymia rates that have been reported globally (see Chapter 2).
Furthermore, the prevalence rate of alexithymia in the psychiatric sample was greater than the
prevalence rates of alexithymia reported in previous European studies involving general
psychiatric outpatients (Joukamaa et al., 2008; Leweke et al., 2012; Porcelli et al., 2004;
Todarello et al., 1995; Tutkun et al., 2004; Vanheule et al., 2007), but was comparable to the
prevalence rate reported in a Canadian study that involved general psychiatric outpatients
(Joyce et al., 2013). This finding supports a trend reported on in Chapter 2 where, on average,
prevalence rates of alexithymia in psychiatric samples tended to be higher across studies
undertaken outside of Europe.
Differences in alexithymia scores between the psychiatric and community samples in
the present study were not explained by the demographic factors of gender, education level,
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and employment status. This finding indicates that demographic factors are unlikely to play a
role in the alexithymia construct. This finding is in contrast to the expectation that differences
in alexithymia scores would be dependent on demographic factors in the community sample,
but not in the psychiatric sample, as most of the studies reviewed in the literature (see
Chapter 2) that involved community samples found a significant influence of demographic
factors on alexithymia scores. However, this finding is partially consistent with the overall
trend reported on in the Chapter 2, which showed that the majority of the reviewed studies
(59.2%) reported no significant differences in alexithymia scores between males and females
(e.g., Bouchard, 2009; Speranza et al., 2004) or between employed and unemployed
participants (e.g., de Haan, Schellekens, et al., 2012; El Rasheed, 2001). The present finding
that education level did not account for differences in alexithymia scores between the sample
groups was in contrast to most of the studies in the same review that reported significantly
higher alexithymia scores in participants with fewer years of education (e.g., Franz et al.,
2008; Leweke et al., 2012). Ultimately, the findings from Study 1 indicate that males, lower
educated individuals, or unemployed individuals are no more at risk of experiencing
alexithymia than females, higher educated individuals, or employed individuals.
In line with previous research (e.g., Antony, Bieling, Cox, Enns, & Swinson, 1998),
the psychiatric patients reported significantly greater psychological distress severity than the
community participants did. The mean DASS score in the psychiatric sample was consistent
with previous studies involving Australian (e.g., Ng et al., 2007; Page et al., 2007) and
Canadian (Clara, Cox, & Enns, 2001) psychiatric patients. The mean DASS score for the
community participants in the present study was also consistent with various studies
involving community and student populations (e.g., Lozano, 2010; Osman et al., 2012;
Sinclair et al., 2012; Tully, Zajac, & Venning, 2009).
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While the psychiatric patients reported greater psychological distress severity than the
community participants, the strength of the association between alexithymia and
psychological distress was similar for both sample groups. Moderate associations were found
in the present study between alexithymia and psychological distress in both the psychiatric
and community samples. This finding was consistent with a number of previous studies
linking alexithymia to various measures of psychological distress in both psychiatric (Evren
et al., 2008; Leweke et al., 2009; C. Spitzer et al., 2005) and community (Bouchard, 2009;
Liang & West, 2011) samples. In addition, this finding supports the hypothesis that inabilities
in recognising and expressing feelings results in a failure to regulate distressing emotions,
leading to elevated psychological distress (Taylor et al., 1997). A similar strength of the
association between alexithymia and psychological distress between the sample groups
indicates that the relationship between alexithymia and psychological distress is not
influenced by, or an outcome of, psychiatric illness. That is, alexithymic individuals in the
community are not exempt from experiencing a similar degree of psychological distress to
alexithymic patients in the general psychiatric population. Essentially, alexithymic
individuals may be vulnerable to developing or maintaining a greater level of psychological
distress regardless of whether they are seeking treatment for a psychiatric disorder or are a
member of the general community.
Limitations and Recommendations
The findings from Study 1 were limited by a cross-sectional design, where no causal
inferences about the relationship between alexithymia and clinical severity could be made. In
addition, a high proportion of community participants were educated to a technical college or
university level. This proportion is much higher than would be expected in a representative
sample of the Australian population (see Australian Bureau of Statistics, 2011). While a high
level of education in the community sample may suggest an increased willingness for highly
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educated individuals to participate in psychological research, it is also possible that the
sampling process was limited by placing recruitment posters at locations in close proximity to
local universities. Some of the present findings may have been biased because there was an
under representation of males in the psychiatric and community samples as well as an
underrepresentation of individuals with a lower level of education in the community sample.
Another potential limitation worth mentioning is that the community participants
completed study materials online whereas the psychiatric patients completed study materials
using a more traditional paper and pencil format. While most studies have shown that
psychometric properties of data do not significantly change when questionnaires are
completed online rather than on paper (e.g., Herrero & Meneses, 2006; E. T. Miller et al.,
2002; Vallejo, Jordán, Díaz, Comeche, & Ortega, 2007), differences in the assessment format
between the present study samples may have had a small impact on participants’ responses
(for a description of the potential problems associated with comparing online and paper
assessments, see Fouladi, McCarthy, & Moller, 2002).
The present findings have implications for clinicians and researchers working in
psychiatric settings. Early recognition of alexithymia in psychiatric patients may be important
to clinicians in managing the psychological distress that is associated with alexithymia. This
is especially important as a large proportion of the psychiatric population (possibly the
majority of them) experiences increased difficulties recognising, communicating and
examining their feelings in treatment. Early recognition of alexithymia in psychiatric patients
may also influence the therapeutic approach chosen by clinicians to treat these patients.
Determining effective interventions to reduce alexithymia levels may be crucial for the
management of psychological distress and potential prognosis in a large percentage of
psychiatric patients. Chapter 5 of the present research will examine the efficacy of different
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group therapy approaches in reducing alexithymia in psychiatric patients and will provide
recommendations to clinicians working with these populations.
Conclusion
The overall aim of Study 1 was to examine differences in alexithymia between
Australian psychiatric and community samples. To the researcher’s knowledge, this is the
first study to have evaluated the reliability of the overall TAS-20 score and separate factors in
an Australian psychiatric sample. It is also one of the few studies to have examined the effect
of demographic variables on differences in alexithymia scores between psychiatric and
community samples from a similar location. The added inclusion of a community sample in
Study 1 meant that any correlates of alexithymia (i.e., demographic variables and
psychological distress) could be attributed to associations with the alexithymia construct,
rather than a mere association with the presence of a psychiatric disorder. In line with
previous research, higher alexithymia scores and a greater prevalence rate of alexithymia
were observed in the psychiatric sample compared to the community sample, which
highlights the predominance of emotion processing difficulties in the Australian psychiatric
outpatient population. More than half of the psychiatric patients were identified as
alexithymic, which was several times the rate of alexithymia identified in the community
sample. Differences in alexithymia scores between the psychiatric and community samples
were not dependent on gender, level of education, or employment status. Thus, identifying
individuals who may be vulnerable to experiencing alexithymia remains a complicated task,
as alexithymia scores are likely to be similar within various demographic groups. Likewise,
the severity of psychological distress is likely to be similar for all individuals with high levels
of alexithymia, regardless of whether they are psychiatric patients or individuals in the
community. This finding supports the theory that alexithymic individuals have a vulnerability
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to developing and/or maintaining psychological distress and psychiatric illness (see Taylor et
al., 1997).
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CHAPTER 5
STUDY 2
Alexithymic patients are thought to respond poorly to many standard therapeutic
interventions (Krystal, 1979; McCallum et al., 2003; Sifneos, 1975; Taylor et al., 1997).
Specifically, core features of alexithymia, such as a reduced capacity for introspection, to
attend to emotional cues, and to communicate feelings to others, are believed to undermine
the therapeutic process and be difficult to treat (McCallum et al., 2003; Sifneos, 1972/1973;
Taylor et al., 1997).
The empirical evidence to support the idea that alexithymia undermines therapeutic
intervention is not consistent. The findings from a systematic review of the literature (see
Chapter 3) indicated that alexithymia scores before treatment did not influence therapeutic
outcome in some studies (e.g., de Haan, Schellekens, et al., 2012; Joyce et al., 2013; Rufer et
al., 2004). On the other hand, some studies reviewed had found a link between high
alexithymia scores before treatment and poor therapeutic outcomes, such as greater alcohol
dependence severity (Stasiewicz et al., 2012) and poor therapeutic alliance (Cleland et al.,
2005). Previous studies have also found that elevated or more stable levels of alexithymia
that persist after treatment are related to poor therapeutic outcomes, such as greater anxiety
severity (Fukunishi, Kikuchi, et al., 1997) and less improvement in interpersonal problems
during treatment (Ogrodniczuk et al., 2012).
It is unclear if the approach or focus of therapy is a factor that influences the
relationship between alexithymia and poor therapeutic outcome. Some researchers have
proposed that alexithymia may have less of a negative impact on behavioural-based
treatments, including CBT (Rufer et al., 2010), because the external focus of alexithymic
patients undergoing CBT may improve their adherence to structured exercises and
behavioural recommendations (Lumley et al., 2007). In contrast, it has been suggested that
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alexithymia may interfere with traditional psychotherapies that demand a greater degree of
insight or emotional awareness, such as psychodynamic psychotherapy, as alexithymic
patients have difficulties examining their problems from a psychological perspective (Lumley
et al., 2007; Sifneos, 1973). Some support has been provided for the idea that alexithymia has
less of a negative impact on CBT compared to other therapeutic approaches, such as
motivational intervention (Rosenblum et al., 2005).
In addition to examining the impact of alexithymia on therapeutic outcome,
researchers have examined how alexithymia might change as a result of undergoing therapy.
Assessing change in alexithymia has typically been approached in two ways: by assessing
mean-level stability, where the average alexithymia score of a whole group is examined over
time; and relative stability, where relative differences among individuals’ alexithymia scores
are examined over time. Analysis of mean-level stability provides a general indication of
change in alexithymia at a group level. However, analysis of mean-level stability does not
provide detailed information of change in alexithymia at an individual level, such as whether
patients’ scores are roughly changing by the same amount. Personality researchers have
argued that mean-level change is commonly observed in personality traits in addition to
relative stability (Allemand et al., 2013).
Previous studies have supported the idea that alexithymia is a personality trait by
finding high degrees of relative stability in alexithymia scores following therapeutic
intervention in spite of significant mean-level declines (e.g., Grabe et al., 2008; Luminet et
al., 2001; Rufer et al., 2010; Speranza et al., 2007). These studies are consistent with findings
of relative stability and mean-level change in other personality traits, such as neuroticism and
extraversion (Santor et al., 1997). It has been suggested that both mean-level and relative
stability of alexithymia should be considered when examining the influence of therapeutic
intervention on alexithymia so that accurate conclusions can be reached concerning the extent
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to which alexithymia can change over time (Mikolajczak & Luminet, 2006). Luminet et al.
(2001) have argued that, in addition to examining different forms of stability, only by
demonstrating the relative stability of alexithymia in the context of acute change in clinical
symptoms is strong evidence provided to support alexithymia as a personality trait. A
systematic review of the literature (see Chapter 3) found that relative stability in alexithymia
scores has been observed alongside acute change in clinical symptoms (e.g., de Timary et al.,
2008; Luminet et al., 2001; Picardi et al., 2012; Todarello et al., 2005).
Studies that have examined change in alexithymia following therapeutic intervention
have employed interventions that are available to treat various psychiatric disorders rather
than interventions designed specifically to treat alexithymia. Some researchers have
speculated about the efficacy of available therapeutic interventions to reduce alexithymia
levels in psychiatric patients. Behavioural-based interventions such as CBT are thought to be
less anxiety provoking for alexithymic patients as they are more directive and focus
externally on coping with unpleasant emotions and bodily sensations (Rufer et al., 2010)
rather than focusing on examining inner thoughts and feelings. In contrast, some researchers
have proposed that emotion-focused interventions with skills-training components that
address emotion awareness and modulation would be effective at reducing alexithymia levels
since these interventions aim to enhance the way patients process and experience emotions
(Hyer et al., 1991; Sifneos, 1973). A number of emotion-focused interventions, which
typically place emphasis on identifying emotions, promoting verbal and non-verbal
expression of emotions, and understanding emotional states and associated bodily sensations,
have been found to be effective at reducing alexithymia (e.g., Beresnevaite, 2000; Kennedy
& Franklin, 2002; Melin et al., 2010).
In addition to differences in therapeutic approach, some researchers have considered a
group therapy format to be effective for alexithymic patients because groups provide a

127

supportive environment for patients that maximises their opportunity to learn about emotions
through a wide range of interpersonal situations (Apfel-Savitz et al., 1977; Swiller, 1988).
Furthermore, alexithymic patients have been shown to prefer group therapy compared to
individual therapy (Ogrodniczuk, Piper, Joyce, & Abbass, 2009), which may enhance their
engagement in treatment and improve therapeutic outcomes.
Studies that have examined the effects of therapeutic intervention on alexithymia
while employing comparative treatment conditions are rare and consequently information
about the superiority of a particular therapeutic approach for reducing alexithymia remains
unclear. Studies that have examined the influence of alexithymia on therapeutic outcome
have also produced inconsistent findings. The idea that alexithymia undermines the
therapeutic process requires further examination because the relevance of alexithymia as a
risk factor in the maintenance of psychiatric illness relies on the value of alexithymia as a
predictor of therapeutic outcome.
The overarching aim of Study 2 was to examine the relationship between alexithymia
and therapeutic intervention. There were four specific aims: 1) to investigate the influence of
alexithymia before treatment on change in psychological distress during treatment, and
examine whether this influence was different for group therapy type (emotion focused
therapy and cognitive-behavioural focused therapy); 2) to examine the mean-level and
relative stability of alexithymia while accounting for group therapy type and change in
psychological distress over time; and 3) to investigate the influence of change in alexithymia
during treatment on psychological distress after treatment, and examine whether this
influence was dependent on group therapy type.
Higher alexithymia scores before treatment were expected to be associated with less
change in psychological distress severity following emotion focused (EF) group therapy but
not following cognitive-behavioural focused (CBF) group therapy, similar to findings by

128

Rosenblum et al. (2005). Mean-level change in alexithymia was expected over time,
independent of group therapy type, in line with the literature. Changes in alexithymia were
also expected to be largely independent of changes in psychological distress, as this finding
would be consistent with previous research. In addition, and in line with previous research, it
was anticipated that alexithymia would show a high degree of relative stability, even after
controlling for the influence of psychological distress severity before and after treatment.
Finally, less change in alexithymia severity during treatment was expected to predict higher
psychological distress scores after treatment, independent of group therapy type, similar to
findings by Ogrodniczuk et al. (2012).
Method
Participants and Procedure
The sample for Study 2 consisted of 61 psychiatric outpatients who were selected
from the original psychiatric sample used in study one (N = 151). The 61 patients were
selected because they had completed corresponding measures of alexithymia and
psychological distress before and after treatment. The sample included 47 (77.0%) females,
with age in the total sample ranging from 19 to 66 years (M = 42.40 years, SD = 12.45 years).
Twenty-seven of the patients had completed some form of post-secondary education
(including technical college and university) and 14 were employed. ANOVA and Chi-Square
tests showed no significant differences in demographic factors and in pre-treatment TAS-20
or DASS-42 scores between the original sample and the subset involved in the present study.
All patients completed TAS-20 and DASS-42 tests before (time 1) and after (time 2)
the completion of a therapy group. Some patients had attended more than one therapy group
and completed additional tests. Therefore, in order to control for the possible confound of a
cumulative treatment effect, only the first alexithymia and psychological distress tests that
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were from a patient’s earliest therapy group were retained for use in the present study.
Recruitment methods, eligibility for service, and details about the present sample can be
found in Chapter 4. Each patient had attended one of the two different types of group therapy
conducted at the outpatient facility: emotion focused group therapy (n = 30) or cognitivebehavioural focused group therapy (n = 31).
Measures
Psychiatric patients completed the 20-item Toronto Alexithymia Scale (TAS-20), the
42-item Depression Anxiety Stress Scale (DASS), and a demographic questionnaire and
consent form for the data to be used in research. The psychometric characteristics of the
measures were reported on in Chapter 4.
Therapy.
The outpatient mental health facility offers a broad range of therapeutic group
interventions to assist patients to recover from a variety of mental health problems. The
facility aims to reduce psychiatric symptomatology and to develop patients’ personal, social,
and emotional skills required for effective self-management of their mental illness. The group
interventions encourage progress towards developing self-respect, balanced thinking, a
healthy lifestyle with meaning, and enhance more effective functioning and a greater sense of
belonging in the wider community.
As part of the induction process, staff at the facility conducted interviews with new
patients to help determine their suitability to group therapy and allocation to a specific
therapy group. Group therapy suitability and allocation was based on a patient’s level of
functioning, current needs and expectations, diagnoses or their most pressing difficulty, and
availability. The groups were therefore diagnostically heterogeneous. All eligible patients
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were required to complete an introductory 4-week therapy group before re-enrolling into
other therapy groups.
Two clinical staff from various disciplines, including clinical psychology, social
work, occupational therapy, and psychiatric nursing facilitated the groups. Each group
included approximately 5 to 12 patients and were run during standard business hours with the
occasional after-hours group for those with daytime commitments. All groups were structured
and time limited: sessions ran for 2 hours over an average of eight weeks (min = 4, max =
10). The theoretical approach to group therapy at the facility was predominately guided by
cognitive-behavioural theory.
Categorising the types of therapy groups for use in this research was based on the
most prominent difference between the groups, which was the therapeutic focus. Two types
of group therapy were designated: emotion focused (EF) group therapy and cognitivebehavioural focused (C F) group therapy. EF group therapy addressed patients’
dysfunctional emotions through various goal-oriented interventions, such as psychoeducation
(in identifying and differentiating emotions, understanding the role of emotions, and the
physiological impact of emotions on the body), emotion awareness and mindfulness training,
assertive communication, relaxation, and homework (e.g., mindfulness techniques). Emotion
expression was encouraged during the sessions. C F group therapy addressed patients’
maladaptive thoughts, behaviours, and emotions through various goal-oriented interventions,
such as psychoeducation (in identifying and challenging maladaptive thoughts and
behaviours, and understanding the interaction between cognition, behaviour, and emotion),
cognitive restructuring, development of adaptive coping strategies, role-play, goal setting,
relaxation, and homework (e.g., thought records). There were no differences in the length of
the sessions or duration of the interventions between the two group types as both group types
ran for 2 hours over an average of 8 weeks.
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Statistical Analysis
Bivariate correlations were calculated to examine relationships between all variables
under consideration at time 1 and time 2. Three bivariate correlations were conducted to
examine the relation between alexithymia at time 1 and change in psychological distress
during treatment (i.e., DASS scores at time 2 minus DASS scores at time 1) for the overall
group, and for each group therapy type. In order to examine mean-level change in
alexithymia over time, a mixed model ANOVA was performed, with alexithymia scores at
time 1 and time 2 as the within-subjects variable and group type as the between-subjects
variable. Pearson’s correlation was used to examine the relative stability of alexithymia
scores from time 1 to time 2. In order to estimate the relative stability of alexithymia while
controlling for psychological distress severity, hierarchical regression analyses were
conducted. Alexithymia scores at time 2 served as the criterion variable. In the first model,
group type was entered as the dummy-coded predictor variable. In the second model,
psychological distress scores at time 1 and time 2 were the predictor variables, and in the
third model alexithymia score at time 1 was added as an additional predictor variable (as was
done by Grabe et al., 2008; Luminet et al., 2001; Picardi et al., 2012). In a separate regression
analysis, change scores in alexithymia (i.e., TAS-20 scores at time 2 minus TAS-20 scores at
time 1) were regressed on change scores in psychological distress to examine the extent to
which expected change in alexithymia might be accounted for by change in psychological
distress. Finally, a multiple regression analysis was conducted to predict psychological
distress at time 2 based on change scores in alexithymia, while controlling for psychological
distress at time 1 and group therapy type.
Cohen’s (1998) guidelines were used to interpret effect sizes. Accordingly, correlation
coefficient (r) values of .10, .30, .50, and .70, correspond to small, medium, large, and very
large effect sizes, respectively. Effect sizes for ANOVA were estimated using partial eta-
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squared (partial η2), where values of .01, .09, and .25, correspond to small, medium, and
large effect sizes, respectively. Effect sizes for simple and multiple regression analyses were
estimated using Cohen’s f (f2), where f2 values of .02, .15, and .35, correspond to small,
medium, and large effect sizes, respectively. Lastly, effect sizes for hierarchical regression
analyses were estimated using ΔR2, where values of .10, .30, .50, and .70, correspond to
small, medium, large, and very large effect sizes, respectively. All data were analysed using
SPSS version 19.0 (IBM Corp., 2010). The TAS-20 and DASS-42 test scores were subject to
a number of data preparation procedures, which were detailed in Chapter 4.
Results
Bivariate Correlations Among Variables
Bivariate correlations between alexithymia and psychological distress at time 1 and
time 2 are reported in Table 9. Alexithymia at time 1 was related to psychological distress at
time 1, and alexithymia at time 2 was related to psychological distress across time.
Table 9
Bivariate Correlations for Variables Under Consideration at Time 1 and Time 2
1

2

3

1. Alexithymia t1

1.0

2. Alexithymia t2

.74***

1.0

3. Psychological Distress t1

.48***

.32*

1.0

4. Psychological Distress t2

.25

.39**

.47***

4

1.0

Note. Boldface coefficients are test-retest correlations.
* p < 0.05.
** p < .01.
*** p < .001.

Influence of Alexithymia at Time 1 on Change in Psychological Distress
Results from Pearson’s correlations showed a medium negative and significant
correlation between alexithymia at time 1 and change in psychological distress, r(61) = -.32,
p = .013 in the overall group. Correlations were not significant between alexithymia and
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change in psychological distress for the EF group, r(30) = -.35, p = .056, or for the CBF
group, r(31) = -.28, p = .125, when examined separately.
Mean-Level Change and Relative Stability of Alexithymia
Results of a mixed model ANOVA showed no significant interaction effect between
change in alexithymia and group therapy type, F(1, 59) = 1.99, p = .163. There was a
significant main effect for change in alexithymia, with a decrease in alexithymia scores from
before (M = 58.98, SD = 13.37) to after group therapy (M = 56.51, SD = 12.35), F(1, 59) =
4.52, p = .038, partial η2 = .07 (small effect size). The main effect for group type was not
significant, F(1, 59) = 0.28, p = .596.
Results of Pearson’s test-retest correlations (see Table 9) showed a high degree of
relative stability in alexithymia evidenced by a very large positive and significant correlation
between alexithymia at time 1 and time 2. A medium positive and significant correlation was
observed between psychological distress at time 1 and time 2.
Explaining the Relative Stability of Alexithymia
Results of the hierarchical regression analyses are presented in Table 10. Group
therapy type did not explain a significant amount of variance in alexithymia at time 2 in the
first model. In the second model, group therapy type and psychological distress at time 1 and
time 2 explained a statistically significant 13.5% of the variance in alexithymia at time 2,
Fchg(2, 57) = 6.18, p = .004, ΔR2 = .18 (small effect size). Psychological distress at time 2 was
a positive predictor of alexithymia at time 2. The addition of alexithymia at time 1 in the third
model explained a statistically significant 59.5% of the variance in alexithymia at time 2, Fchg
(1, 56) = 65.78, p < .001, ΔR2 = .44 (medium effect size), which was beyond that explained
by group therapy type and psychological distress at time 1 and time 2. Alexithymia at time 1
was a positive predictor of alexithymia at time 2. Inspection of the standardised coefficients
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revealed that alexithymia at time 1 explained approximately 8 times the variance in
alexithymia at time 2 compared to psychological distress at time 2.
Table 10
Hierarchical Regression Summary Explaining the Relative Stability of Alexithymia
Model

Unstandardised
Coefficient

Std. Error

β

t

p

1

Group Type

-0.02

3.19

-.001

-0.005

.996

2

Group Type

0.47

2.95

.02

0.16

.874

Psychological
Distress t1

0.08

0.06

.18

1.31

.194

Psychological
Distress t2

0.18

0.08

.31

2.27

.027

Group Type

-1.89

2.04

-.08

-0.93

.359

Psychological
Distress t1

-0.79

0.04

-.18

-1.74

.087

Psychological
Distress t2

0.16

0.05

.27

2.95

.005

Alexithymia t1

0.71

0.09

.77

8.11

.000

3

Note. β = Standardised Coefficient; outcome variable was Alexithymia t2; Group Type dummy coding 0 = C F
group therapy and 1 = EF group therapy; multicollinearity was not considered a problem (tolerance level for
each predictor was > 0.60).

Influence of Change in Alexithymia on Change in Psychological Distress
Change scores in alexithymia were regressed on change scores in psychological
distress. Results showed that change in psychological distress explained 17.5% of the
variance in change in alexithymia, β = .42, F(1,59) = 12.51, p = .001, f2 = .21 (medium effect
size). That is, as alexithymia change score increased by 1 standard deviation, psychological
distress change score increased by .42 of a standard deviation.
Influence of Change in Alexithymia on Psychological Distress at Time 2
Results of the multiple regression analysis are presented in Table 11. The model
explained a statistically significant 30.4% of the variance in psychological distress at time 2,
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F(3, 57) = 8.31, p < .001, f2 = .44 (large effect size). After controlling for psychological
distress at time 1 and group type, alexithymia change score made a significant contribution to
the model: as alexithymia change score increased by 1 standard deviation, psychological
distress at time 2 increased by .30 of a standard deviation.
Table 11
Multiple Regression Summary Examining the Influence of Change in Alexithymia on Psychological
Distress at Time 2
Unstandardised
Coefficient

Std. Error

β

t

p

Psychological Distress t1

0.41

0.09

.55

4.77

.000

Alexithymia Change Score

0.69

0.27

.30

2.59

.012

Group Type

-0.69

4.72

-.02

-0.15

.884

Note. β = Standardised Coefficient; outcome variable was Psychological Distress t2; Assumption of independent
errors was met (Durbin-Watson = 1.79); and multicollinearity was not considered a problem (tolerance level for
each predictor was > 0.89).

Discussion
The purpose of Study 2 was to investigate the relationship between alexithymia and
therapeutic intervention for psychiatric patients by examining the influence of alexithymia
before treatment on psychological distress severity (as a measure of therapeutic outcome) for
all of the participants as well as each group therapy type. In addition, this study examined the
extent of stability in alexithymia scores following group therapy in terms of mean-level and
relative stability. The potential influences of different group therapy approaches as well as
change in psychological distress severity on alexithymia stability were accounted for. Lastly,
this study examined the influence of stability in alexithymia on psychological distress after
treatment, while controlling for group therapy type and psychological distress before
treatment.
Alexithymia before treatment was found to influence therapeutic outcome, as higher
alexithymia scores correlated significantly with less reduction in psychological distress in the
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overall group. That is, patients with higher alexithymia scores made less improvement in
psychological distress from before to after group therapy compared to patients with lower
alexithymia scores. This finding supports previous studies that have shown alexithymia
scores before treatment to negatively influence therapeutic outcomes (e.g., Fukunishi,
Kikuchi, et al., 1997; Özsahin et al., 2003; Stasiewicz et al., 2012). This finding is also
consistent with the idea that alexithymia poses a particular problem for psychiatric patients
by contributing to the maintenance of their disorder and interfering with their recovery
(Taylor et al., 1997).
There are a number of possible reasons why alexithymia was found to negatively
influence therapeutic outcome in the present study. It has been suggested that alexithymic
patients’ difficulties with empathy and perspective-taking may partly explain the association
between alexithymia and psychological distress as these difficulties lead to the contagion of
others distress (Moriguchi et al., 2007; Moriguchi et al., 2006). Psychological distress
severity may have been exaggerated for alexithymic patients during treatment in the present
study since, by the nature of group therapy, alexithymic patients would have interacted and/or
been in close contact with several other highly distressed patients during each therapy
session. In addition, difficulties communicating feelings to others may have made it difficult
for alexithymic patients in the present study to elicit support and comfort from others during
group therapy by limiting their chances of developing social relationships with their peers
(see C. Spitzer et al., 2005).
The influence of alexithymia before treatment on change in psychological distress in
the present study was not moderated by group therapy type as this relationship dropped below
significance levels when each type of group therapy was examined separately. The effect of
the relationship between alexithymia and change in psychological distress may not have been
large enough to replicate this outcome in smaller groups, such as in the present emotion
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focused (EF) and cognitive-behavioural focused (CBF) therapy groups. Suggestions that
alexithymia may interfere less with certain therapeutic approaches, such as behavioural –
based treatments (Rufer et al., 2010), could not be addressed in the present study and remains
inconclusive in the literature.
Although alexithymia before treatment was found to influence group therapy outcome
in the present study, the moderate relationship between alexithymia and change in
psychological distress indicates that patients are not strongly disadvantaged during treatment
by lacking emotion awareness, introspection, and the ability to communication their feelings.
In combination with inconsistent findings in the literature, the present finding indicates that
the influence of alexithymia on therapeutic outcome may not be direct. A study of emotion
regulation skills by Berking et al. (2008) showed that emotion modification and acceptance of
negative emotions contributed significantly to the prediction of mental health and treatment
gains, over and above awareness of emotion-related sensations, awareness of emotions, and
emotional clarity. The authors hypothesised that awareness and understanding of emotion are
important but only to the extent that they facilitate the modification and acceptance of
emotions. Therefore, an awareness and understanding of emotional states may be the basic or
primary skills needed to utilise successive and adaptive emotion regulation skills (Berking et
al., 2008; Lumley et al., 2005). Information about the influence of alexithymia on therapeutic
outcome would be enhanced if alexithymia were examined in conjunction with other related
constructs, such as emotion regulation, because researchers could observe the complex
connections and interactions alexithymia may have with other constructs that influence the
therapeutic process.
Group therapy was effective at reducing alexithymia scores for the psychiatric sample
as a whole. This finding was in line with numerous studies that have found significant meanlevel reductions in alexithymia scores following group therapy for various psychiatric
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disorders (e.g., Grabe et al., 2008; Ogrodniczuk et al., 2012; Stasiewicz et al., 2012). In
addition, the approach to group therapy in the present study did not account for the reduction
in patients’ alexithymia scores following treatment as mean-level change in alexithymia was
found to be independent of group therapy type (EF or CBF group therapy). In other words,
the cognitive-behavioural focused and emotion-focused group therapy approaches were
equally effective at reducing alexithymia levels in the psychiatric patients.
Although group therapy was effective at reducing alexithymia scores for the
psychiatric sample as a whole, the effect was small. In addition, the small reduction in
alexithymia could not be directly accounted for by the reduction in psychological distress as
less than one fifth of the variance in the change of alexithymia scores was explained by the
change of psychological distress scores from before to after treatment. The finding of a small
mean-level change in alexithymia scores following group intervention is consistent with the
idea that alexithymia is a personality trait (Taylor et al., 1997) that hence is unlikely to show
change over time that is large in magnitude (Allemand et al., 2013). Moreover, the finding
that mean-level change in alexithymia was largely independent of change in clinical severity
indicates that alexithymia is not exclusively dependent on the severity of clinical states.
In addition to the present finding of a small mean-level reduction in alexithymia, a
high degree of relative stability in alexithymia was observed from before to after treatment.
Stronger evidence for the relative stability of alexithymia was provided by hierarchical
regression analyses where alexithymia scores before treatment were found to make a
significant contribution to the prediction of alexithymia scores after treatment over the effects
contributed by group therapy type and psychological distress severity before and after
treatment. This finding is in line with several previous studies (de Timary et al., 2008;
Luminet et al., 2001; Picardi et al., 2012; Todarello et al., 2005) where alexithymia scores
before treatment have been found to be the best predictor of alexithymia scores after
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treatment. In this respect, alexithymia can be compared to other personality traits such as
neuroticism and extraversion, which have shown a high degree of relative stability and a lack
of mean-level stability over short periods in the presence of change in clinical symptoms
(Santor et al., 1997).
The present findings of a small mean-level reduction in alexithymia as well as relative
stability in alexithymia in the context of change in psychological distress indicate that
patients who enter treatment with pronounced difficulties in recognising, examining, and
communicating their feelings are likely to find that these difficulties persist after treatment
despite experiencing a marked decline in psychological distress. In fact, reduction in
alexithymia severity during treatment explained a significant amount of variance in
therapeutic outcome. Patients who reported less reduction in alexithymia during treatment
were more likely to report higher psychological distress scores after treatment compared to
patients who reported greater reduction in alexithymia during treatment. This finding
indicates that continued difficulties in recognising, verbalising, and examining ones feelings
once treatment has ended may interfere with patients’ abilities to use psychotherapy
effectively. Similar findings were made by Ogrodniczuk et al. (2012) where less change in
alexithymia during treatment (i.e., more stable alexithymia) was associated with less
improvement in interpersonal problems. Patients with resistant or more stable levels of
alexithymia are likely to be at greater risk of experiencing persistent clinical symptomatology
after treatment, which as a result may contribute to the maintenance of their psychiatric
illness.
Limitations and Recommendations
The findings of the present study were limited by the method of data collection. Since
the data were archival, the researcher could not control for a number of variables that may
have influenced outcomes of the present study, including the number or types of concomitant
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treatments patients received and the psychometric scale used to assess therapeutic outcome.
Since many patients had attended more than one therapy group at the outpatient facility, an
attempt was made to manage this by only retaining a patient’s earliest set of completed tests
(i.e., the first group a patient attended where they completed pre and post TAS-20 and DASS
tests). In addition, the varied lengths of therapy across the different groups at the facility may
have confounded treatment effects, yet the sample size was not large enough to control for
treatment duration. Findings concerning the relationship between alexithymia and therapeutic
outcome were limited to the data provided by using one general measure of psychological
distress to assess therapeutic outcome, rather than using multiple measures to assess general
symptomatic improvement or other aspects of outcome, such as therapeutic alliance.
Based on outcomes and restrictions from the present study, it is recommend that
future studies employ comparative treatment formats (e.g., group therapy compared to
individual therapy) as well as distinctive approaches to treatment (e.g., CBT compared to
psychodynamic psychotherapy) when examining the role of alexithymia in therapeutic
intervention. In addition, it will be important for future researchers to consider different
forms of stability in the assessment of alexithymia as growing evidence shows that
alexithymia is relatively stable and can change in response to therapeutic intervention.
The present evidence of alexithymia as a personality trait underscores how difficult it
will be to enact large or acute changes in alexithymia. On the other hand, if alexithymia is a
stable trait, then any real changes that result from therapeutic intervention will likely have
long lasting effects. Longitudinal studies involving longer follow up periods would help to
establish if changes in alexithymia were stable over time following intervention and if
elevated levels of alexithymia that persisted after treatment had an impact on longstanding
therapeutic outcome. Clinicians are encouraged to monitor the progress of patients who score
high in alexithymia throughout treatment to prepare these patients for a potentially slower
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recovery and/or the use of ongoing specialised care as alexithymia may offer a more stable
prediction of therapeutic efficacy in the presence of marked improvement in clinical
symptoms.
Conclusion
The overall aim of Study 2 was to investigate the influence of alexithymia on
therapeutic outcome across comparative treatment approaches as well as the effects of
comparative treatment approaches on the stability of alexithymia over time. To the
researcher’s knowledge, this is the first study to have examined the impact of alexithymia on
group therapy outcome in a general psychiatric outpatient sample. It is also one of the few
studies to compare different approaches to treatment in relation to alexithymia and to
examine the stability of alexithymia in the context of change in clinical symptoms. Overall,
alexithymic patients are therapeutically disadvantaged, to some extent, compared to nonalexithymic patients as higher alexithymia scores at the beginning of treatment were
moderately associated with poor therapeutic outcome. Present findings provided evidence to
suggest that alexithymia is a personality trait that is somewhat responsive to therapeutic
intervention as the small mean-level reduction and high degree of relative stability in
alexithymia during treatment were largely independent of the reduction in psychological
distress during treatment. Patients who reported more stable alexithymia scores over the
course of treatment were more likely to experience greater psychological distress after
treatment compared to patients who reported greater reductions in alexithymia over the
course of treatment. Therefore, despite observing noticeable improvement to patients’ general
wellbeing, many alexithymic patients are likely to experience ongoing difficulties identifying,
communicating, and examining their feelings after treatment, as well as ongoing psychiatric
problems and a need for ongoing therapeutic intervention.
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CHAPTER 6
GENERAL DISCUSSION
The central purpose of this thesis was to advance the understanding of alexithymia by
addressing a number of gaps in the literature relating to the prevalence of alexithymia in the
psychiatric and community populations, the role alexithymia plays in explaining the
perpetuation of psychiatric symptomatology, and the extent to which alexithymia can be
mitigated by different therapeutic interventions. This research was conducted in four stages,
which involved two systematic literature reviews and two empirical studies. Although this
research essentially has a clinical focus, this research also investigated the prevalence of
alexithymia in the community population to provide a comparative perspective. Accordingly,
the first literature review (Chapter 2) evaluated the prevalence of alexithymia in psychiatric
and community samples and Study 1 (Chapter 4) examined the prevalence of alexithymia in
Australian psychiatric and community samples. The second literature review (Chapter 3)
examined the role of alexithymia in the therapeutic process across the psychiatric literature.
Study 2 (Chapter 5) extended the clinical focus of the present research by examining the role
of alexithymia in different group therapy interventions for psychiatric outpatients.
The main findings were detailed and summarised within the respective chapters:
Chapter 2 through 5. The overall purpose of this chapter is to synthesise the findings of the
systematic literature reviews and the empirical studies to address the goals of the present
research.
The Prevalence of Alexithymia in the Psychiatric and Community Populations
The systematic review in Chapter 2 found that prevalence rates of alexithymia
reported across the psychiatric literature were typically far greater than the rates reported
across the community literature. In addition, there was a very high range in prevalence rates
of alexithymia in psychiatric samples. Following a more detailed evaluation of this literature,
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it was found that certain populations may have a higher prevalence rate of alexithymia (e.g.,
patients diagnosed with depressive, somatoform, and addictive disorders; and psychiatric
populations receiving treatment outside of Europe), but this cannot be concluded on the basis
of the available data. It is unclear why the prevalence of alexithymia should be higher in nonEuropean samples of psychiatric patients. Given that rates of alexithymia were found to be
similar in European and non-European studies involving community samples, it is possible
that differences in psychopathology (e.g., diagnostic severity) between European and nonEuropean samples will have contributed to the variation in prevalence rates of alexithymia in
the psychiatric population. Direct comparisons between different psychiatric populations are
required to accurately assess the relative prevalence of alexithymia in different cultures and
countries.
The results from Study 1 were consistent with the overall trend in the literature as
there was a significantly greater prevalence rate of alexithymia, and higher alexithymia
scores, in the psychiatric sample compared to the community sample. In addition, the
particularly high prevalence rate of alexithymia that was found in the Australian psychiatric
sample in Study 1 was consistent with the trend in the literature where high rates of
alexithymia were reported in non-European psychiatric samples compared to European
psychiatric samples. If the findings of the present study were generalised to other tertiary
hospitals in Australia, then more than half of all outpatients receiving treatment for a
psychiatric disorder in Australia experience difficulties recognising, communicating, and
examining their feelings.
There were a large number of inconsistencies across the literature regarding the
influence of demographic factors on alexithymia, including the influence of gender, age,
education, employment, socioeconomic status, income, and marital status. This trend
suggests that certain demographic factors may influence alexithymia scores but are unlikely
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to be leading contributors to variance in the prevalence rate of alexithymia in the psychiatric
or community populations. The findings from Study 1 supported the trend in the literature as
no differences were found in alexithymia scores between males and females and between
employed and unemployed psychiatric and community participants. In contrast to most of the
studies in the literature however, no differences were found in alexithymia scores between
lower educated (secondary and high school) and higher educated (technical and tertiary)
psychiatric and community participants. Together, the overall trend from the literature
review and findings from Study 1 suggest that no particular demographic group is likely to be
more vulnerable to experiencing alexithymia. Instead, difficulties recognising,
communicating, and examining ones feelings are widespread; particularly in populations that
are receiving treatment for a psychiatric disorder.
The Role of Alexithymia in Explaining the Perpetuation of Psychiatric Symptomatology
The systematic review in Chapter 3 found inconsistent findings across the studies that
examined the influence of alexithymia scores before treatment on therapeutic outcome, with
some studies finding higher alexithymia scores to have a negative influence on some
therapeutic outcomes and other studies finding alexithymia to have no influence on
therapeutic outcomes. Studies that examined the impact of change in alexithymia on
therapeutic outcome found that elevated or more stable levels of alexithymia that persist after
treatment were related to poor therapeutic outcome on some measures (Fukunishi, Kikuchi, et
al., 1997; Ogrodniczuk et al., 2012). The overall finding from this review was that
alexithymia was more likely to interfere with therapeutic outcome in certain contexts, such as
in treatments conducted for patients diagnosed with addictive disorders as well as treatments
conducted in North America.
The findings in Study 2 were consistent with some studies in the literature, as higher
alexithymia score before treatment was associated with poorer therapeutic outcome (less
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reduction in psychological distress severity during treatment). However, this finding did not
resolve speculation about the influence of alexithymia being treatment specific (i.e., that
alexithymia interferes less with behavioural-based interventions such as CBT, Rufer et al.,
2010) because the association between alexithymia and therapeutic outcome was not found in
either treatment approach (cognitive-behavioural focused and emotion-focused group
therapy) when examined separately. In addition, Study 2 found that less reduction in
alexithymia over the course of treatment (more stable levels of alexithymia) was associated
with higher psychological distress after treatment. Overall, findings from Study 2 indicate
that psychiatric patients are vulnerable to experiencing ongoing clinical symptomatology
after treatment when their level of alexithymia is high before treatment or changes little
during treatment.
The Extent to Which Alexithymia can be Mitigated by Therapeutic Intervention
The majority of studies in the literature review that was conducted in Chapter 3
reported a reduction in alexithymia scores following various therapeutic interventions.
Results of Study 2 were in line with this literature as alexithymia scores reduced following
group therapy, independent of the two group therapy approaches. In general, it remains
unclear whether alexithymia is more responsive to specific treatments as few studies have
compared the efficacy of different therapeutic interventions for treating alexithymia in
psychiatric patients. Further investigation is needed to determine the most effective
therapeutic context for treating alexithymia.
What was observed in Study 2 was that the reduction in alexithymia scores were small
and largely independent of the reduction in psychological distress scores. Alexithymia was
also found to be relatively stable even after controlling for psychological distress severity
before and after treatment and type of group therapy. This finding is in line with the literature
where alexithymia has been consistently found to be relatively stable. Evidence in the
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literature, and from Study 2, support the proposition (Taylor et al., 1997) that alexithymia is a
personality trait as evidenced by a high degree of relative stability, independent of change in
clinical symptoms. Overall findings indicate that while alexithymia can improve with
therapeutic intervention to a certain degree, clinically problematic levels of alexithymia are
likely to persist after treatment in spite of apparent reductions in clinical symptomatology.
Implications of the Research
The present studies have provided support for the theoretical framework underlying
this research, wherein the alexithymia construct was considered a potential predisposing
factor that interacts with stressors to increase general susceptibility to psychopathology. The
high rates of alexithymia amongst psychiatric samples and the therapeutic challenge that
alexithymia represents, indicates that alexithymia is an important construct to consider within
the psychiatric domain.
The present findings have a number of implications for future research. Increased
recognition of the prevalence of alexithymia amongst psychiatric patients should encourage
researchers to consider alexithymia as a confounding factor when evaluating the efficacy of
existing and novel therapeutic interventions. That is, a large proportion of alexithymic
patients in a sample group are likely to impact on the efficacy of therapeutic interventions by
increasing the severity of clinical symptomatology both during and after treatment for the
overall sample.
Strong empirical evidence of relative stability in alexithymia in the context of change
in clinical symptoms will contribute to the acknowledgment of alexithymia as a personality
trait. Increased recognition of alexithymia as a personality trait may in turn influence research
methods by encouraging researchers to consider more complex models that differentiate
relative stability from mean-level change when assessing how alexithymia and clinical states
relate during therapeutic intervention. For instance, change in alexithymia may be a direct
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outcome of therapeutic effects on alexithymia or an indirect outcome of change in clinical
states influencing other important variables, which moderate or mediate the relationship
between alexithymia and clinical states.
The present research has raised doubt as to whether alexithymia would be considered
a major obstacle to therapeutic success. Although the present research indicates that there is
an increased risk imposed by alexithymia on therapeutic outcome for psychiatric patients,
evidence in the literature about the influence of alexithymia on therapeutic outcome has been
inconsistent, with many studies finding that alexithymia scores before treatment had no
impact on therapeutic outcomes (e.g., Rufer et al., 2010; Spek et al., 2008). The effects of
alexithymia, both before and during treatment, on therapeutic outcome in the present study
were significant, yet they were small to moderate. The present findings should encourage
researchers to consider broader elements of the therapeutic context in an attempt to expand
the theoretical understanding of alexithymia in the therapeutic process. For instance, other
factors related to alexithymia that have a more direct influence on or that are more essential
to the success or failure of therapeutic intervention need to be investigated. The direct role of
alexithymia in the therapeutic process may need to be reconsidered to involve examinations
of variables that may moderate or mediate the relationship between alexithymia and
therapeutic outcome. For example, given that emotion regulation is gaining popularity in the
transdiagnostic understanding of therapeutic outcome, and that alexithymia has been found to
be negatively correlated with several measures of emotion regulation (e.g., Pandey, Saxena,
& Dubey, 2011; Stasiewicz et al., 2012), examination of the relation between alexithymia and
emotion regulation skills may help to explain the mechanism through which alexithymia
influences therapeutic outcome (for an overview of the potential mediating mechanisms that
link alexithymia with physical and mental health related problems, see Dubey, Pandey, &
Mishra, 2010).
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Additionally, increased recognition of alexithymia as a personality trait that affects a
considerable number of psychiatric patients in many countries is important for the psychiatric
care of alexithymic patients. The present findings that higher alexithymia scores before
treatment and greater stability of alexithymia during the course of treatment were related to
poorer therapeutic outcome show that alexithymic patients are more vulnerable to
experiencing greater clinical severity after treatment than non-alexithymic patients are. It is
likely that alexithymic patients will require longer periods of treatment over the course of
their illness in order to achieve a similar rate of recovery to non-alexithymic patients.
Subsequently, alexithymic patients are likely to be engaged with mental health services for
considerably longer periods compared to non-alexithymic patients. Assessing alexithymia at
intake will be important for clinicians and mental health services as alexithymic patients have
different treatment responses and may require different service delivery responses, such as
parallel treatment where patients are treated for alexithymia at the same time as receiving
treatment for a primary psychiatric disorder. Early detection and successful treatment of
alexithymia is likely to impact on future service usage and costs in mental health settings.
Findings from the present research indicate that successful treatment of alexithymia
has the potential to result in improved therapeutic outcomes, as non-alexithymic patients and
patients who made greater reductions in alexithymia during treatment reported lower levels of
psychological distress following treatment. Successful treatment of alexithymia could be
defined as at least moderate to large mean-level reductions in scores, which would be in line
with the average effects of psychotherapy that are widely shown to be significant and large
(for a review of psychotherapy efficacy and effectiveness research, see Lambert & Ogles,
2004). However, the enduring nature of alexithymia as a personality trait combined with
small reductions in alexithymia scores following group therapy found in the present research
indicate that successful treatment of alexithymia by this comparison may prove difficult.
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Moreover, attempts to uncover the most effective therapeutic intervention to treat
alexithymia may be unproductive because comparisons of different therapeutic interventions
for treating psychiatric disorders, including personality disorders, have been shown to result
in similar treatment outcomes (see Livesley, 2007; Wampold, 2001). Wampold (2001) has
provided evidence to indicate that interventions developed for particular deficits (e.g.,
cognitive-behavioural therapy for patients with maladaptive cognitions) are no more effective
than interventions not developed for the deficit (interpersonal therapy for patients with
maladaptive cognitions). The present finding that the reduction in alexithymia during
treatment was not differentiated by the approach to group therapy supports the argument that
different therapeutic approaches result in similar treatment outcomes and thus clarity about
the treatment of alexithymia is unlikely to be achieved by comparing the effectiveness of
interventions based on theoretical orientation. Rather, to improve the treatment of
alexithymia it is suggested that researchers and clinicians examine common factors of
treatment, such as therapeutic alliance, therapist competence, and therapist allegiance to
theoretical orientation, that have been found to account for more variance in therapeutic
outcome than specific approach to treatment (see Messer & Wampold, 2002).
Strengths and Limitations of the Research
There were a number of strengths in the present research. The present research was
carefully designed and empirically rigorous. This included evaluating the reliability of the
total TAS-20 and three factors for use in the present empirical studies. Two extensive
literature bases were complied, upon which further empirical examination can develop. A
systematic review of prevalence data on alexithymia was undertaken for the first time, which
helped to clarify the global prevalence rate of alexithymia in both psychiatric and community
populations. The addition of community samples in the literature review and in the first
empirical study also provided a comparative perspective on the prevalence of alexithymia.
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The second empirical study expanded previous research on the role of alexithymia in
therapeutic outcome by comparing cognitive-behavioural focused and emotion focused
approaches not previously examined. The potential therapeutic efficacy of these different
approaches in treating alexithymia was examined through robust statistical methods, which
considered different forms of stability in alexithymia. In addition, issues of dependence
between change in alexithymia and change in clinical states were addressed.
In contrast to the strengths of the present research, there were also a number of
limitations. The conceptualisation of the alexithymia construct was restricted to how it is
defined by the TAS-20 as the present research focused solely on the TAS-20 as a measure of
alexithymia. However, the TAS-20 was judged the most psychometrically sound and
applicable measure to use when comparing international studies and for use in the present
samples of the empirical studies. Furthermore, the use of archival data for the psychiatric
sample in the empirical stages of this research limited the design and direction of the research
as the variables under consideration were predetermined. This limitation included a lack of
follow-up data to confirm whether alexithymia scores before or after treatment had longstanding influence on therapeutic outcome. This limitation also included the use of one
measure to assess therapeutic outcome. Measuring different aspects of outcome would have
been ideal to determine the influence of alexithymia on multiple aspects of therapeutic
outcome, including general domains of well-being and functioning as well as specific
changes in clinical symptoms.
Directions for Future Research
There are several directions for alexithymia research based on the findings of the
present research. While the systematic literature reviews provided comprehensive summaries
of relevant studies on the prevalence of alexithymia and role of alexithymia in the therapeutic
process, respectively, clinicians and future researchers would benefit from further empirical
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examination of these data. Specifically, meta-analyses will yield a more precise (narrower
confidence intervals) overall estimate of the prevalence rate of alexithymia in the psychiatric
and community populations and a more precise effect of alexithymia on therapeutic outcome.
Future research examining the role of alexithymia in the therapeutic process would
benefit from replicating the findings of the present research with a larger sample size while
addressing the methodological limitations mentioned above. It is also important for future
researchers to conduct longitudinal studies to provide a more comprehensive understanding
of the role of alexithymia in the therapeutic process over time. Studies involving longer
periods of follow-up would help to confirm expectations of the long-standing influence of
alexithymia on therapeutic outcome as well as long-term stability of alexithymia following
therapeutic intervention.
Findings from the present research indicate that alexithymia is a complex construct
that requires equally complex methods for assessing its role in the therapeutic process. In this,
future researchers could examine potential mediating or moderating factors that may be
related to alexithymia and the therapeutic context. In particular, investigation into the
interaction of common treatment factors with alexithymia (e.g., therapeutic alliance and
therapist characteristics) will expand the understanding of alexithymia and provide valuable
information for the treatment of alexithymic patients.
Conclusion
The present research examined the prevalence of alexithymia in the psychiatric and
community populations, the role alexithymia plays in explaining the perpetuation of
psychiatric symptomatology, and the extent to which alexithymia can be mitigated by
different therapeutic interventions. Findings from this research substantiated the strong
presence of alexithymia in the psychiatric population and contributed to improving the
understanding of the role of alexithymia in the therapeutic process. There is evidence to
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suggest that the influence of alexithymia on therapeutic outcome is indirect and to challenge
the notion that specific therapeutic interventions may have superior treatment effects on
reducing alexithymia in psychiatric patients. The present findings will incite future
researchers to advance sophisticated inquiry into the influence of alexithymia on therapeutic
outcome. Strong evidence of the persistent nature of alexithymia as a personality trait
supports the need for future researchers to understand the exact mechanisms underlying the
relationship between alexithymia and therapeutic intervention. Although alexithymia cannot
provide a single explanation for patient response to therapeutic intervention, the principal
conclusion of the present research is that alexithymia should be considered a connected part
of an overall strategy for the prevention and treatment of psychopathology.

153

References
Aftanas, L. I., & Varlamov, A. A. (2007). Effects of alexithymia on the activity of the
anterior and posterior areas of the cortex of the right hemisphere in positive and
negative emotional activation. Neuroscience and Behavioral Physiology, 37(1), 6773. doi: 0097-0549/07/3701-0067
AIHW, Begg, S., Vos, T., Barker, B., Stevenson, C., Stanley, L., & Lopez, A. (2007). The
burden of disease and injury in Australia 2003. Retrieved PHE 82, from
http://www.aihw.gov.au/publication-detail/?id=6442467990
Akkerman, R. L. (1996). Exploring the comorbidity of alexithymia, depressive disorders, and
personality disorders in a substance abuse population. (Doctor of Philosophy), Texas
Tech University, Lubbock. Retrieved from http://hdl.handle.net/2346/18811 ProQuest
Dissertations and Theses Database database. (9707322)
Alexander, F. (1950). Psychosomatic Medicine. New York: Norton.
Allemand, M., Steiger, A. E., & Hill, P. L. (2013). Stability of personality traits in adulthood:
Mechanisms and implications. GeroPsych: The Journal of Gerontopsychology and
Geriatric Psychiatry, 26(1), 5-13. doi: 10.1024/1662-9647/a000080
Anderson, J. C., & Gerbing, D. W. (1988). Structural Equation Modeling in Practice: A
Review and Recommended Two-Step Approach. Psychological Bulletin, 103(3), 411423.
Antony, M. M., Bieling, P. J., Cox, B. J., Enns, M. W., & Swinson, R. P. (1998).
Psychometric properties of the 42-item and 21-item versions of the Depression
Anxiety Stress Scales in clinical groups and a community sample. Psychological
Assessment, 10(2), 176-181.

154

Apfel-Savitz, R., Silverman, D., & Bennett, M. I. (1977). Group psychotherapy of patients
with somatic illnesses and alexithymia. Psychotherapy and Psychosomatics, 28(1-4),
323-329.
Apfel, R. J., & Sifneos, P. E. (1979). Alexithymia: concept and measurement. Psychotherapy
and Psychosomatics, 32(1-4), 180-190.
Asay, T. P., Lambert, M. J., Gregersen, A. T., & Goates, M. K. (2002). Using patient-focused
research in evaluating treatment outcome in private practice. Journal of Clinical
Psychology, 58(10), 1213-1225. doi: 10.1002/jclp.10107
Australian Bureau of Statistics. (2011). Education and Work. (6227.0). Australia: Retrieved
from
http://www.abs.gov.au/AUSSTATS/abs@.nsf/Lookup/6227.0Explanatory%20Notes1
May%202011.
Bach, M., & Bach, D. (1995). Predictive value of alexithymia: a prospective study in
somatizing patients. Psychotherapy and Psychosomatics, 64(1), 43-48.
Bach, M., Bach, D., Bohmer, F., & Nutzinger, D. O. (1994). Alexithymia and somatization:
relationship to DSM-III-R diagnoses. Journal of Psychosomatic Research, 38(6), 529538.
Bagby, R. M., Parker, J. D. A., & Taylor, G. J. (1994). The twenty-item Toronto Alexithymia
Scale--I. Item selection and cross-validation of the factor structure. Journal of
Psychosomatic Research, 38(1), 23-32.
Bagby, R. M., Taylor, G. J., & Parker, J. D. A. (1994). The Twenty-item Toronto
Alexithymia Scale--II. Convergent, discriminant, and concurrent validity. Journal of
Psychosomatic Research, 38(1), 33-40.
Bagby, R. M., Taylor, G. J., Parker, J. D., & Dickens, S. E. (2006). The development of the
Toronto Structured Interview for Alexithymia: item selection, factor structure,

155

reliability and concurrent validity. Psychotherapy and Psychosomatics, 75(1), 25-39.
doi: 10.1159/000089224
Baker, R., Owens, M., Thomas, S., Whittlesea, A., Abbey, G., Gower, P., . . . Thomas, P. W.
(2012). Does CBT facilitate emotional processing? Behavioural and Cognitive
Psychotherapy, 40(1), 19-37. doi: 10.1017/s1352465810000895
Balaban, H., Semiz, M., Senturk, I. A., Kavakci, O., Cinar, Z., Dikici, A., & Topaktas, S.
(2012). Migraine prevalence, alexithymia, and post-traumatic stress disorder among
medical students in Turkey. The Journal of Headache and Pain, 13(6), 459-467. doi:
10.1007/s10194-012-0452-7
Balestrieri, M., Isola, M., Baiano, M., & Ciano, R. (2013). Psychoeducation in Binge Eating
Disorder and EDNOS: a pilot study on the efficacy of a 10-week and a 1-year
continuation treatment. Eating and Weight Disorders - Studies on Anorexia, Bulimia
and Obesity, 18(1), 45-51. doi: 10.1007/s40519-013-0014-2
Bamonti, P. M., Heisel, M. J., Topciu, R. A., Franus, N., Talbot, N. L., & Duberstein, P. R.
(2010). Association of alexithymia and depression symptom severity in adults aged 50
years and older. The American Journal of Geriatric Psychiatry, 18(1), 51-56. doi:
10.1097/JGP.0b013e3181bd1bfe
Bandelow, B. (1995). Assessing the efficacy of treatments for panic disorder and
agoraphobia. II. The Panic and Agoraphobia Scale. International Clinical
Psychopharmacology, 10(2), 73-81.
Bankier, B., Aigner, M., & Bach, M. (2001). Alexithymia in DSM-IV disorder: comparative
evaluation of somatoform disorder, panic disorder, obsessive-compulsive disorder,
and depression. Psychosomatics, 42(3), 235-240. doi: 10.1176/appi.psy.42.3.235
Baughman, H. M., Schwartz, S., Schermer, J. A., Veselka, L., Petrides, K. V., & Vernon, P.
A. (2012). A Behavioral-Genetic Study of Alexithymia and its Relationships with

156

Trait Emotional Intelligence. Twin Research and Human Genetics, 14(06), 539-543.
doi: 10.1375/twin.14.6.539
Beales, D. L., & Dolton, R. (2000). Eating disordered patients: personality, alexithymia, and
implications for primary care. The British Journal of General Practice, 20(450), 2126.
Beck, A. T., Steer, R. A., & Brown, G. K. (1996). BDI-II, Beck depression inventory :
manual. San Antonio, Tex: Psychological Corp.
Becker-Stoll, F., & Gerlinghoff, M. (2004). The impact of a four-month day treatment
programme on alexithymia in eating disorders. European Eating Disorders Review,
12(3), 159-163. doi: 10.1002/erv.566
Berenbaum, H., Davis, R., & McGrew, J. (1998). Alexithymia and the interpretation of
hostile-provoking situations. Psychotherapy and Psychosomatics, 67(4-5), 254-258.
Berenbaum, H., & James, T. (1994). Correlates and retrospectively reported antecedents of
alexithymia. Psychosomatic Medicine, 56(4), 353-359.
Berenbaum, H., & Prince, J. D. (1994). Alexithymia and the interpretation of emotionrelevant information. Cognition and Emotion, 8(3), 231-244.
Beresnevaite, M. (2000). Exploring the benefits of group psychotherapy in reducing
alexithymia in coronary heart disease patients: a preliminary study. Journal of
Psychotherapy and Psychosomatics, 69(3), 117-122. doi: 12378
Berking, M., Wupperman, P., Reichardt, A., Pejic, T., Dippel, A., & Znoj, H. (2008).
Emotion-regulation skills as a treatment target in psychotherapy. Behaviour Research
and Therapy, 46(11), 1230-1237. doi: 10.1016/j.brat.2008.08.005
Bermond, B., Vorst, H. C., Vingerhoets, A. J., & Gerritsen, W. (1999). The Amsterdam
Alexithymia Scale: its psychometric values and correlations with other personality
traits. Psychotherapy and Psychosomatics, 68(5), 241-251. doi: 12340

157

Berthoz, S., Artiges, E., Van De Moortele, P. F., Poline, J. B., Rouquette, S., Consoli, S. M.,
& Martinot, J. L. (2002). Effect of impaired recognition and expression of emotions
on frontocingulate cortices: an fMRI study of men with alexithymia. The American
Journal of Psychiatry, 159(6), 961-967.
Berthoz, S., Haviland, M. G., Riggs, M. L., Perdereau, F., & Bungener, C. (2005). Assessing
alexithymia in French-speaking samples: psychometric properties of the Observer
Alexithymia Scale-French translation. European Psychiatry, 20(7), 497-502. doi:
10.1016/j.eurpsy.2004.10.001
Besharat, M. A. (2008). Assessing reliability and validity of the Farsi version of the Toronto
Alexithymia Scale in a sample of substance-using patients. Psychological Reports,
102(1), 259-270. doi: 10.2466/pr0.102.1.259-270
Beyer, J. A. (2008). Alexithymia and verbal emotional expression evaluating the criterion
validity of the Toronto Alexithymia Scale-20 in a community sample of adults. (Master
of Arts in Clinical Psychology), Wayne State University, Detroit, Michigan.
ProQuest Dissertations & Theses Database database. (1450512)
Bhar, S. S., & Beck, A. T. (2009). Treatment Integrity of Studies That Compare Short-Term
Psychodynamic Psychotherapy With Cognitive-Behavior Therapy. Clinical
Psychology: Science and Practice, 16(3), 370-378. doi: 10.1111/j.14682850.2009.01176.x
ogutyn, T., Kokoszka, A., Pałczyński, J., & Holas, P. (1999). Defense mechanisms in
alexithymia. Psychological Reports, 84(1), 183-187.
Bonnaire, C., Bungener, C., & Varescon, I. (2009). Subtypes of French pathological
gamblers: comparison of sensation seeking, alexithymia and depression scores.
Journal of Gambling Studies, 25(4), 455-471. doi: 10.1007/s10899-009-9142-z

158

Bonnet, A., Brejard, V., & Pedinielli, J. L. (2013). Emotional dispositions and substance use:
mediating effect of alexithymia. Psychological Reports, 112(1), 289-302. doi:
10.2466/18.09.20.pr0.112.1.289-302
Borens, R., Grosse-Schulte, E., Jaensch, W., & Kortemme, K. H. (1977). Is 'alexithymia' but
a social phenomenon? An empirical investigation in psychosomatic patients.
Psychotherapy and Psychosomatics, 28(1-4), 193-198.
Bouchard, G. (2009). Alexithymia among Students and Professionals in Function of
Disciplines. Social Behavior and Personality, 36(3), 303-314.
Bowlby, J. (1969). Attachment and loss: Vol. 1. Attachment. New York: Basic Books.
Bowlby, J. (1973). Attachment and loss: Vol. 2. Separation, anxiety and anger. New York:
Basic Books.
r utigam, W., & Rad, M. (Eds.). (1977). Toward a theory of psychosomatic disorders :
alexithymia, pensée opératoire, psychosomatisches Phänomen : proceedings of the
11th European Conference on Psychosomatic Research, Heidelberg, September 1417, 1976 (Vol. 28). Switzerland: Basel; New York: Karger.
Bressi, C., Taylor, G., Parker, J., Bressi, S., Brambilla, V., Aguglia, E., . . . Invernizzi, G.
(1996). Cross validation of the factor structure of the 20-item Toronto Alexithymia
Scale: an Italian multicenter study. Journal of Psychosomatic Research, 41(6), 551559.
Breuer, J., & Freud, S. (1895). Studies on hysteria J. Strachey, Strachey, A., & Richards, A.
(Ed.) translated [from the German] by James and Alix Strachey (pp. 376).
Burba, B., Oswald, R., Grigaliunien, V., Neverauskiene, S., Jankuviene, O., & Chue, P.
(2006). A controlled study of alexithymia in adolescent patients with persistent
somatoform pain disorder. Canadian Journal of Psychiatry, 51(7), 468-471.

159

Byrne, N., & Ditto, B. (2005). Alexithymia, cardiovascular reactivity, and symptom reporting
during blood donation. Psychosomatic Medicine, 67(3), 471-475. doi:
10.1097/01.psy.0000160471.66399.12
Campos, A., Chiva, M., & Moreau, M. (2000). Alexithymia and mental imagery. Personality
and Individual Differences, 29(5), 787-791. doi: http://dx.doi.org/10.1016/S01918869(99)00231-7
Carano, A., De Berardis, D., Gambi, F., Di Paolo, C., Campanella, D., Pelusi, L., . . . Ferro,
F. M. (2006). Alexithymia and body image in adult outpatients with binge eating
disorder. International Journal of Eating Disorders, 39(4), 332-340. doi:
10.1002/eat.20238
Caretti, V., Porcelli, P., Solano, L., Schimmenti, A., Bagby, R. M., & Taylor, G. J. (2011).
Reliability and validity of the Toronto Structured Interview for Alexithymia in a
mixed clinical and nonclinical sample from Italy. Psychiatry Research, 187(3), 432436. doi: 10.1016/j.psychres.2011.02.015
Carpenter, K. M., & Addis, M. E. (2000). Alexithymia, Gender, and Responses to Depressive
Symptoms. Sex Roles, 43(9-10), 629-644. doi: 10.1023/A:1007100523844
Carton, S., Bayard, S., Paget, V., Jouanne, C., Varescon, I., Edel, Y., & Detilleux, M. (2010).
Emotional awareness in substance-dependent patients. Journal of Clinical
Psychology, 66(6), 599-610. doi: 10.1002/jclp.20662
Cassidy, J. (1994). Emotion regulation: influences of attachment relationships. Monographs
of the Society for Research in Child Development, 59(2-3), 228-249.
Celikel, F. C., Kose, S., Erkorkmaz, U., Sayar, K., Cumurcu, B. E., & Cloninger, C. R.
(2010). Alexithymia and temperament and character model of personality in patients
with major depressive disorder. Comprehensive Psychiatry, 51(1), 64-70. doi:
10.1016/j.comppsych.2009.02.004

160

Celikel, F. C., & Saatcioglu, O. (2006). Alexithymia and anxiety in female chronic pain
patients. Annals of General Psychiatry, 5(1), 1-5. doi: 10.1186/1744-859X-5-13
Celikel, F. C., & Saatcioglu, O. (2007). Alexithymia and anxiety sensitivity in Turkish
depressive, anxiety and somatoform disorder outpatients. International Journal of
Psychiatry in Clinical Practice, 11(2), 140-145. doi: 10.1080/13651500600971521
Chen, J., Xu, T., Jing, J., & Chan, R. C. (2011). Alexithymia and emotional regulation: A
cluster analytical approach. BMC Psychiatry, 11, 33. doi: 10.1186/1471-244X-11-33
Clara, I. P., Cox, B. J., & Enns, M. W. (2001). Confirmatory Factor Analysis of the
Depression–Anxiety–Stress Scales in Depressed and Anxious Patients. Journal of
Psychopathology and Behavioral Assessment, 23(1), 61-67. doi:
10.1023/A:1011095624717
Cleland, C., Magura, S., Foote, J., Rosenblum, A., & Kosanke, N. (2005). Psychometric
properties of the Toronto Alexithymia Scale (TAS-20) for substance users. Journal of
Psychosomatic Research, 58(3), 299-306. doi: 10.1016/j.jpsychores.2004.11.002
Clyne, C., & Blampied, N. M. (2004). Training in Emotion Regulation as a Treatment for
Binge Eating: A Preliminary Study. Behaviour Change, 21(4), 269-281. doi:
10.1375/bech.21.4.269.66105
Cohen, J. (1988). Statistical Power Analysis for the Behavioral Sciences (2nd Edition).
Hillsdale, NJ: L. Erlbaum Associates.
Coriale, G., Bilotta, E., Leone, L., Cosimi, F., Porrari, R., De Rosa, F., & Ceccanti, M.
(2012). Avoidance coping strategies, alexithymia and alcohol abuse: a mediation
analysis. Addictive Behaviors, 37(11), 1224-1229. doi: 10.1016/j.addbeh.2012.05.018
Cox, B. J., Kuch, K., Parker, J. D., Shulman, I. D., & Evans, R. J. (1994). Alexithymia in
somatoform disorder patients with chronic pain. Journal of Psychosomatic Research,
38(6), 523-527.

161

Cox, B. J., Swinson, R. P., Shulman, I. D., & Bourdeau, D. (1995). Alexithymia in panic
disorder and social phobia. Comprehensive Psychiatry, 36(3), 195-198.
Crawford, J. R., & Henry, J. D. (2003). The Depression Anxiety Stress Scales (DASS):
normative data and latent structure in a large non-clinical sample. British Journal of
Clinical Psychology, 42(Pt 2), 111-131. doi: 10.1348/014466503321903544
Cucchi, M., Cavadini, D., Bottelli, V., Riccia, L., Conca, V., Ronchi, P., & Smeraldi, E.
(2012). Alexithymia and anxiety sensitivity in populations at high risk for panic
disorder. Comprehensive Psychiatry, 53(6), 868-874. doi:
10.1016/j.comppsych.2012.01.005
Davidson, R., & Raistrick, D. (1986). The validity of the Short Alcohol Dependence Data
(SADD) Questionnaire: a short self-report questionnaire for the assessment of alcohol
dependence. British Journal of Addiction, 81(2), 217-222.
De Berardis, D., Campanella, D., Gambi, F., La Rovere, R., Sepede, G., Core, L., . . . Ferro,
F. M. (2007). Alexithymia, fear of bodily sensations, and somatosensory
amplification in young outpatients with panic disorder. Psychosomatics, 48(3), 239246. doi: 10.1176/appi.psy.48.3.239
De Berardis, D., Campanella, D., Gambi, F., Sepede, G., Salini, G., Carano, A., . . . Ferro, F.
M. (2005). Insight and alexithymia in adult outpatients with obsessive-compulsive
disorder. European Archives of Psychiatry and Clinical Neuroscience, 255(5), 350358. doi: 10.1007/s00406-005-0573-y
De Berardis, D., Serroni, N., Campanella, D., Carano, A., Gambi, F., Valchera, A., . . . Ferro,
F. M. (2009). Alexithymia and its relationships with dissociative experiences, body
dissatisfaction and eating disturbances in a non-clinical female sample. Cognitive
Therapy and Research, 33(5), 471-479. doi: 10.1007/s10608-009-9247-9

162

De Gucht, V., Fischler, B., & Heiser, W. (2004). Neuroticism, alexithymia, negative affect,
and positive affect as determinants of medically unexplained symptoms. Personality
and Individual Differences, 36(7), 1655-1667. doi: 10.1016/j.paid.2003.06.012
de Haan, H. A., Joosten, E. A., de Haan, L., Schellekens, A. F., Buitelaar, J. K., van der
Palen, J., & De Jong, C. A. (2013). A family history of alcoholism relates to
alexithymia in substance use disorder patients. Comprehensive Psychiatry, 54(7), 911917. doi: 10.1016/j.comppsych.2013.03.021
de Haan, H. A., Joosten, E., Wijdeveld, T., Boswinkel, P., van der Palen, J., & De Jong, C.
(2012). Alexithymia is not a stable personality trait in patients with substance use
disorders. Psychiatry Research, 198(1), 123-129. doi: 10.1016/j.psychres.2011.09.027
de Haan, H. A., Schellekens, A. F., van der Palen, J., Verkes, R. J., Buitelaar, J. K., & De
Jong, C. A. (2012). The level of alexithymia in alcohol-dependent patients does not
influence outcomes after inpatient treatment. The American Journal of Drug Alcohol
Abuse, 38(4), 299-304. doi: 10.3109/00952990.2012.668597
de Haan, H. A., van der Palen, J., Wijdeveld, T. G., Buitelaar, J. K., & De Jong, C. A. (2014).
Alexithymia in patients with substance use disorders: state or trait? Psychiatry
Research, 216(1), 137-145. doi: 10.1016/j.psychres.2013.12.047
De Panfilis, C., Rabbaglio, P., Rossi, C., Zita, G., & Maggini, C. (2003). Body image
disturbance, parental bonding and alexithymia in patients with eating disorders.
Psychopathology, 36(5), 239-246. doi: 73449
De Panfilis, C., Salvatore, P., Marchesi, C., Cazzolla, R., Tonna, M., & Maggini, C. (2008).
Parental bonding and personality disorder: the mediating role of alexithymia. Journal
of Personality Disorders, 22(5), 496-508. doi: 10.1521/pedi.2008.22.5.496
de Timary, P., Luts, A., Hers, D., & Luminet, O. (2008). Absolute and relative stability of
alexithymia in alcoholic inpatients undergoing alcohol withdrawal: relationship to

163

depression and anxiety. Psychiatry Research, 157(1-3), 105-113. doi:
10.1016/j.psychres.2006.12.008
de Vente, W., Kamphuis, J. H., & Emmelkamp, P. M. (2006). Alexithymia, risk factor or
consequence of work-related stress? Psychotherapy and Psychosomatics, 75(5), 304311. doi: 10.1159/000093953
Deborde, A. S., Berthoz, S., Wallier, J. M., Fermanian, J., Falissard, B., Jeammet, P., &
Corcos, M. (2008). The Bermond-Vorst Alexithymia Questionnaire cutoff scores: a
study in eating-disordered and control subjects. Psychopathology, 41(1), 43-49. doi:
10.1159/000109955
Declercq, F., Vanheule, S., & Deheegher, J. (2010). Alexithymia and posttraumatic stress:
subscales and symptom clusters. Journal of Clinical Psychology, 66(10), 1076-1089.
doi: 10.1002/jclp.20715
Derogatis, L.R. (1983). SCL–90–R: Administration, scoring, and procedures manual II.
Baltimore: Clinical Psychometric Research.
Dion, K. L. (1996). Ethnolinguistic correlates of alexithymia: toward a cultural perspective.
Journal of Psychosomatic Research, 41(6), 531-539.
Dubey, A., Pandey, R., & Mishra, K. (2010). Role of emotion regulation difficulties and
positive/negative affectivity in explaining alexithymia-health relationship: An
overview. Indian Journal of Social Science Researches, 7(1), 20-31.
Duddu, V., Isaac, M. K., & Chaturvedi, S. K. (2003). Alexithymia in somatoform and
depressive disorders. Journal of Psychosomatic Research, 54(5), 435-438.
Eid, M., & Diener, E. (Eds.). (2006). Handbook of multimethod measurement in psychology.
Washington, DC: American Psychological Association.
Eisenberg, N., Cumberland, A., & Spinrad, T. L. (1998). Parental Socialization of Emotion.
Psychological Inquiry, 9(4), 241-273.

164

Eisenberg, N., Spinrad, T. L., & Eggum, N. D. (2010). Emotion-related self-regulation and its
relation to children's maladjustment. Annual Review of Clinical Psychology, 6, 495525. doi: 10.1146/annurev.clinpsy.121208.131208
Eizaguirre, E. A., de Cabezón, A. O. S., de Alda, I. O., Olariaga, L. J., & Juaniz, M. (2004).
Alexithymia and its relationships with anxiety and depression in eating disorders.
Personality and Individual Differences, 36(2), 321-331. doi: 10.1016/s01918869(03)00099-0
El Rasheed, A. H. (2001). Alexithymia in Egyptian Substance Abusers. Journal of Substance
Abuse Treatment, 22(1), 11-21. doi: 10.1080/08897070109511442
Evren, C., Cagil, D., Ulku, M., Ozcetinkaya, S., Gokalp, P., Cetin, T., & Yigiter, S. (2012).
Relationship between defense styles, alexithymia, and personality in alcoholdependent inpatients. Comprehensive Psychiatry, 53(6), 860-867. doi:
10.1016/j.comppsych.2012.01.002
Evren, C., Cinar, O., & Evren, B. (2012). Relationship of alexithymia and dissociation with
severity of borderline personality features in male substance-dependent inpatients.
Comprehensive Psychiatry, 53(6), 854-859. doi: 10.1016/j.comppsych.2011.11.009
Evren, C., Dalbudak, E., & Çakmak, D. (2008). Alexithymia and personality in relation to
dimensions of psychopathology in male alcohol-dependent inpatients. Bulletin of
Clinical Psychopharmacology, 18(1), 1-8.
Evren, C., Dalbudak, E., Cetin, R., Durkaya, M., & Evren, B. (2010). Relationship of
alexithymia and temperament and character dimensions with lifetime post-traumatic
stress disorder in male alcohol-dependent inpatients. Psychiatry and Clinical
Neurosciences, 64(2), 111-119. doi: 10.1111/j.1440-1819.2009.02052.x

165

Evren, C., Evren, B., Dalbudak, E., Ozcelik, B., & Oncu, F. (2009). Childhood abuse and
neglect as a risk factor for alexithymia in adult male substance dependent inpatients.
Journal of Psychoactive Drugs, 41(1), 85-92.
Eysenck, H. J. (1952). The effects of psychotherapy: an evaluation. Journal of Consulting
Psychology, 16(5), 319-324. doi: 10.1037/h0063633
Faraone, S. V., Sergeant, J., Gillberg, C., & Biederman, J. (2003). The worldwide prevalence
of ADHD: is it an American condition? World Psychiatry, 2(2), 104-113.
Fichman, M., & Cummings, J. N. (2003). Multiple imputation for missing data: Making the
most of what you know. Organizational Research Methods, 6(3), 282-308. doi:
10.1177/1094428103255532
Field, A. P. (2005). Discovering statistics using SPSS (2nd ed.). London: Sage.
Fonagy, P., Gergely, G., Jurist, E.L., & Target, M. (2002). Affect regulation, mentalisation
and the development of the self. New York: Other Press.
Fouladi, R. T., McCarthy, C. J., & Moller, N. P. (2002). Paper-and-pencil or online?
Evaluating mode effects on measures of emotional functioning and attachment.
Assessment, 9(2), 204-215.
Fraley, R. Chris. (2002). Attachment Stability From Infancy to Adulthood: Meta-Analysis
and Dynamic Modeling of Developmental Mechanisms. Personality and Social
Psychology Review, 6(2), 123-151. doi: 10.1207/s15327957pspr0602_03
Franz, M., Popp, K., Schaefer, R., Sitte, W., Schneider, C., Hardt, J., . . . Braehler, E. (2008).
Alexithymia in the German general population. Social Psychiatry and Psychiatric
Epidemiology, 43(1), 54-62. doi: 10.1007/s00127-007-0265-1
Franz, M., Schaefer, R., & Schneider, C. (2003). Psychophysiological response patterns of
high and low alexithymics under mental and emotional load conditions. Journal of
Psychophysiology, 17(4), 203-213. doi: 10.1027/0269-8803.17.4.203

166

Freund, S. (2012). An examination of the cognitive, affective, and physiological aspects of
alexithymia. (Master of Arts), University of Windsor, Electronic Theses and
Dissertations. Retrieved from http://scholar.uwindsor.ca/etd/4805/ (4805)
Frewen, P. A., Dozois, D. J., Neufeld, R. W., & Lanius, R. A. (2008). Meta-analysis of
alexithymia in posttraumatic stress disorder. Journal of Traumatic Stress, 21(2), 243246. doi: 10.1002/jts.20320
Frewen, P. A., Lanius, R. A., Dozois, D. J., Neufeld, R. W., Pain, C., Hopper, J. W., . . .
Stevens, T. K. (2008). Clinical and neural correlates of alexithymia in posttraumatic
stress disorder. Journal of Abnormal Psychology, 117(1), 171-181. doi:
10.1037/0021-843X.117.1.171
Frewen, P. A., Pain, C., Dozois, D. J., & Lanius, R. A. (2006). Alexithymia in PTSD:
psychometric and FMRI studies. Annals of the New York Academy of Sciences, 1071,
397-400. doi: 10.1196/annals.1364.029
Freyberger, H. (1977). Supportive psychotherapeutic techniques in primary and secondary
alexithymia. Psychotherapy and Psychosomatics, 28(1-4), 337-342.
Friedlander, L., Lumley, M. A., Farchione, T., & Doyal, G. (1997). Testing the alexithymia
hypothesis: physiological and subjective responses during relaxation and stress. The
Journal of Nervous and Mental Disease, 185(4), 233-239.
Fukunishi, I., Kikuchi, M., Wogan, J., & Takubo, M. (1997). Secondary alexithymia as a
state reaction in panic disorder and social phobia. Comprehensive Psychiatry, 38(3),
166-170.
Fukunishi, I., Nakagawa, T., Nakamura, H., Kikuchi, M., & Takubo, M. (1997). Is
alexithymia a culture-bound construct? Validity and reliability of the Japanese
versions of the 20-item Toronto Alexithymia Scale and modified Beth Israel Hospital

167

Psychosomatic Questionnaire. Psychological Reports, 80(3 Pt 1), 787-799. doi:
10.2466/pr0.1997.80.3.787
Fukunishi, I., Sei, H., Morita, Y., & Rahe, R. H. (1999). Sympathetic activity in alexithymics
with mother's low care. Journal of Psychosomatic Research, 46(6), 579-589.
Galderisi, S., Mancuso, F., Mucci, A., Garramone, S., Zamboli, R., & Maj, M. (2008).
Alexithymia and cognitive dysfunctions in patients with panic disorder.
Psychotherapy and Psychosomatics, 77(3), 182-188. doi: 10.1159/000119738
Gardos, G., Schniebolk, S., Mirin, S. M., Wolk, P. C., & Rosenthal, K. L. (1984).
Alexithymia: towards validation and measurement. Comprehensive Psychiatry, 25(3),
278-282.
Garner, D. M., Olmstead, M. P., & Polivy, J. (1983). Development and validation of a
multidimensional eating disorder inventory for anorexia nervosa and bulimia.
International Journal of Eating Disorders, 2(2), 15-34. doi: 10.1002/1098108X(198321)2:2<15::AID-EAT2260020203>3.0.CO;2-6
Gay, M-C., Hanin, D., & Luminet, O. (2008). Effectiveness of an hypnotic imagery
intervention on reducing alexithymia. Contemporary Hypnosis, 25(1), 1-13. doi:
10.1002/ch.344
George, D., & Mallery, P. (2003). SPSS for Windows step by step: A simple guide and
reference. 11.0 update (4th ed.). Boston: Allyn & Bacon.
Gignac, G. E., Palmer, B. R., & Stough, C. (2007). A confirmatory factor analytic
investigation of the TAS-20: corroboration of a five-factor model and suggestions for
improvement. Journal of Personality Assessment, 89(3), 247-257. doi:
10.1080/00223890701629730
Goodman, W. K., Price, L. H., Rasmussen, S. A., Mazure, C., Fleischmann, R. L., Hill, C. L.,
. . . Charney, D. S. (1989). The Yale-Brown Obsessive Compulsive Scale. I.

168

Development, use, and reliability. Archives of General Psychiatry, 46(11), 10061011.
Gormally, J., Black, S., Daston, S., & Rardin, D. (1982). The assessment of binge eating
severity among obese persons. Addictive Behaviors, 7(1), 47-55. doi:
http://dx.doi.org/10.1016/0306-4603(82)90024-7
Grabe, H. J., Frommer, J., Ankerhold, A., Ulrich, C., Gröger, R., Franke, G. H., . . . Spitzer,
C. (2008). Alexithymia and outcome in psychotherapy. Psychotherapy and
Psychosomatics, 77(3), 189-194. doi: 10.1159/000119739
Grabe, H. J., Lobel, S., Dittrich, D., Bagby, R. M., Taylor, G. J., Quilty, L. C., . . . Rufer, M.
(2009). The German version of the Toronto Structured Interview for Alexithymia:
factor structure, reliability, and concurrent validity in a psychiatric patient sample.
Comprehensive Psychiatry, 50(5), 424-430. doi: 10.1016/j.comppsych.2008.11.008
Grabe, H. J., Möller, B., Willert, C., Spitzer, C., Rizos, T., & Freyberger, H. J. (2004).
Interhemispheric transfer in alexithymia: a transcallosal inhibition study.
Psychotherapy and Psychosomatics, 73(2), 117-123. doi: 10.1159/000075543
Grabe, H. J., Ruhrmann, S., Ettelt, S., Müller, A., Buhtz, F., Hochrein, A., . . . Freyberger, H.
J. (2006). Alexithymia in obsessive-compulsive disorder - results from a family study.
Psychotherapy and Psychosomatics, 75(5), 312-318. doi: 10.1159/000093954
Graugaard, P. K., Holgersen, K., & Finset, A. (2004). Communicating with alexithymic and
non-alexithymic patients: an experimental study of the effect of psychosocial
communication and empathy on patient satisfaction. Psychotherapy and
Psychosomatics, 73(2), 92-100. doi: 10.1159/000075540
Gregorio, L. (2010). Psychometric Properties of the Depression Anxiety Stress Scales-21 in a
Nonclinical Sample. (Master of Science in Psychology), University of Texas, San
Antonio. ProQuest Dissertations & Theses database database. (1480485)

169

Gross, J. J. (2013). Handbook of Emotion Regulation, Second Edition Retrieved from
http://ECU.eblib.com.au/patron/FullRecord.aspx?p=1578364
Groth-Marnat, G. (2009). Handbook of Psychological Assessment (5th ed.). Hoboken, NJ:
Wiley.
Grynberg, D., Chang, B., Corneille, O., Maurage, P., Vermeulen, N., Berthoz, S., & Luminet,
O. (2012). Alexithymia and the processing of emotional facial expressions (EFEs):
systematic review, unanswered questions and further perspectives. PLoS One, 7(8),
e42429. doi: 10.1371/journal.pone.0042429
Grynberg, D., Luminet, O., Corneille, O., Grèzes, J., & Berthoz, S. (2010). Alexithymia in
the interpersonal domain: A general deficit of empathy? Personality and Individual
Differences, 49(8), 845-850. doi: 10.1016/j.paid.2010.07.013
Güleç, M. Y., Altintaş, M., İnanç, L., ezgin, C. H., Koca, E. K., & Güleç, H. (2013). Effects
of childhood trauma on somatization in major depressive disorder: The role of
alexithymia. Journal of Affective Disorders, 146(1), 137-141. doi:
10.1016/j.jad.2012.06.033
Gündel, H., Greiner, A., Ceballos-Baumann, A. O., Von Rad, M., Förstl, H., & Jahn, T.
(2002). [Increased level of tonic sympathetic arousal in high-vs. low-alexithymic
cervical dystonia patients]. Psychotherapie, Psychosomatik, medizinische
Psychologie, 52(11), 461-468. doi: 10.1055/s-2002-35277
Guttman, H., & Laporte, L. (2002). Alexithymia, empathy, and psychological symptoms in a
family context. Comprehensive Psychiatry, 43(6), 448-455. doi:
10.1053/comp.2002.35905
Guy, William National Institute of Mental Health Psychopharmacology Research Branch
Early Clinical Drug Evaluation Program. (1976). ECDEU assessment manual for
psychopharmacology. Rockville, Md.: U.S. Dept. of Health, Education, and Welfare,

170

Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration,
National Institute of Mental Health, Psychopharmacology Research Branch, Division
of Extramural Research Programs.
Hamilton, M. (1959). The assessment of anxiety states by rating. The British Journal of
Medical Psychology, 32(1), 50-55.
Hamilton, M. (1960). A rating scale for depression. Journal of Neurology, Neurosurgery, and
Psychiatry, 23, 56-62.
Hariri, A. R., Bookheimer, S. Y., & Mazziotta, J. C. (2000). Modulating emotional responses:
effects of a neocortical network on the limbic system. Neuroreport, 11(1), 43-48.
Harris, P. L. (1999). Individual differences in understanding emotion: the role of attachment
status and psychological discourse. Attachment & Human Development, 1(3), 307324. doi: 10.1080/14616739900134171
Hatin, B. D. M. (2011). Alexithymia: Right hemisphere dysfunction or interhemispheric
transfer deficit? (Master of Arts in Psychology), University of Regina, Canada.
Available from ProQuest Dissertations and Theses
Haviland, M. G., Hendryx, M. S., Shaw, D. G., & Henry, J. P. (1994). Alexithymia in women
and men hospitalized for psychoactive substance dependence. Comprehensive
Psychiatry, 35(2), 124-128.
Haviland, M. G., Warren, W. L., & Riggs, M. L. (2000). An observer scale to measure
alexithymia. Psychosomatics, 41(5), 385-392.
Haviland, M. G., Warren, W. L., Riggs, M. L., & Gallacher, M. (2001). Psychometric
properties of the Observer Alexithymia Scale in a clinical sample. Journal of
Personality Assessment, 77(1), 176-186. doi: 10.1207/S15327752JPA7701_12

171

Haviland, M. G., Warren, W. L., Riggs, M. L., & Nitch, S. R. (2002). Concurrent validity of
two observer-rated alexithymia measures. Psychosomatics, 43(6), 472-477. doi:
10.1176/appi.psy.43.6.472
Heiberg, A., & Heiberg, A. (1977). Alexithymia -- an inherited trait? Psychotherapy and
Psychosomatics, 28(1-4), 221-225.
Heinrichs, M., Wagner, D., Schoch, W., Soravia, L. M., Hellhammer, D. H., & Ehlert, U.
(2005). Predicting posttraumatic stress symptoms from pretraumatic risk factors: a 2year prospective follow-up study in firefighters. The American Journal of Psychiatry,
162(12), 2276-2286. doi: 10.1176/appi.ajp.162.12.2276
Heinzel, A., Schafer, R., Muller, H. W., Schieffer, A., Ingenhag, A., Eickhoff, S. B., . . .
Hautzel, H. (2010). Increased activation of the supragenual anterior cingulate cortex
during visual emotional processing in male subjects with high degrees of alexithymia:
an event-related fMRI study. Psychotherapy and Psychosomatics, 79(6), 363-370.
doi: 10.1159/000320121
Hendriks, V. M., Kaplan, C. D., van Limbeek, J., & Geerlings, P. (1989). The Addiction
Severity Index: reliability and validity in a Dutch addict population. Journal of
Substance Abuse Treatment, 6(2), 133-141.
Herrero, J., & Meneses, J. (2006). Short Web-based versions of the perceived stress (PSS)
and Center for Epidemiological Studies-Depression (CESD) Scales: a comparison to
pencil and paper responses among Internet users. Computers in Human Behavior,
22(5), 830-846. doi: http://dx.doi.org/10.1016/j.chb.2004.03.007
Honkalampi, K., Hintikka, J., Antikainen, R., Lehtonen, J., & Viinamäki, H. (2001).
Alexithymia in patients with major depressive disorder and comorbid cluster C
personality disorders: a 6-month follow-up study. Journal of Personality Disorders,
15(3), 245-254.

172

Honkalampi, K., Hintikka, J., Koivumaa-Honkanen, H., Antikainen, R., Haatainen, K., &
Viinamaki, H. (2007). Long-term alexithymic features indicate poor recovery from
depression and psychopathology. A six-year follow-up. Psychotherapy and
Psychosomatics, 76(5), 312-314. doi: 10.1159/000104709
Honkalampi, K., Hintikka, J., Laukkanen, E., Lehtonen, J., & Viinamäki, H. (2001).
Alexithymia and depression: a prospective study of patients with major depressive
disorder. Psychosomatics, 42(3), 229-234.
Honkalampi, K., Hintikka, J., Saarinen, P., Lehtonen, J., & Viinamäki, H. (2000). Is
alexithymia a permanent feature in depressed patients? Results from a 6-month
follow-up study. Psychotherapy and Psychosomatics, 69(6), 303-308. doi: 12412
Honkalampi, K., Hintikka, J., Tanskanen, A., Lehtonen, J., & Viinamäki, H. (2000).
Depression is strongly associated with alexithymia in the general population. Journal
of Psychosomatic Research, 48(1), 99-104.
Honkalampi, K., Koivumaa-Honkanen, H., Antikainen, R., Haatainen, K., Hintikka, J., &
Viinamäki, H. (2004). Relationships among alexithymia, adverse childhood
experiences, sociodemographic variables, and actual mood disorder: a 2-year clinical
follow-up study of patients with major depressive disorder. Psychosomatics, 45(3),
197-204. doi: 10.1176/appi.psy.45.3.197
Horowitz, L. M., Rosenberg, S. E., Baer, B. A., Ureño, G., & Villaseñor, V. S. (1988).
Inventory of interpersonal problems: psychometric properties and clinical
applications. Journal of Consulting and Clinical Psychology, 56(6), 885-892.
Horowitz, L.M., Alden, L.E., Wiggins, J.S., & Pincus, A.L. (2000). Inventory of
Interpersonal Problems Manual. Odessa, FL: The Psychological Corporation.

173

Humphreys, T. P., Wood, L. M., & Parker, J. D. A. (2009). Alexithymia and satisfaction in
intimate relationships. Personality and Individual Differences, 46(1), 43-47. doi:
10.1016/j.paid.2008.09.002
Hund, A. R., & Espelage, D. L. (2005). Childhood Sexual Abuse, Disordered Eating,
Alexithymia, and General Distress: A Mediation Model. Journal of Counseling
Psychology, 52(4), 559-573. doi: 10.1037/0022-0167.52.4.559
Hyer, L. A., Woods, M. G., & Boudewyns, P. A. (1991). PTSD and alexithymia: Importance
of emotional clarification in treatment. Psychotherapy: Theory, Research, Practice,
Training, 28(1), 129-139. doi: 10.1037/0033-3204.28.1.129
IBM Corp. (2010). IBM SPSS Statistics for Windows (Version 19.0). Armonk, NY: IMB
Corp.
Inslegers, R., Meganck, R., Ooms, E., Vanheule, S., Bagby, M., Taylor, G., . . . Desmet, M.
(2013). The Dutch language version of the Toronto structured interview for
Alexithymia: reliability, concurrent validity, and factor structure. Psychologica
Belgica, 53(1), 93-116.
Jessimer, M., & Markham, R. (1997). Alexithymia: a right hemisphere dysfunction specific
to recognition of certain facial expressions? Brain and Cognition, 34(2), 246-258. doi:
10.1006/brcg.1997.0900
Jørgensen, M. M., Zachariae, R., Skytthe, A., & Kyvik, K. (2007). Genetic and
environmental factors in alexithymia: a population-based study of 8,785 Danish twin
pairs. Psychotherapy and Psychosomatics, 76(6), 369-375. doi: 10.1159/000107565
Joukamaa, M., Kokkonen, P., Veijola, J., Läksy, K., Karvonen, J. T., Jokelainen, J., &
Järvelin, M. R. (2003). Social situation of expectant mothers and alexithymia 31 years
later in their offspring: a prospective study. Psychosomatic Medicine, 65(2), 307-312.

174

Joukamaa, M., Luutonen, S., von Reventlow, H., Patterson, P., Karlsson, H., & Salokangas,
R. K. (2008). Alexithymia and childhood abuse among patients attending primary and
psychiatric care: results of the RADEP Study. Psychosomatics, 49(4), 317-325. doi:
10.1176/appi.psy.49.4.317
Joyce, A. S., Fujiwara, E., Cristall, M., Ruddy, C., & Ogrodniczuk, J. S. (2013). Clinical
correlates of alexithymia among patients with personality disorder. Psychotherapy
Research : Journal of the Society for Psychotherapy Research, 23(6), 690-704. doi:
10.1080/10503307.2013.803628
Joyce, A. S., O'Kelly, J. G., Ogrodniczuk, J. S., Piper, W. E., & Rosie, J. S. (2012). A
naturalistic trial of brief psychodynamic therapy for recurrent major depression.
Psychodynamic Psychiatry, 40(4), 645-671. doi: 10.1521/pdps.2012.40.4.645
Kano, M., Fukudo, S., Gyoba, J., Kamachi, M., Tagawa, M., Mochizuki, H., . . . Yanai, K.
(2003). Specific brain processing of facial expressions in people with alexithymia: an
H2 15O-PET study. Brain, 126(Pt 6), 1474-1484.
Karlsson, H., Näätänen, P., & Stenman, H. (2008). Cortical activation in alexithymia as a
response to emotional stimuli. The British Journal of Psychiatry, 192(1), 32-38. doi:
10.1192/bjp.bp.106.034728
Karvonen, J. T., Veijola, J., Kokkonen, P., Läksy, K., Miettunen, J., & Joukamaa, M. (2005).
Somatization and alexithymia in young adult Finnish population. General Hospital
Psychiatry, 27(4), 244-249. doi: 10.1016/j.genhosppsych.2005.04.005
Katz, J., Martin, A. L., Page, M. G., & Calleri, V. (2009). Alexithymia and fear of pain
independently predict heat pain intensity ratings among undergraduate university
students. Pain Research & Management, 14(4), 299-305.
Kellner, R. (1975). Psychotherapy in psychosomatic disorders. Archives of General
Psychiatry, 32(8), 1021-1028.

175

Kench, S., & Irwin, H. J. (2000). Alexithymia and childhood family environment. Journal of
Clinical Psychology, 56(6), 737-745.
Kennedy, M., & Franklin, J. (2002). Skills-based Treatment for Alexithymia: An Exploratory
Case Series. Behaviour Change, 19(03), 158-171. doi: doi:10.1375/bech.19.3.158
Keppel, G., & Wickens, T. D. (2004). Design and Analysis: A Researcher's Handbook (4th
ed.). Upper Saddle River, N.J.: Pearson Prentice Hall.
Kim, J. H., Lee, S. J., Rim, H. D., Kim, H. W., Bae, G. Y., & Chang, S. M. (2008). The
Relationship between Alexithymia and General Symptoms of Patients with
Depressive Disorders. Psychiatry Investigation, 5(3), 179-185. doi:
10.4306/pi.2008.5.3.179
Kiyotaki, Y., & Yokoyama, K. (2006). Relationships of eating disturbances to alexithymia,
need for social approval, and gender identity among Japanese female undergraduate
students. Personality and Individual Differences, 41(4), 609-618. doi:
http://dx.doi.org/10.1016/j.paid.2006.02.013
Kleiger, J. H., & Kinsman, R. A. (1980). The development of an MMPI alexithymia scale.
Psychotherapy and Psychosomatics, 34(1), 17-24.
Kojima, M. (2012). Alexithymia as a prognostic risk factor for health problems: a brief
review of epidemiological studies. BioPsychoSocial Medicine, 6(1), 21. doi:
10.1186/1751-0759-6-21
Kojima, M., Senda, Y., Nagaya, T., Tokudome, S., & Furukawa, T. A. (2003). Alexithymia,
depression and social support among Japanese workers. Psychotherapy and
Psychosomatics, 72(6), 307-314. doi: 73027
Kooiman, C. G., Spinhoven, P., & Trijsburg, R. W. (2002). The assessment of alexithymia: a
critical review of the literature and a psychometric study of the Toronto Alexithymia
Scale-20. Journal of Psychosomatic Research, 53(6), 1083-1090.

176

Kreitler, S. (2002). The psychosemantic approach to alexithymia. Personality and Individual
Differences, 33(3), 393-407. doi: http://dx.doi.org/10.1016/S0191-8869(01)00163-5
Krystal, H. (1979). Alexithymia and psychotherapy. American Journal of Psychotherapy,
33(1), 17-31.
Krystal, H. (1988). Integration and Self-Healing: Affect, Trauma, Alexithymia. Hillsdale,
N.J.: The Analytic Press, Inc.
Kubota, M., Miyata, J., Sasamoto, A., Kawada, R., Fujimoto, S., Tanaka, Y., . . . Murai, T.
(2012). Alexithymia and reduced white matter integrity in schizophrenia: a diffusion
tensor imaging study on impaired emotional self-awareness. Schizophrenia Research,
141(2-3), 137-143. doi: 10.1016/j.schres.2012.08.026
Lambert, M. J., & Ogles, B. M. (2004). The efficacy and effectiveness of psychotherapy. In
M. Lambert (Ed.), Bergin and Garfield’s handbook of psychotherapy and behavior
change (5th ed., pp. 139–193). New York: Wiley.
Landa, A. (2009). Beyond the unexplainable pain: relational dynamics and alexithymia in
somatization. (Doctor of Philosophy), Richard L. Conolly College of Long Island
University, Brooklyn. ProQuest Dissertations and Theses Database database.
(3364804)
Lane, R. D., & Schwartz, G. E. (1987). Levels of emotional awareness: a cognitivedevelopmental theory and its application to psychopathology. The American Journal
of Psychiatry, 144(2), 133-143.
Lane, R. D., Sechrest, L., & Riedel, R. (1998). Sociodemographic correlates of alexithymia.
Comprehensive Psychiatry, 39(6), 377-385.
Le, H-N., Berenbaum, H., & Raghavan, C. (2002). Culture and alexithymia: Mean levels,
correlates and the role of parental socialization of emotions. Emotion, 2(4), 341-360.
doi: 10.1037//1528-3542.2.4.341

177

Lecours, S., & Bouchard, M. A. (2011). Verbal elaboration of distinct affect categories and
BPD symptoms. Psychology and Psychotherapy, 84(1), 26-41; discussion 98-110.
doi: 10.1111/j.2044-8341.2010.02006.x
Lee, B. T., Lee, H. Y., Park, S. A., Lim, J. Y., Tae, W. S., Lee, M. S., . . . Ham, B. J. (2011).
Neural substrates of affective face recognition in alexithymia: a functional magnetic
resonance imaging study. Neuropsychobiology, 63(2), 119-124. doi:
10.1159/000318086
Lehman, A. F. (1996). Measures of quality of life among persons with severe and persistent
mental disorders. Social Psychiatry and Psychiatric Epidemiology, 31(2), 78-88.
Leising, D., Grande, T., & Faber, R. (2009). The Toronto Alexithymia Scale (TAS-20): A
measure of general psychological distress. Journal of Research in Personality, 43(4),
707-710. doi: 10.1016/j.jrp.2009.03.009
Levant, R. F. (1992). Toward the reconstruction of masculinity. Journal of Family
Psychology, 5(3-4), 379.
Levant, R. F., Good, G. E., Cook, S. W., O'Neil, J. M., Smalley, K. B., Owen, K., &
Richmond, K. (2006). The normative Male Alexithymia Scale: Measurement of a
gender-linked syndrome. Psychology of Men & Masculinity, 7(4), 212-224. doi:
10.1037/1524-9220.7.4.212
Levant, R. F., Richmond, K., Majors, R. G., Inclan, J. E., Rossello, J. M., Heesacker, M., . . .
Sellers, A. (2003). A multicultural investigation of masculinity ideology and
alexithymia. Psychology of Men & Masculinity, 4(2), 91-99. doi: 10.1037/15249220.4.2.91
Leweke, F., Bausch, S., Leichsenring, F., Walter, B., & Stingl, M. (2009). Alexithymia as a
predictor of outcome of psychodynamically oriented inpatient treatment.
Psychotherapy Research, 19(3), 323-331. doi: 10.1080/10503300902870554

178

Leweke, F., Leichsenring, F., Kruse, J., & Hermes, S. (2012). Is alexithymia associated with
specific mental disorders? Psychopathology, 45(1), 22-28. doi: 10.1159/000325170
Liang, B., & West, J. (2011). Relational health, alexithymia, and psychological distress in
college women: testing a mediator model. American Journal of Orthopsychiatry,
81(2), 246-254. doi: 10.1111/j.1939-0025.2011.01093.x
Lipowski, Z., J. (1968). Review of Consultation Psychiatry and Psychosomatic Medicine: III.
Theoretical Issues. Psychosomatic Medicine, 30(4), 395-422.
Livesley, W. J. (2007). An integrated approach to the treatment of personality disorder.
Journal of Mental Health, 16(1), 131-148. doi: doi:10.1080/09638230601182086
Loas, G., Corcos, M., Stephan, P., Pellet, J., Bizouard, P., Venisse, J. L., . . . Jeammet, P.
(2001). Factorial structure of the 20-item Toronto Alexithymia Scale: confirmatory
factorial analyses in nonclinical and clinical samples. Journal of Psychosomatic
Research, 50(5), 255-261.
Loas, G., Fremaux, D., Otmani, O., Lecercle, C., & Delahousse, J. (1997). Is alexithymia a
negative factor for maintaining abstinence? A follow-up study. Comprehensive
Psychiatry, 38(5), 296-299.
Loas, G., Otmani, O., Fremaux, D., Lecercle, C., Duflot, M., & Delahousse, J. (1996).
[External validity, reliability and basic score determination of the Toronto
Alexithymia Scales (TAS and TAS-20) in a group of alcoholic patients]. L'Encephale,
22(1), 35-40.
Loiselle, C. G., & Cossette, S. (2001). Cross-Cultural Validation of the Toronto Alexithymia
Scale (TAS-20) in U.S. and Peruvian Populations. Transcultural Psychiatry, 38(3),
348-362. doi: 10.1177/136346150103800305
Lovibond, P. F., & Lovibond, S. H. (1995). The structure of negative emotional states:
comparison of the Depression Anxiety Stress Scales (DASS) with the Beck

179

Depression and Anxiety Inventories. Behaviour Research and Therapy, 33(3), 335343.
Lozano, G. (2010). Psychometric properties of the Depression Anxiety Stress Scales-21 in a
nonclinical sample. (Master of Science), The University of Texas at San Antonio,
United States. Retrieved from http://search.proquest.com/docview/751926614 (1283)
Luborsky, L., Barber, J. P., Siqueland, L., Johnson, S., Najavits, L. M., Frank, A., & Daley,
D. (1996). The Revised Helping Alliance Questionnaire (HAq-II) : Psychometric
Properties. The Journal of Psychotherapy Practice and Research, 5(3), 260-271.
Luminet, O., Bagby, R. M., & Taylor, G. J. (2001). An evaluation of the absolute and relative
stability of alexithymia in patients with major depression. Psychotherapy and
Psychosomatics, 70(5), 254-260. doi: 56263
Lumley, M. A., Gustavson, B. J., Partridge, R. T., & Labouvie-Vief, G. (2005). Assessing
alexithymia and related emotional ability constructs using multiple methods:
interrelationships among measures. Emotion, 5(3), 329-342. doi: 10.1037/15283542.5.3.329
Lumley, M. A., Mader, C., Gramzow, J., & Papineau, K. (1996). Family factors related to
alexithymia characteristics. Psychosomatic Medicine, 58(3), 211-216.
Lumley, M. A., Neely, L. C., & Burger, A. J. (2007). The assessment of alexithymia in
medical settings: implications for understanding and treating health problems. Journal
of Personality Assessment, 89(3), 230-246. doi: 10.1080/00223890701629698
Lumley, M. A., & Sielky, K. (2000). Alexithymia, gender, and hemispheric functioning.
Comprehensive Psychiatry, 41(5), 352-359. doi: 10.1053/comp.2000.9014
Lundh, L-G., & Broman, J-E. (2006). Alexithymia and insomnia. Personality and Individual
Differences, 40(8), 1615-1624. doi: 10.1016/j.paid.2005.11.026

180

Lundh, L-G., Johnsson, A., Sundqvist, K., & Olsson, H. (2002). Alexithymia, memory of
emotion, emotional awareness, and perfectionism. Emotion, 2(4), 361-379. doi:
10.1037//1528-3542.2.4.361
Lundh, L-G., & Simonsson-Sarnecki, M. (2001). Alexithymia, emotion, and somatic
complaints. Journal of Personality, 69(3), 483-510.
Lyvers, M., Onuoha, R., Thorberg, F. A., & Samios, C. (2012). Alexithymia in relation to
parental alcoholism, everyday frontal lobe functioning and alcohol consumption in a
non-clinical sample. Addictive Behaviors, 37(2), 205-210. doi:
10.1016/j.addbeh.2011.10.012
Macalpine, I. (1952). Psychosomatic Symptom Formation. The Lancet, 259(6702), 278-282.
MacLean, P. D. (1949). Psychosomatic disease and the visceral brain; recent developments
bearing on the Papez theory of emotion. Psychosomatic Medicine, 11(6), 338-353.
Mallinckrodt, B., & Wei, M. (2005). Attachment, Social Competencies, Social Support, and
Psychological Distress. Journal of Counseling Psychology, 52(3), 358-367. doi:
10.1037/0022-0167.52.3.358
Marchesi, C., Fonto, S., Balista, C., Cimmino, C., & Maggini, C. (2005). Relationship
between alexithymia and panic disorder: a longitudinal study to answer an open
question. Psychotherapy and Psychosomatics, 74(1), 56-60. doi: 10.1159/000082028
Martínez-Sánchez, F. (1996). The Spanish version of the Toronto Alexithymia
Scale (TAS-20). Clínica y Salud, 7, 19-32.
Marty, P., & de M'Uzan, M. (1963). La pensée opératoire. Intervention sur le rapport de M.
Fain et Ch. David: Aspects fonctionnels de la view onirique. Paper presented at the
XXIIIe Congrès des psychanalystes de langues romanes, Barcelona.
Martίnez-Sanchez, F., Ato-Gárcίa, M., & Ortiz-Soria, B. (2003). Alexithymia--state or trait?
The Spanish Journal of Psychology, 6(1), 51-59.

181

Mason, O., Tyson, M., Jones, C., & Potts, S. (2005). Alexithymia: its prevalence and
correlates in a British undergraduate sample. Psychology and Psychotherapy, 78(1),
113-125. doi: 10.1348/147608304x21374
Mattila, A. K., Keefer, K. V., Taylor, G. J., Joukamaa, M., Jula, A., Parker, J. D. A., &
Bagby, R. M. (2010). Taxometric analysis of alexithymia in a general population
sample from Finland. Personality and Individual Differences, 49(3), 216-221. doi:
10.1016/j.paid.2010.03.038
Mattila, A. K., Salminen, J. K., Nummi, T., & Joukamaa, M. (2006). Age is strongly
associated with alexithymia in the general population. Journal of Psychosomatic
Research, 61(5), 629-635. doi: 10.1016/j.jpsychores.2006.04.013
Mauss, I. B., Levenson, R. W., McCarter, L., Wilhelm, F. H., & Gross, J. J. (2005). The tie
that binds? Coherence among emotion experience, behavior, and physiology.
Emotion, 5(2), 175-190. doi: 10.1037/1528-3542.5.2.175
Mayer, J. D., Caruso, D.R., & Salovey, P. (2000). Selecting a measure of emotional
intelligence: the case for ability scales. In R. Bar-On & J. D. A. Parker (Eds.), The
handbook of emotional intelligence: Theory, development, assessment, and
application at home, school, and in the workplace (Vol. xv, pp. 320-342). San
Francisco, CA, US: Jossey-Bass.
Mazzeo, S. E., & Espelage, D. L. (2002). Association between childhood physical and
emotional abuse and disordered eating behaviors in female undergraduates: An
investigation of the mediating role of alexithymia and depression. Journal of
Counseling Psychology, 49(1), 86-100. doi: 10.1037//0022-0167.49.1.86
McCallum, M., Piper, W. E., Ogrodniczuk, J. S., & Joyce, A. S. (2003). Relationships among
psychological mindedness, alexithymia and outcome in four forms of short-term

182

psychotherapy. Psychology and Psychotherapy, 76(Pt 2), 133-144. doi:
10.1348/147608303765951177
McCaslin, S. E., Metzler, T. J., Best, S. R., Liberman, A., Weiss, D. S., Fagan, J., & Marmar,
C. R. (2006). Alexithymia and PTSD symptoms in urban police officers: crosssectional and prospective findings. Journal of Traumatic Stress, 19(3), 361-373. doi:
10.1002/jts.20133
McCrae, R. R. (1994). The Counterpoint of Personality Assessment: Self-Reports and
Observer Ratings. Assessment, 1(2), 159-172.
McDougall, J. (1982). Alexithymia: a psychoanalytic viewpoint. Psychotherapy and
Psychosomatics, 38(1), 81-90.
McLean, L. M., Toner, B., Jackson, J., Desrocher, M., & Stuckless, N. (2006). The
relationship between childhood sexual abuse, complex post-traumatic stress disorder
and alexithymia in two outpatient samples: examination of women treated in
community and institutional clinics. Journal of Child Sexual Abuse, 15(3), 1-17. doi:
10.1300/J070v15n03_01
McLellan, A. T., Kushner, H., Metzger, D., Peters, R., Smith, I., Grissom, G., . . . Argeriou,
M. (1992). The Fifth Edition of the Addiction Severity Index. Journal of Substance
Abuse Treatment, 9(3), 199-213.
McNeill, P. D. (2014). Duet for life: Is alexithymia a key note in couples’ empathy, emotional
connection, relationship dissatisfaction, and therapy outcomes? (Unpublished
doctoral dissertation), Edith Cowan University, Australia.
Meganck, R., Vanheule, S., & Desmet, M. (2008). Factorial validity and measurement
invariance of the 20-item Toronto Alexithymia Scale in clinical and nonclinical
samples. Assessment, 15(1), 36-47. doi: 10.1177/1073191107306140

183

Meganck, R., Vanheule, S., Desmet, M., & Inslegers, R. (2010). The Observer Alexithymia
Scale: a reliable and valid alternative for alexithymia measurement? Journal of
Personality Assessment, 92(2), 175-185. doi: 10.1080/00223890903510449
Meganck, R., Vanheule, S., Inslegers, R., & Desmet, M. (2009). Alexithymia and
interpersonal problems: A study of natural language use. Personality and Individual
Differences, 47(8), 990-995. doi: 10.1016/j.paid.2009.08.005
Melin, E. O., Thulesius, H. O., & Persson, B. A. (2010). Affect School for chronic benign
pain patients showed improved alexithymia assessments with TAS-20.
BioPsychoSocial Medicine, 4(1), 5. doi: 10.1186/1751-0759-4-5
Messer, S. B., & Wampold, B. E. (2002). Let's Face Facts: Common Factors Are More Potent
Than Specific Therapy Ingredients. Clinical Psychology: Science and Practice, 9(1),
21-25. doi: 10.1093/clipsy.9.1.21
Messina, A., Fogliani, A. M., & Paradiso, S. (2010). Association between alexithymia,
neuroticism, and social desirability scores among Italian graduate students.
Psychological Reports, 107(1), 185-192. doi: 10.2466/02.07.13.15.pr0.107.4.185-192
Mikolajczak, M., & Luminet, O. (2006). Is alexithymia affected by situational stress or is it a
stable trait related to emotion regulation? Personality and Individual Differences,
40(7), 1399-1408. doi: 10.1016/j.paid.2005.10.020
Miller, E. T., Neal, D. J., Roberts, L. J., Baer, J. S., Cressler, S. O., Metrik, J., & Marlatt, G.
A. (2002). Test-retest reliability of alcohol measures: is there a difference between
internet-based assessment and traditional methods? Psychology of Addictive
Behaviors, 16(1), 56-63.
Miller, W. R., Tonigan, J. S., & Longabaugh, R. (1995). The Drinker Inventory of
Consequences (DrInC): An instrument for assessing adverse consequences of alcohol

184

abuse (Vol. 4, Project MATCH Monograph Series). Rockville, MD: National Institute
on Alcohol Abuse and Alcoholism DHHS.
Montebarocci, O., Codispoti, M., Baldaro, B., & Rossi, N. (2004). Adult attachment style and
alexithymia. Personality and Individual Differences, 36(3), 499-507. doi:
10.1016/s0191-8869(03)00110-7
Montori, V. M., Swiontkowski, M. F., & Cook, D. J. (2003). Methodologic issues in
systematic reviews and meta-analyses. Clinical Orthopaedics and Related
Research(413), 43-54. doi: 10.1097/01.blo.0000079322.41006.5b
Moriguchi, Y., Decety, J., Ohnishi, T., Maeda, M., Mori, T., Nemoto, K., . . . Komaki, G.
(2007). Empathy and judging other's pain: an fMRI study of alexithymia. Cerebral
Cortex, 17(9), 2223-2234. doi: 10.1093/cercor/bhl130
Moriguchi, Y., Ohnishi, T., Decety, J., Hirakata, M., Maeda, M., Matsuda, H., & Komaki, G.
(2009). The human mirror neuron system in a population with deficient selfawareness: an fMRI study in alexithymia. Human Brain Mapping, 30(7), 2063-2076.
doi: 10.1002/hbm.20653
Moriguchi, Y., Ohnishi, T., Lane, R. D., Maeda, M., Mori, T., Nemoto, K., . . . Komaki, G.
(2006). Impaired self-awareness and theory of mind: an fMRI study of mentalizing in
alexithymia. NeuroImage, 32(3), 1472-1482. doi: 10.1016/j.neuroimage.2006.04.186
Müller, J., & Bühner, M. (2006). Two facets of non-expression of emotions: Relationship
between dimensions of alexithymia and the repressive coping style. Personality and
Individual Differences, 41(7), 1337-1347. doi: 10.1016/j.paid.2006.04.023
Müller, J., Bühner, M., & Ellgring, H. (2003). Is there a reliable factorial structure in the 20item Toronto Alexithymia Scale? A comparison of factor models in clinical and
normal adult samples. Journal of Psychosomatic Research, 55(6), 561-568. doi:
10.1016/s0022-3999(03)00033-3

185

Müller, J., Bühner, M., & Ellgring, H. (2004). The assessment of alexithymia: psychometric
properties and validity of the Bermond–Vorst alexithymia questionnaire. Personality
and Individual Differences, 37(2), 373-391. doi: 10.1016/j.paid.2003.09.010
Murray, C. J. L., & Lopez, A. D. (Eds.). (1996). The global burden of disease: a
comprehensive assessment of mortality and disability from diseases, injuries and risk
factors in 1990 and projected to 2020 (Vol. 1). Cambridge, MA: Havard School of
Public Health on behalf of the World Health Organization and the World Bank
(Global Burden of Disease and Injury Series).
Nemiah, J. C., & Sifneos, P. E. (1970). Psychosomatic illness: a problem in communication.
Psychotherapy and Psychosomatics, 18(1), 154-160.
Neumann, S. A., Sollers, J. J., 3rd, Thayer, J. F., & Waldstein, S. R. (2004). Alexithymia
predicts attenuated autonomic reactivity, but prolonged recovery to anger recall in
young women. International Journal of Psychophysiology, 53(3), 183-195. doi:
10.1016/j.ijpsycho.2004.03.008
Newton, T. L., & Contrada, R. J. (1994). Alexithymia and repression: contrasting emotionfocused coping styles. Psychosomatic Medicine, 56(5), 457-462.
Ng, F., Trauer, T., Dodd, S., Callaly, T., Campbell, S., & Berk, M. (2007). The validity of the
21-item version of the Depression Anxiety Stress Scales as a routine clinical outcome
measure. Acta Neuropsychiatrica, 19(5), 304-310. doi: 10.1111/j.16015215.2007.00217.x
Nieuwenhuijsen, K., de Boer, A. G., Verbeek, J. H., Blonk, R. W., & van Dijk, F. J. (2003).
The Depression Anxiety Stress Scales (DASS): detecting anxiety disorder and
depression in employees absent from work because of mental health problems.
Occupational and Environmental Medicine, 60 Suppl 1, i77-82.

186

Ogrodniczuk, J. S., Joyce, A. S., & Piper, W. E. (2013). Change in alexithymia in two
dynamically informed individual psychotherapies. Psychotherapy and
Psychosomatics, 82(1), 61-63. doi: 10.1159/000341180
Ogrodniczuk, J. S., Piper, W. E., & Joyce, A. S. (2004). Alexithymia as a predictor of
residual symptoms in depressed patients who respond to short-term psychotherapy.
American Journal of Psychotherapy, 58(2), 150-161.
Ogrodniczuk, J. S., Piper, W. E., & Joyce, A. S. (2005). The negative effect of alexithymia on
the outcome of group therapy for complicated grief: what role might the therapist
play? Comprehensive Psychiatry, 46(3), 206-213. doi:
10.1016/j.comppsych.2004.08.005
Ogrodniczuk, J. S., Piper, W. E., Joyce, A. S., & Abbass, A. A. (2009). Alexithymia and
treatment preferences among psychiatric outpatients. Psychotherapy and
Psychosomatics, 78(6), 383-384. doi: 10.1159/000235981
Ogrodniczuk, J. S., Sochting, I., Piper, W. E., & Joyce, A. S. (2012). A naturalistic study of
alexithymia among psychiatric outpatients treated in an integrated group therapy
program. Psychology and Psychotherapy: Theory, Research and Practice, 85(3), 278291. doi: 10.1111/j.2044-8341.2011.02032.x
Onur, E., Alkin, T., Sheridan, M. J., & Wise, T. N. (2013). Alexithymia and emotional
intelligence in patients with panic disorder, generalized anxiety disorder and major
depressive disorder. The Psychiatrist Quarterly, 84(3), 303-311. doi: 10.1007/s11126012-9246-y
Oskis, A., Clow, A., Hucklebridge, F., Bifulco, A., Jacobs, C., & Loveday, C. (2013).
Understanding alexithymia in female adolescents: The role of attachment style.
Personality and Individual Differences, 54(1), 97-102. doi:
10.1016/j.paid.2012.08.023

187

Osman, A., Wong, J. L., Bagge, C. L., Freedenthal, S., Gutierrez, P. M., & Lozano, G.
(2012). The Depression Anxiety Stress Scales-21 (DASS-21): further examination of
dimensions, scale reliability, and correlates. Journal of Clinical Psychology, 68(12),
1322-1338. doi: 10.1002/jclp.21908
Özsahin, A., Uzun, Ö., Cansever, A., & Gulcat, Z. (2003). The effect of alexithymic features
on response to antidepressant medication in patients with major depression.
Depression and Anxiety, 18(2), 62-66. doi: 10.1002/da.10117
Page, A. C., Hooke, G. R., & Morrison, D. L. (2007). Psychometric properties of the
Depression Anxiety Stress Scales (DASS) in depressed clinical samples. British
Journal of Clinical Psychology, 46(Pt 3), 283-297. doi: 10.1348/014466506X158996
Pandey, R., Mandal, M. K., Taylor, G. J., & Parker, J. D. (1996). Cross-cultural alexithymia:
development and validation of a Hindi translation of the 20-Item Toronto Alexithymia
Scale. Journal of Clinical Psychology, 52(2), 173-176. doi: 10.1002/(sici)10974679(199603)52:2<173::aid-jclp8>3.0.co;2-v
Pandey, R., Saxena, P., & Dubey, A. . (2011). Emotion regulation difficulties in alexithymia
and mental health. Europe’s Journal of Psychology, 74(4), 604-623. doi:
10.5964/ejop.v7i4.155
Paradiso, S., Vaidya, J. G., McCormick, L. M., Jones, A., & Robinson, R. G. (2008). Aging
and alexithymia: association with reduced right rostral cingulate volume. The
American Journal of Geriatric Psychiatry, 16(9), 760-769. doi:
10.1097/JGP.0b013e31817e73b0
Parker, J. D. A., Bagby, R. M., Taylor, G. J., Endler, N. S., & Schmitz, P. (1993). Factorial
validity of the 20-item Toronto Alexithymia Scale. European Journal of Personality,
7(4), 221-232. doi: 10.1002/per.2410070403

188

Parker, J. D. A., Keefer, K. V., Taylor, G. J., & Bagby, R. M. (2008). Latent structure of the
alexithymia construct: a taxometric investigation. Psychological Assessment, 20(4),
385-396. doi: 10.1037/a0014262
Parker, J. D. A., Keightley, M. L., Smith, C. T., & Taylor, G. J. (1999). Interhemispheric
transfer deficit in alexithymia: an experimental study. Psychosomatic Medicine, 61(4),
464-468.
Parker, J. D. A., Shaughnessy, P. A., Wood, L. M., Majeski, S. A., & Eastabrook, J. M.
(2005). Cross-cultural alexithymia: validity of the 20-item Toronto Alexithymia Scale
in North American aboriginal populations. Journal of Psychosomatic Research, 58(1),
83-88. doi: 10.1016/j.jpsychores.2004.06.003
Parker, J. D. A., Taylor, G. J., & Bagby, R. M. (1993). Alexithymia and the recognition of
facial expressions of emotion. Psychotherapy and Psychosomatics, 59(3-4), 197-202.
Parker, J. D. A., Taylor, G. J., & Bagby, R. M. (2001). The relationship between emotional
intelligence and alexithymia. Personality and Individual Differences, 30(1), 107-115.
doi: http://dx.doi.org/10.1016/S0191-8869(00)00014-3
Parker, J. D. A., Taylor, G. J., & Bagby, R. M. (2003). The 20-Item Toronto Alexithymia
Scale. Journal of Psychosomatic Research, 55(3), 269-275. doi: 10.1016/s00223999(02)00578-0
Parker, J. D. A., Wood, L. M., Bond, B. J., & Shaughnessy, P. (2005). Alexithymia in young
adulthood: a risk factor for pathological gambling. Psychotherapy and
Psychosomatics, 74(1), 51-55. doi: 10.1159/000082027
Parry, C. L. (2012). The nature of the association between male violent offending and
alexithymia. (Doctor of Philosophy), Edith Cowan University, Perth, Western
Australia. Retrieved from http://ro.ecu.edu.au/theses/483 (483)

189

Peters, R. M. (2006). The relationship of racism, chronic stress emotions, and blood pressure.
Journal of Nursing Scholarship, 38(3), 234-240.
Picardi, A., Caroppo, E., Porcelli, P., Di Maria, G., Munittola, G., & Martinotti, G. (2012).
Alexithymia and severe psychopathology: a study on psychiatric inpatients.
Psychopathology, 45(3), 159-166. doi: 10.1159/000330261
Picardi, A., Toni, A., & Caroppo, E. (2005). Stability of alexithymia and its relationships
with the 'big five' factors, temperament, character, and attachment style.
Psychotherapy and Psychosomatics, 74(6), 371-378. doi: 10.1159/000087785
Pinaquy, S., Chabrol, H., Simon, C., Louvet, J. P., & Barbe, P. (2003). Emotional eating,
alexithymia, and binge-eating disorder in obese women. Obesity Research, 11(2),
195-201. doi: 10.1038/oby.2003.31
Pinard, L., Negrete, J. C., Annable, L., & Audet, N. (1996). Alexithymia in Substance
Abusers. The American Journal on Addictions, 5(1), 32-39. doi: 10.1111/j.15210391.1996.tb00281.x
Polanczyk, G., de Lima, M. S., Horta, B. L., Biederman, J., & Rohde, L. A. (2007). The
worldwide prevalence of ADHD: a systematic review and metaregression analysis.
The American Journal of Psychiatry, 164(6), 942-948. doi:
10.1176/ajp.2007.164.6.942
Pollatos, O., Schubo, A., Herbert, B. M., Matthias, E., & Schandry, R. (2008). Deficits in
early emotional reactivity in alexithymia. Psychophysiology, 45(5), 839-846. doi:
10.1111/j.1469-8986.2008.00674.x
Porcelli, P., Affatati, V., Bellomo, A., De Carne, M., Todarello, O., & Taylor, G. J. (2004).
Alexithymia and psychopathology in patients with psychiatric and functional
gastrointestinal disorders. Psychotherapy and Psychosomatics, 73(2), 84-91. doi:
10.1159/000075539

190

Posse, M., Hallstrom, T., & Backenroth-Ohsako, G. (2002). Alexithymia, social support,
psycho-social stress and mental health in a female population. Nordic Journal of
Psychiatry, 56(5), 329-334. doi: 10.1080/080394802760322088
Reese, J. B. (2008). Predicting improvement in cognitive behavioral therapy for somatization
disorder: the role of alexithymia. (Doctor of Philosophy), Rutgers, The State
University of New Brunswick, New Jersey. Retrieved from
http://hdl.rutgers.edu/1782.2/rucore10001600001.ETD.17555 Proquest, UMI
Dissertation Publishing database.
Richter, J., Moller, B., Spitzer, C., Letzel, S., Bartols, S., Barnow, S., . . . Grabe, H. J. (2006).
Transcallosal inhibition in patients with and without alexithymia.
Neuropsychobiology, 53(2), 101-107. doi: 10.1159/000092218
Roedema, T. M., & Simons, R. F. (1999). Emotion-processing deficit in alexithymia.
Psychophysiology, 36(3), 379-387.
Romei, V., De Gennaro, L., Fratello, F., Curcio, G., Ferrara, M., Pascual-Leone, A., &
Bertini, M. (2008). Interhemispheric transfer deficit in alexithymia: a transcranial
magnetic stimulation study. Psychotherapy and Psychosomatics, 77(3), 175-181. doi:
10.1159/000119737
Rosenblum, A., Foote, J., Cleland, C., Magura, S., Mahmood, D., & Kosanke, N. (2005).
Moderators of Effects of Motivational Enhancements to Cognitive Behavioral
Therapy. The American Journal of Drug and Alcohol Abuse, 31(1), 35-58. doi:
10.1081/ada-200037562
Ruesch, J. (1948). The infantile personality. The core problem of psychosomatic medicine.
Psychosomatic Medicine, 10(3), 134-144.
Rufer, M., Albrecht, R., Zaum, J., Schnyder, U., Mueller-Pfeiffer, C., Hand, I., & Schmidt, O.
(2010). Impact of alexithymia on treatment outcome: a naturalistic study of short-term

191

cognitive-behavioral group therapy for panic disorder. Psychopathology, 43(3), 170179. doi: 10.1159/000288639
Rufer, M., Hand, I., Braatz, A., Alsleben, H., Fricke, S., & Peter, H. (2004). A prospective
study of alexithymia in obsessive-compulsive patients treated with multimodal
cognitive-behavioral therapy. Psychotherapy and Psychosomatics, 73(2), 101-106.
doi: 10.1159/000075541
Rufer, M., Ziegler, A., Alsleben, H., Fricke, S., Ortmann, J., Brückner, E., . . . Peter, H.
(2006). A prospective long-term follow-up study of alexithymia in obsessivecompulsive disorder. Comprehensive Psychiatry, 47(5), 394-398. doi:
http://dx.doi.org/10.1016/j.comppsych.2005.12.004
Saarijärvi, S., Salminen, J. K., & Toikka, T. (2006). Temporal stability of alexithymia over a
five-year period in outpatients with major depression. Psychotherapy and
Psychosomatics, 75(2), 107-112. doi: 10.1159/000090895
Saarijärvi, S., Salminen, J. K., & Toikka, T. B. (2001). Alexithymia and depression: a 1-year
follow-up study in outpatients with major depression. Journal of Psychosomatic
Research, 51(6), 729-733.
Saladin, M. E., Santa Ana, E. J., LaRowe, S. D., Simpson, A. N., Tolliver, B. K., Price, K. L.,
. . . Brady, K. T. (2012). Does alexithymia explain variation in cue-elicited craving
reported by methamphetamine-dependent individuals? The American Journal on
Addictions, 21(2), 130-135. doi: 10.1111/j.1521-0391.2011.00214.x
Salminen, J. K., Saarijärvi, S., Äärelä, E., Toikka, T., & Kauhanen, J. (1999). Prevalence of
alexithymia and its association with sociodemographic variables in the general
population of Finland. Journal of Psychosomatic Research, 46(1), 75-82.
Samson, A. C., Huber, O., & Gross, J. J. (2012). Emotion regulation in Asperger's syndrome
and high-functioning autism. Emotion, 12(4), 659-665. doi: 10.1037/a0027975

192

Santor, D. A., Bagby, R. M., & Joffe, R. T. (1997). Evaluating stability and change in
personality and depression. Journal of Personality and Social Psychology, 73(6),
1354-1362.
Sayar, K., Acar, B., & Ak, I. (2003). Alexithymia and suicidal behavior. The Israel Journal
of Psychiatry and Related Sciences, 40(3), 165-173.
Schmidt, U., Jiwany, A., & Treasure, J. (1993). A controlled study of alexithymia in eating
disorders. Comprehensive Psychiatry, 34(1), 54-58.
Scimeca, G., Bruno, A., Pandolfo, G., Mico, U., Romeo, V. M., Abenavoli, E., . . .
Muscatello, M. R. (2013). Alexithymia, negative emotions, and sexual behavior in
heterosexual university students from Italy. Archives of Sexual Behavior, 42(1), 117127. doi: 10.1007/s10508-012-0006-8
Scott, J. S. (2009). Exploring sex differences in alexithymia: Does sex moderate the
relationship between alexithymia and impulsivity? (Doctor of Philosophy), Long
Island University, Brooklyn. Available from ProQuest Dissertations and Theses
Sifneos, P. E. (1972/1973). Is dynamic psychotherapy contraindicated for a large number of
patients with psychosomatic diseases? Psychotherapy and Psychosomatics, 21(1-6),
133-136. doi: 10.1159/000287665
Sifneos, P. E. (1973). The prevalence of 'alexithymic' characteristics in psychosomatic
patients. Psychotherapy and Psychosomatics, 22(2), 255-262.
Sifneos, P. E. (1975). Problems of psychotherapy of patients with alexithymic characteristics
and physical disease. Psychotherapy and Psychosomatics, 26(2), 65-70.
Sifneos, P. E. (1983). Psychotherapies for psychosomatic and alexithymic patients.
Psychotherapy and Psychosomatics, 40(1-4), 66-73.
Sifneos, P. E. (1988). Alexithymia and its relationship to hemispheric specialization, affect,
and creativity. The Psychiatric Clinics of North America, 11(3), 287-292.

193

Sifneos, P. E. (1994). Affect deficit and alexithymia. New Trends in Experimental and
Clinical Psychiatry, 10(4), 193-195

Sifneos, P. E. (1996). Alexithymia: past and present. The American Journal of Psychiatry,
153(7 Suppl), 137-142.
Sinclair, S. J., Siefert, C. J., Slavin-Mulford, J. M., Stein, M. B., Renna, M., & Blais, M. A.
(2012). Psychometric evaluation and normative data for the depression, anxiety, and
stress scales-21 (DASS-21) in a nonclinical sample of U.S. adults. Evaluation & the
Health Professions, 35(3), 259-279. doi: 10.1177/0163278711424282
Smith, S. D., & Bulman-Fleming, M. B. (2005). An examination of the right-hemisphere
hypothesis of the lateralization of emotion. Brain and Cognition, 57(2), 210-213. doi:
10.1016/j.bandc.2004.08.046
Sobell, L. C., & Sobell, M. B. (1992). Timeline Follow-Back. In R. Litten & J. Allen (Eds.),
Measuring Alcohol Consumption (pp. 41-72): Humana Press.
Son, S. H., Jo, H., Rim, H. D., Kim, J. H., Kim, H. W., Bae, G. Y., & Lee, S. J. (2012). A
Comparative Study on Alexithymia in Depressive, Somatoform, Anxiety, and
Psychotic Disorders among Koreans. Psychiatry Investigation, 9(4), 325-331. doi:
10.4306/pi.2012.9.4.325
Spek, V., Nyklίček, I., Cuijpers, P., & Pop, V. (2008). Alexithymia and cognitive behaviour
therapy outcome for subthreshold depression. Acta Psychiatrica Scandinavica,
118(2), 164-167. doi: 10.1111/j.1600-0447.2008.01199.x
Speranza, M., Corcos, M., Stéphan, P., Loas, G., Pérez-Diaz, F., Lang, F., . . . Jeammet, P.
(2004). Alexithymia, Depressive Experiences, and Dependency in Addictive
Disorders. Substance Use & Misuse, 39(4), 551-579. doi: 10.1081/ja-120030058

194

Speranza, M., Loas, G., Guilbaud, O., & Corcos, M. (2011). Are treatment options related to
alexithymia in eating disorders? Results from a three-year naturalistic longitudinal
study. Biomedicine & Pharmacotherapy, 65(8), 585-589. doi:
10.1016/j.biopha.2010.01.009
Speranza, M., Loas, G., Wallier, J., & Corcos, M. (2007). Predictive value of alexithymia in
patients with eating disorders: a 3-year prospective study. Journal of Psychosomatic
Research, 63(4), 365-371. doi: 10.1016/j.jpsychores.2007.03.008
Spielberger, C. D. (1983). Manual for the State-Trait Anxiety Inventory. Palo Alto, CA:
Consulting Psychology Press.
Spitzer, C., Siebel-Jürges, U., Barnow, S., Grabe, H. J., & Freyberger, H. J. (2005).
Alexithymia and interpersonal problems. Psychotherapy and Psychosomatics, 74(4),
240-246. doi: 10.1159/000085148
Spitzer, R. L., Yanovski, S., Wadden, T., Wing, R., Marcus, M. D., Stunkard, A., . . . Horne,
R. L. (1993). Binge eating disorder: its further validation in a multisite study.
International Journal of Eating Disorders, 13(2), 137-153.
Stasiewicz, P. R., Bradizza, C. M., Gudleski, G. D., Coffey, S. F., Schlauch, R. C., Bailey, S.
T., . . . Gulliver, S. B. (2012). The relationship of alexithymia to emotional
dysregulation within an alcohol dependent treatment sample. Addictive Behaviors,
37(4), 469-476. doi: 10.1016/j.addbeh.2011.12.011
Stern, B. L., Kim, Y., Trull, T. J., Scarpa, A., & Pilkonis, P. (2000). Inventory of
Interpersonal Problems Personality Disorder scales: operating characteristics and
confirmatory factor analysis in nonclinical samples. Journal of Personality
Assessment, 74(3), 459-471. doi: 10.1207/s15327752jpa7403_9

195

Stone, L. A., & Nielson, K. A. (2001). Intact physiological response to arousal with impaired
emotional recognition in alexithymia. Psychotherapy and Psychosomatics, 70(2), 92102. doi: 56232
Subic-Wrana, C., Bruder, S., Thomas, W., Lane, R. D., & Kohle, K. (2005). Emotional
awareness deficits in inpatients of a psychosomatic ward: a comparison of two
different measures of alexithymia. Psychosomatic Medicine, 67(3), 483-489. doi:
10.1097/01.psy.0000160461.19239.13
Suslow, T., & Junghanns, K. (2002). Impairments of emotion situation priming in
alexithymia. Personality and Individual Differences, 32(3), 541-550. doi:
http://dx.doi.org/10.1016/S0191-8869(01)00056-3
Swiller, H. I. (1988). Alexithymia: treatment utilizing combined individual and group
psychotherapy. International Journal of Group Psychotherapy, 38(1), 47-61.
Tabachnick, B. G., & Fidell, L. S. (2007). Using Multivariate Statistics (5th ed.). Boston:
Pearson/Allyn & Bacon.
Tabibnia, G., & Zaidel, E. (2005). Alexithymia, interhemispheric transfer, and right
hemispheric specialization: a critical review. Psychotherapy and Psychosomatics,
74(2), 81-92. doi: 10.1159/000083166
Taylor, G. J. (1977). Alexithymia and the counter-transference. Psychotherapy and
Psychosomatics, 28(1-4), 141-147. doi: 10.1159/000287056
Taylor, G. J. (1984). Alexithymia: concept, measurement, and implications for treatment. The
American Journal of Psychiatry, 141(6), 725-732.
Taylor, G. J. (1987). I Alexithymia: History Validation of the Concept. Transcultural
Psychiatry, 24(2), 85-95. doi: 10.1177/136346158702400201

196

Taylor, G. J. (1992). Psychosomatics and self-regulation. In J. W. Barron, Eagle, M. N., &
Wolitzky, D. L. (Ed.), Interface of psychoanalysis and psychology (Vol. xix, pp. 464488). Washington, DC: American Psychological Association.
Taylor, G. J., & Bagby, R. M. (1988). Measurement of alexithymia. Recommendations for
clinical practice and future research. The Psychiatric Clinics of North America, 11(3),
351-366.
Taylor, G. J., & Bagby, R. M. (2004). New trends in alexithymia research. Psychotherapy
and Psychosomatics, 73(2), 68-77. doi: 10.1159/000075537
Taylor, G. J., Bagby, R. M., & Luminet, O. (2000). Assessment of alexithymia: Self-report
and observer-rated measures. In J. D. A. Parker & R. Bar-On (Eds.), The handbook of
emotional intelligence: Theory, development, assessment, and application at home,
school, and in the workplace (pp. 301-319). San Francisco, CA: Jossey-Bass.
Taylor, G. J., Bagby, R. M., & Parker, J. D. A. (1991). The Alexithymia Construct: A
Potential Paradigm for Psychosomatic Medicine. Psychosomatics, 32(2), 153-164.
doi: 10.1016/s0033-3182(91)72086-0
Taylor, G. J., Bagby, R. M., & Parker, J. D. A. (1992). The Revised Toronto Alexithymia
Scale: some reliability, validity, and normative data. Psychotherapy and
Psychosomatics, 57(1-2), 34-41.
Taylor, G. J., Bagby, R. M., & Parker, J. D. A. (1997). Disorders of affect regulation.
Alexithymia in medical and psychiatric illness. Cambridge, England: Cambridge
University Press.
Taylor, G. J., Bagby, R. M., & Parker, J. D. A. (2003). The 20-Item Toronto Alexithymia
Scale. IV. Reliability and factorial validity in different languages and cultures.
Journal of Psychosomatic Research, 55(3), 277-283.

197

Taylor, G. J., Doody, K., & Newman, A. (1981). Alexithymic characteristics in patients with
inflammatory bowel disease. Canadian Journal of Psychiatry, 26(7), 470-474.
Taylor, G. J., Parker, J. D. A., Bagby, R. M., & Acklin, M. W. (1992). Alexithymia and
somatic complaints in psychiatric outpatients. Journal of Psychosomatic Research,
36(5), 417-424.
Taylor, G. J., Parker, J. D., Bagby, R. M., & Bourke, M. P. (1996). Relationships between
alexithymia and psychological characteristics associated with eating disorders.
Journal of Psychosomatic Research, 41(6), 561-568.
Taylor, G. J., Ryan, D., & Bagby, R. M. (1985). Toward the development of a new self-report
alexithymia scale. Psychotherapy and Psychosomatics, 44(4), 191-199.
The University of New South Wales, School of Psychology. (2013). Depression & Anxiety
Stress Scales (DASS). from http://www2.psy.unsw.edu.au/groups/dass/
Thorberg, F. A., Young, R. M., Sullivan, K. A., Lyvers, M., Connor, J. P., & Feeney, G. F.
(2011). Alexithymia, craving and attachment in a heavy drinking population.
Addictive Behaviors, 36(4), 427-430. doi: 10.1016/j.addbeh.2010.12.016
Thorberg, F. A., Young, R. McD., Sullivan, K. A., Lyvers, M., Connor, J. P., & Feeney, G. F.
X. (2010). A psychometric comparison of the Toronto Alexithymia Scale (TAS-20)
and the Observer Alexithymia Scale (OAS) in an alcohol-dependent sample.
Personality and Individual Differences, 49(2), 119-123. doi:
10.1016/j.paid.2010.03.018
Todarello, O., Porcelli, P., Grilletti, F., & Bellomo, A. (2005). Is alexithymia related to
negative symptoms of schizophrenia? A preliminary longitudinal study.
Psychopathology, 38(6), 310-314. doi: 10.1159/000088919

198

Todarello, O., Taylor, G. J., Parker, J. D., & Fanelli, M. (1995). Alexithymia in essential
hypertensive and psychiatric outpatients: a comparative study. Journal of
Psychosomatic Research, 39(8), 987-994.
Tolmunen, T., Heliste, M., Lehto, S. M., Hintikka, J., Honkalampi, K., & Kauhanen, J.
(2011). Stability of alexithymia in the general population: an 11-year follow-up.
Comprehensive Psychiatry, 52(5), 536-541. doi: 10.1016/j.comppsych.2010.09.007
Toneatto, T., Lecce, J., & Bagby, M. (2009). Alexithymia and pathological gambling.
Journal of Addictive Diseases, 28(3), 193-198. doi: 10.1080/10550880903014775
Troisi, A., D'Argenio, A., Peracchio, F., & Petti, P. (2001). Insecure attachment and
alexithymia in young men with mood symptoms. The Journal of Nervous and Mental
Disease, 189(5), 311-316.
Tsaousis, I., Taylor, G., Quilty, L., Georgiades, S., Stavrogiannopoulos, M., & Bagby, R. M.
(2010). Validation of a Greek adaptation of the 20-item Toronto Alexithymia Scale.
Comprehensive Psychiatry, 51(4), 443-448. doi: 10.1016/j.comppsych.2009.09.005
Tully, P. J., Zajac, I. T., & Venning, A. J. (2009). The structure of anxiety and depression in a
normative sample of younger and older Australian adolescents. Journal of Abnormal
Child Psychology, 37(5), 717-726. doi: 10.1007/s10802-009-9306-4
Tutkun, H., Savas, H. A., Zoroglu, S. S., Esgi, K., Herken, H., & Tiryaki, N. (2004).
Relationship between alexithymia, dissociation and anxiety in psychiatric outpatients
from Turkey. The Israel Journal of Psychiatry and Related Sciences, 41(2), 118-124.
Uzun, Ö. (2003). Alexithymia in male alcoholics: study in a Turkish sample. Comprehensive
Psychiatry, 44(4), 349-352. doi: 10.1016/s0010-440x(03)00009-9
Valera, E. M., & Berenbaum, H. (2001). A twin study of alexithymia. Psychotherapy and
Psychosomatics, 70(5), 239-246. doi: 56261

199

Vallejo, M. A., Jordán, C. M., Díaz, M. I., Comeche, M. I., & Ortega, J. (2007).
Psychological Assessment via the Internet: A Reliability and Validity Study of Online
(vs Paper-and-Pencil) Versions of the General Health Questionnaire-28 (GHQ-28)
and the Symptoms Check-List-90-Revised (SCL-90-R). Journal of Medical Internet
Research, 9(1), e2. doi: 10.2196/jmir.9.1.e2
Vanheule, S., Desmet, M., Meganck, R., & Bogaerts, S. (2007). Alexithymia and
interpersonal problems. Journal of Clinical Psychology, 63(1), 109-117. doi:
10.1002/jclp.20324
Vanheule, S., Verhaeghe, P., & Desmet, M. (2011). In search of a framework for the
treatment of alexithymia. Psychology and Psychotherapy: Theory, Research and
Practice, 84(1), 84-97; discussion 98-110. doi: 10.1348/147608310X520139
Verrocchio, M. C., Conti, C., & Fulcheri, M. (2010). Deliberate self-harm in substancedependent patients and relationship with alexithymia and personality disorders: a
case-control study. Journal of Biological Regulators and Homeostatic Agents, 24(4),
461-469.
Viinamäki, H., Hintikka, J., Tanskanen, A., Honkalampi, K., Antikainen, R., KoivumaaHonkanen, H., . . . Lehtonen, J. (2002). Partial remission in major depression: a twophase, 12-month prospective study. Nordic Journal of Psychiatry, 56(1), 33-37. doi:
10.1080/08039480252803891
Viinamäki, H., Tanskanen, A., Koivumaa-Honkanen, H., Haatainen, K., Honkalampi, K.,
Antikainen, R., & Hintikka, J. (2003). Cluster C personality disorder and recovery
from major depression: 24-month prospective follow-up. Journal of Personality
Disorders, 17(4), 341-350.

200

Viinikangas, A., Lahti, S., Tolvanen, M., Freeman, R., Humphris, G., & Joukamaa, M.
(2009). Dental anxiety and alexithymia: gender differences. Acta Odontologica
Scandinavica, 67(1), 13-18. doi: 10.1080/00016350802459264
Vorst, H. C. M., & Bermond, B. (2001). Validity and reliability of the Bermond–Vorst
Alexithymia Questionnaire. Personality and Individual Differences, 30(3), 413-434.
doi: http://dx.doi.org/10.1016/S0191-8869(00)00033-7
Waldstein, S. R., Kauhanen, J., Neumann, S. A., & Katzel, L. I. (2002). Alexithymia and
cardiovascular risk in older adults: Psychosocial, psychophysiological, and
biomedical correlates. Psychology & Health, 17(5), 597-610. doi:
10.1080/08870440290025803
Wampold, B. E. (2001). The great psychotherapy debate: Models, methods, and findings.
Mahwah, NJ: Lawrence Erlbaum.
Ware, J. E., Jr., & Sherbourne, C. D. (1992). The MOS 36-item short-form health survey (SF36). I. Conceptual framework and item selection. Medical Care, 30(6), 473-483.
Wearden, A. J., Lamberton, N., Crook, N., & Walsh, V. (2005). Adult attachment,
alexithymia, and symptom reporting: an extension to the four category model of
attachment. Journal of Psychosomatic Research, 58(3), 279-288. doi:
10.1016/j.jpsychores.2004.09.010
Wehmer, F., Brejnak, C., Lumley, M., & Stettner, L. (1995). Alexithymia and physiological
reactivity to emotion-provoking visual scenes. The Journal of Nervous and Mental
Disease, 183(6), 351-357.
Widiger, T. A. (2003). Personality disorder and Axis I psychopathology: the problematic
boundary of Axis I and Axis II. Journal of Personality Disorders, 17(2), 90-108.
Willemsen, J., Markey, S., Declercq, F., & Vanheule, S. (2011). Negative emotionality in a
large community sample of adolescents: the factor structure and measurement

201

invariance of the short version of the depression anxiety stress scales (DASS-21).
Stress and Health, 27(3), e120-e128. doi: 10.1002/smi.1342
World Health Organization. (2001). The World health report : 2001 : Mental health : new
understanding, new hope. Geneva, Switzerland: World Health Organization.
World Health Organization. (2010). International Classification of Diseases and Related
Health Problems 10th Revision (Vol. V Mental and behavioural disorders (F00-F99)).
Geneva: World Health Organization.
Yao, S., Yi, J., Zhu, X., & Haviland, M. G. (2005). Reliability and factorial validity of the
Observer Alexithymia Scale-Chinese translation. Psychiatry Research, 134(1), 93100. doi: 10.1016/j.psychres.2004.08.010
Yehuda, R., Steiner, A., Kahana, B., Binder-Brynes, K., Southwick, S. M., Zemelman, S., &
Giller, E. L. (1997). Alexithymia in Holocaust survivors with and without PTSD.
Journal of Traumatic Stress, 10(1), 93-100.
Yelsma, P., Hovestadt, A. J., Anderson, W. T., & Nilsson, J. E. (2000). Family-of-origin
expressiveness: measurement, meaning, and relationship to alexithymia. Journal of
Marital and Family Therapy, 26(3), 353-363.
Zech, E., Luminet, O., Rimé, B., & Wagner, H. (1999). Alexithymia and its measurement:
confirmatory factor analyses of the 20-item Toronto Alexithymia Scale and the
Bermond–Vorst Alexithymia Questionnaire. European Journal of Personality, 13(6),
511-532. doi: 10.1002/(SICI)1099-0984(199911/12)13:6<511::AIDPER347>3.0.CO;2-0
Zeitlin, S. B., McNally, R. J., & Cassiday, K. L. (1993). Alexithymia in victims of sexual
assault: an effect of repeated traumatization? The American Journal of Psychiatry,
150(4), 661-663.

202

Zhu, X., Yi, J., Yao, S., Ryder, A. G., Taylor, G. J., & Bagby, R. M. (2007). Cross-cultural
validation of a Chinese translation of the 20-item Toronto Alexithymia Scale.
Comprehensive Psychiatry, 48(5), 489-496. doi: 10.1016/j.comppsych.2007.04.007
Zigmond, A. S., & Snaith, R. P. (1983). The hospital anxiety and depression scale. Acta
Psychiatrica Scandinavica, 67(6), 361-370.
Zuckerman, M. (1999). Vulnerability to psychopathology: A biosocial model: American
Psychological Association.

203

Appendix A
Depression Anxiety Stress Scale Version 42

DASS

Name:

Date:

Please read each statement and circle a number 0, 1, 2 or 3 that indicates how much the statement applied to you over
the past week. There are no right or wrong answers. Do not spend too much time on any statement.
The rating scale is as follows:
0
1
2
3

Did not apply to me at all
Applied to me to some degree, or some of the time
Applied to me to a considerable degree, or a good part of time
Applied to me very much, or most of the time
1

I found myself getting upset by quite trivial things

0

1

2

3

2

I was aware of dryness of my mouth

0

1

2

3

3

I couldn't seem to experience any positive feeling at all

0

1

2

3

4

I experienced breathing difficulty (eg, excessively rapid breathing,
breathlessness in the absence of physical exertion)

0

1

2

3

5

I just couldn't seem to get going

0

1

2

3

6

I tended to over-react to situations

0

1

2

3

7

I had a feeling of shakiness (eg, legs going to give way)

0

1

2

3

8

I found it difficult to relax

0

1

2

3

9

I found myself in situations that made me so anxious I was most
relieved when they ended

0

1

2

3

10

I felt that I had nothing to look forward to

0

1

2

3

11

I found myself getting upset rather easily

0

1

2

3

12

I felt that I was using a lot of nervous energy

0

1

2

3

13

I felt sad and depressed

0

1

2

3

14

I found myself getting impatient when I was delayed in any way
(eg, elevators, traffic lights, being kept waiting)

0

1

2

3

15

I had a feeling of faintness

0

1

2

3

16

I felt that I had lost interest in just about everything

0

1

2

3

17

I felt I wasn't worth much as a person

0

1

2

3

18

I felt that I was rather touchy

0

1

2

3

19

I perspired noticeably (eg, hands sweaty) in the absence of high
temperatures or physical exertion

0

1

2

3

20

I felt scared without any good reason

0

1

2

3

21

I felt that life wasn't worthwhile

0

1

2

3
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Reminder of rating scale:
0
1
2
3

Did not apply to me at all
Applied to me to some degree, or some of the time
Applied to me to a considerable degree, or a good part of time
Applied to me very much, or most of the time
22

I found it hard to wind down

0

1

2

3

23

I had difficulty in swallowing

0

1

2

3

24

I couldn't seem to get any enjoyment out of the things I did

0

1

2

3

25

I was aware of the action of my heart in the absence of physical
exertion (eg, sense of heart rate increase, heart missing a beat)

0

1

2

3

26

I felt down-hearted and blue

0

1

2

3

27

I found that I was very irritable

0

1

2

3

28

I felt I was close to panic

0

1

2

3

29

I found it hard to calm down after something upset me

0

1

2

3

30

I feared that I would be "thrown" by some trivial but
unfamiliar task

0

1

2

3

31

I was unable to become enthusiastic about anything

0

1

2

3

32

I found it difficult to tolerate interruptions to what I was doing

0

1

2

3

33

I was in a state of nervous tension

0

1

2

3

34

I felt I was pretty worthless

0

1

2

3

35

I was intolerant of anything that kept me from getting on with
what I was doing

0

1

2

3

36

I felt terrified

0

1

2

3

37

I could see nothing in the future to be hopeful about

0

1

2

3

38

I felt that life was meaningless

0

1

2

3

39

I found myself getting agitated

0

1

2

3

40

I was worried about situations in which I might panic and make
a fool of myself

0

1

2

3

41

I experienced trembling (eg, in the hands)

0

1

2

3

42

I found it difficult to work up the initiative to do things

0

1

2

3
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Appendix B
Demographic Questionnaire and Consent Form for Psychiatric Patients

Group Therapy Program, Ellen Street
Surname:

Introductory
Planning Session

URMN:

Sex:

Forenames:

Birth date:

Address:

Phone:

GP details: ___________________________________________________________________
Who referred you? ____________________________________________________________
To help us assist you with planning suitable groups, and so that we can monitor if the groups
have helped you, please complete the following questions as openly and honestly as possible:

Do you have any physical health concerns?

□No □Yes

If yes, please describe: ______________________________________________________________
_________________________________________________________________________________
_________________________________________________________________________________
Other factors (those factors apart from the physical problems just described) that might interfere
with your attendance at the group program (e.g. work, transport, sleep pattern, reading, and
writing)
_________________________________________________________________________________
_________________________________________________________________________________
_________________________________________________________________________________
What are your reasons for attending the Group Therapy Program at Ellen Street?
_________________________________________________________________________________
_________________________________________________________________________________
What are you hoping to get out of groups?
_________________________________________________________________________________
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_________________________________________________________________________________
Tell us about your hobbies and/or interests?
_________________________________________________________________________________
_________________________________________________________________________________
General Information:
What country were you born in? ___________________________
What language do you speak at home? _________________________
Do you live:

□Alone □With family □Shared accommodation

Do you have supportive:

□Family □Friends □Neither

Current employment type

□
□
□
□
□
□

No current employment
Casual paid work
Part-time paid work
Full time paid work
Voluntary work
Other, please specify: ____________________________

Work – Have you been employed in the last 2 years:

□
□
□
□
□
□

No current employment
Casual paid work
Part-time paid work
Full time paid work
Voluntary work
Other, please specify: ____________________________

What education have you completed:

□
□
□
□

Primary school
High school
University
Technical Education

How many years of education have you completed in total? __________________________

Do you identify any communication or learning difficulties?
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□No □Yes

Please specify: ___________________________________________________________________
_________________________________________________________________________________
Would you like to attend other groups aimed at?

□

Domestic Violence

By signing this form you are giving the Group Therapy Program, Ellen Street, permission to
use the information on this questionnaire, as well as other questionnaires during intake and
when attending groups, for evaluation and research purposes. Personal information will not be
released in any form to protect your privacy.
Signature: _______________________________________Date: ____/____/_______
Clinician: (print name) __________________________________________
Signature: _________________________________________________
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Appendix C
Depression Anxiety Stress Scale Version 21

DASS21

Name:

Date:

Please read each statement and circle a number 0, 1, 2 or 3 that indicates how much the statement applied to you over the
past week. There are no right or wrong answers. Do not spend too much time on any statement.
The rating scale is as follows:
0
1
2
3

Did not apply to me at all
Applied to me to some degree, or some of the time
Applied to me to a considerable degree, or a good part of time
Applied to me very much, or most of the time
1

I found it hard to wind down

0

1

2

3

2

I was aware of dryness of my mouth

0

1

2

3

3

I couldn't seem to experience any positive feeling at all

0

1

2

3

4

I experienced breathing difficulty (eg, excessively rapid breathing,
breathlessness in the absence of physical exertion)

0

1

2

3

5

I found it difficult to work up the initiative to do things

0

1

2

3

6

I tended to over-react to situations

0

1

2

3

7

I experienced trembling (eg, in the hands)

0

1

2

3

8

I felt that I was using a lot of nervous energy

0

1

2

3

9

I was worried about situations in which I might panic and make
a fool of myself

0

1

2

3

10

I felt that I had nothing to look forward to

0

1

2

3

11

I found myself getting agitated

0

1

2

3

12

I found it difficult to relax

0

1

2

3

13

I felt down-hearted and blue

0

1

2

3

14

I was intolerant of anything that kept me from getting on with
what I was doing

0

1

2

3

15

I felt I was close to panic

0

1

2

3

16

I was unable to become enthusiastic about anything

0

1

2

3

17

I felt I wasn't worth much as a person

0

1

2

3

18

I felt that I was rather touchy

0

1

2

3

19

I was aware of the action of my heart in the absence of physical
exertion (eg, sense of heart rate increase, heart missing a beat)

0

1

2

3

20

I felt scared without any good reason

0

1

2

3

21

I felt that life was meaningless

0

1

2

3
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Appendix D
Demographic Questionnaire for Community Participants

Do you live in Perth, Western Australia?
Yes

No

Male

Female

Gender

Age at last birthday
......................
Employment
Full-time

Part-time/Casual

Unemployed

Technical/Tafe

University

Education
High school

If you have attended university, are you a current student?
Yes
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No

Appendix E
Consent Form for Community Participants

Please read the following statements and click ‘Yes, I consent to participate in this
study’ if you agree.


I have read and understand the information sheet and wish to participate in the
research.



I understand that my participation in this study is entirely voluntary, that my name
and contact details are not required, and that I am free to quit the survey at any time
before submission without consequence.



I understand that if I experience any distress I will be provided with the details of
support services following this survey.



I understand that any identifying information will be erased from the final project, that
I have the right to view the results of the final project, and that the study may be
published.
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Appendix F
Study Flyer

Do you want to be part of a
psychology study?
You could win one of two $100 Myer gift
vouchers.
My name is Lauren McGillivray and I am a PhD student in Clinical Psychology at Edith
Cowan University. I am studying people’s ability to connect with and talk about their
emotions. People who experience difficulties with emotion may also have problems with
other aspects of their lives. Emotion is an important area in mental health and this study
will help inform future therapeutic applications.
If you are over the age of 18 year, your participation would be greatly appreciated. You
will need to complete a short online survey, which will take approximately 20 minutes.
Go to the following website to learn more:

“URL link”
Thank you for your time!

This study has been approved by the Edith Cowan University Human Research Ethics
Committee. Your participation can be anonymous - your contact details are not
required, unless you enter the prize draw. All information will remain strictly
confidential.
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Appendix G
Information Sheet for Community Participants

Thank you for your interest. My name is Lauren McGillivray and I am a PhD candidate
studying Clinical Psychology at Edith Cowan University. My research, titled Alexithymia in a
psychiatric population: stability and relationship with therapeutic outcome, involves an
investigation into the relationship between Alexithymia (a deficit in identifying and
describing emotion) and therapeutic intervention. Although this research is primarily focused
on the psychiatric population, for one of my studies I require student and community
participants as a comparison sample, which is where I need your help.
Please note that this project has received ethical approval from the Faculty of Computing
Health and Science Ethics Committee at Edith Cowan University.
This survey includes three sections for you to complete: one demographic questionnaire and
two assessments.
If you choose to participate in this project, you may enter into the draw to win one of
two $100 Myer gift vouchers.
Please note that your contact details are not required unless you enter the draw to win a $100
Myer gift voucher. In this case, you will be required to send an email to an address separate
from this survey, thus your details will not be linked back to any assessment results. Any
information collected will remain strictly confidential, between my supervisors and me, with
any identifying information being erased from the final project.
You may quit the survey at any time before submission without consequence. However, it
would be beneficial for the research if you could take the time to answer all of the questions:
there are no right or wrong answers.
Participants will be able to access results of the final research project. If you have any
questions or concerns please feel free to email me at lmcgilli@our.ecu.edu.au or call my
supervisors: Dr. Rodrigo Becerra and Dr. Craig Harms on (08) 6304 2786 and (08) 6304
5715, respectively. Alternatively, if you wish to contact someone who is not connected with
this study, please call the ECU ethics research officer, Kim Griftkins on (08) 6304 2170.
Thank you for reading this information and I hope you can participate in my study.

Kind regards
Lauren McGillivray
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Appendix H
Counselling and Support Organisations for Community Participants

Centrecare
Confidential counselling service
Ph: (08) 9325 6644
Email: www.centrecare.com.au

Crisis Care
Confidential counselling service
Ph: (08) 9223 1111 (24hr)
Email: www.dcp.wa.gov.au/crisisandemergency/pages/crisiscare.aspx

Lifeline
Confidential telephone counselling service
Ph: 13 11 14 (24hr)
Email: www.lifeline.org.au

Edith Cowan University Psychological Services
Confidential counselling service
Joondalup House, 8 Davidson Terrace, Joondalup
Ph: (08) 9301 0011
Email: www.ecu.edu.au/schools/psychology-and-social-science/facilities

Edith Cowan University Student Counselling Service
Confidential counselling service for ECU students on all campuses
Ph: (08) 9370 6706
Email: student.ecu.edu.au/support/counselling
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